<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Mycopathologia</journal-id>
<journal-id journal-id-type="iso-abbrev">Mycopathologia</journal-id>
<journal-title-group>
<journal-title>Mycopathologia</journal-title>
</journal-title-group>
<issn pub-type="ppub">0301-486X</issn>
<issn pub-type="epub">1573-0832</issn>
<publisher>
<publisher-name>Springer Netherlands</publisher-name>
<publisher-loc>Dordrecht</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31894501</article-id>
<article-id pub-id-type="pmc">7223441</article-id>
<article-id pub-id-type="publisher-id">413</article-id>
<article-id pub-id-type="doi">10.1007/s11046-019-00413-z</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>The Mycobiome in Health and Disease: Emerging Concepts, Methodologies and Challenges</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Tiew</surname>
<given-names>Pei Yee</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Mac Aogain</surname>
<given-names>Micheál</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ali</surname>
<given-names>Nur A’tikah Binte Mohamed</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Thng</surname>
<given-names>Kai Xian</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Goh</surname>
<given-names>Karlyn</given-names>
</name>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lau</surname>
<given-names>Kenny J. X.</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0417-7607</contrib-id>
<name>
<surname>Chotirmall</surname>
<given-names>Sanjay H.</given-names>
</name>
<address>
<email>schotirmall@ntu.edu.sg</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.59025.3b</institution-id><institution-id institution-id-type="ISNI">0000 0001 2224 0361</institution-id><institution>Lee Kong Chian School of Medicine, </institution><institution>Nanyang Technological University, </institution></institution-wrap>11 Mandalay Road, Singapore, 308232 Singapore </aff>
<aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.163555.1</institution-id><institution-id institution-id-type="ISNI">0000 0000 9486 5048</institution-id><institution>Department of Respiratory and Critical Care Medicine, </institution><institution>Singapore General Hospital, </institution></institution-wrap>Singapore, Singapore </aff>
<aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.59025.3b</institution-id><institution-id institution-id-type="ISNI">0000 0001 2224 0361</institution-id><institution>School of Biological Sciences, </institution><institution>Nanyang Technological University, </institution></institution-wrap>Singapore, Singapore </aff>
<aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.59025.3b</institution-id><institution-id institution-id-type="ISNI">0000 0001 2224 0361</institution-id><institution>Singapore Centre for Environmental Life Sciences Engineering, </institution><institution>Nanyang Technological University, </institution></institution-wrap>Singapore, Singapore </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>1</day>
<month>1</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="ppub">
<year>2020</year>
</pub-date>
<volume>185</volume>
<issue>2</issue>
<fpage>207</fpage>
<lpage>231</lpage>
<history>
<date date-type="received">
<day>15</day>
<month>7</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>2</day>
<month>12</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>© Springer Nature B.V. 2020</copyright-statement>
<license>
<license-p>This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<p id="Par1">Fungal disease is an increasingly recognised global clinical challenge associated with high mortality. Early diagnosis of fungal infection remains problematic due to the poor sensitivity and specificity of current diagnostic modalities. Advances in sequencing technologies hold promise in addressing these shortcomings and for improved fungal detection and identification. To translate such emerging approaches into mainstream clinical care will require refinement of current sequencing and analytical platforms, ensuring standardisation and consistency through robust clinical benchmarking and its validation across a range of patient populations. In this state-of-the-art review, we discuss current diagnostic and therapeutic challenges associated with fungal disease and provide key examples where the application of sequencing technologies has potential diagnostic application in assessing the human ‘mycobiome’. We assess how ready access to fungal sequencing may be exploited in broadening our insight into host–fungal interaction, providing scope for clinical diagnostics and the translation of emerging mycobiome research into clinical practice.</p>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>Mycobiome</kwd>
<kwd>ITS sequencing</kwd>
<kwd>Metagenomics</kwd>
<kwd>Bioinformatics</kwd>
<kwd>Clinical</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution>National Medical Research Council Singapore</institution>
</funding-source>
<award-id>NMRC/Fellowship/0049/2017</award-id>
<award-id>MOH-000141</award-id>
<principal-award-recipient>
<name>
<surname>Tiew</surname>
<given-names>Pei Yee</given-names>
</name>
<name>
<surname>Chotirmall</surname>
<given-names>Sanjay H.</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution>Singapore Ministry of Education</institution>
</funding-source>
<award-id>2016-T1-001-050</award-id>
<principal-award-recipient>
<name>
<surname>Chotirmall</surname>
<given-names>Sanjay H.</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001475</institution-id>
<institution>Nanyang Technological University</institution>
</institution-wrap>
</funding-source>
<award-id>NIM/03/2018</award-id>
<principal-award-recipient>
<name>
<surname>Chotirmall</surname>
<given-names>Sanjay H.</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution>Nanyang Technological University (SG)</institution>
</funding-source>
<award-id>ARISE/2017/6</award-id>
<principal-award-recipient>
<name>
<surname>Chotirmall</surname>
<given-names>Sanjay H.</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© Springer Nature B.V. 2020</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1">
<title>Introduction</title>
<p id="Par2">Fungal disease affects over 300 million people worldwide causing over 1.6 million deaths annually [<xref ref-type="bibr" rid="CR1">1</xref>]. Despite their natural environmental abundance, few fungi are human pathogens, and while fulminant fungal infection is uncommon in the healthy individuals, invasive fungal disease is a concern in the immuno-compromised host with significant associated morbidity and mortality [<xref ref-type="bibr" rid="CR2">2</xref>]. Increasing numbers of patients are at risk of invasive fungal disease including those with human immunodeficiency virus (HIV), malignancy and transplant recipients on immunosuppressive or immunomodulatory therapies, each contributing to the rising global trend of fungal infections among susceptible populations. Global warming and climate change also have significant impacts on the pathogenicity and survival of fungi [<xref ref-type="bibr" rid="CR3">3</xref>]. Acclimatisation to higher temperatures increases their ability to replicate in the human body with high basal temperature, resulting in increased pathogenic potential even for species previously reported as non-pathogenic [<xref ref-type="bibr" rid="CR3">3</xref>]. This impacts fungal distribution where increases in heat-resistant species facilitate human interaction, infection and transmission through skin contact, inhalation and/or ingestion [<xref ref-type="bibr" rid="CR3">3</xref>]. Fungal infection therefore can manifest as superficial infections of the skin, nail, hair and mucous membranes, by dermatophytes and <italic>Candida</italic> spp. or as invasive disease caused by opportunistic and endemic mycoses [<xref ref-type="bibr" rid="CR4">4</xref>]. Superficial disease is generally mild and easily diagnosed with readily available treatment. However, in the immuno-compromised individual, such infections may progress to invasive disease. Opportunistic fungal disease is primarily seen in the immuno-compromised with aspergillosis, candidiasis and cryptococcosis most commonly reported. The annual incidence ranges from 200,000 to 1 million, with high and variable mortality rates ranging from 20 to 90% [<xref ref-type="bibr" rid="CR5">5</xref>]. Table <xref ref-type="table" rid="Tab1">1</xref> and Fig. <xref ref-type="fig" rid="Fig1">1</xref> summarise the most common invasive fungal diseases and the anatomical sites involved. Endemic fungal diseases occur in distinct geographic regions, apparently driven by environment and climate. Irrespective of underlying host immunity, individuals residing in endemic regions are at higher risk of life-threatening disease. Blastomycosis and histoplasmosis are endemic in the Midwestern United States (US), coccidioidomycosis in the Southwestern US, paracoccidioidomycosis in Brazil and talaromycosis in Southeast Asia [<xref ref-type="bibr" rid="CR5">5</xref>]. Worryingly, endemic fungal disease continues to propagate even expanding beyond traditional accepted boundaries, again driven at least in part by climate change, urbanisation, land development and ease of travel [<xref ref-type="bibr" rid="CR6">6</xref>]. A key example is the outbreak of <italic>Cryptococcus gattii</italic> at Vancouver Island and the Pacific Northwest of the USA [<xref ref-type="bibr" rid="CR7">7</xref>]. This poses significant and emerging challenges for diagnosis, which in turn delays treatment initiation with adverse clinical consequence.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Review of major invasive fungal disease with organ involvement, disease manifestation, susceptibility, diagnosis and management</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Fungal infection</th><th align="left">Mortality</th><th align="left">Organisms</th><th align="left">Organ involvement</th><th align="left">Disease manifestations</th></tr></thead><tbody><tr><td align="left" rowspan="4">Aspergillosis</td><td align="left" rowspan="4">30–95% [<xref ref-type="bibr" rid="CR228">228</xref>]</td><td align="left" rowspan="4"><p><italic>A. fumigatus</italic></p><p><italic>A. niger</italic></p><p><italic>A. flavus</italic></p><p><italic>A. terreus</italic></p></td><td align="left">Pulmonary</td><td align="left">Pneumonia, cavity, aspergilloma, tracheobronchitis [<xref ref-type="bibr" rid="CR229">229</xref>]</td></tr><tr><td align="left">CNS</td><td align="left">Meningitis, meningoencephalitis, cerebral infarction, haemorrhage, mycotic aneurysm [<xref ref-type="bibr" rid="CR232">232</xref>]</td></tr><tr><td align="left">GIT</td><td align="left">Intestinal oedema, obstruction, haemorrhage, perforation [<xref ref-type="bibr" rid="CR233">233</xref>]</td></tr><tr><td align="left">Cutaneous</td><td align="left">Pustules, haemorrhagic bulla, ulcerative lesion, cellulitis, abscess [<xref ref-type="bibr" rid="CR234">234</xref>]</td></tr><tr><td align="left" rowspan="6">Candidiasis</td><td align="left" rowspan="6">19–30% [<xref ref-type="bibr" rid="CR235">235</xref>, <xref ref-type="bibr" rid="CR236">236</xref>]</td><td align="left" rowspan="6"><p><italic>C. albican</italic></p><p><italic>C. tropicalis</italic></p><p><italic>C.glabrata</italic></p><p><italic>C. krusei</italic></p><p><italic>C. parapsilosis</italic></p></td><td align="left">Blood</td><td align="left">Candidaemia [<xref ref-type="bibr" rid="CR237">237</xref>]</td></tr><tr><td align="left">Pulmonary</td><td align="left">Pneumonia [<xref ref-type="bibr" rid="CR237">237</xref>]</td></tr><tr><td align="left">CNS</td><td align="left">Meningitis, abscess [<xref ref-type="bibr" rid="CR232">232</xref>]</td></tr><tr><td align="left">Eye</td><td align="left">Chorioretinitis, endophthalmitis [<xref ref-type="bibr" rid="CR238">238</xref>]</td></tr><tr><td align="left">GIT</td><td align="left">Peritonitis, oesophagitis, liver abscess [<xref ref-type="bibr" rid="CR237">237</xref>]</td></tr><tr><td align="left">Mucosal</td><td align="left">Oral, vulvovaginal candidiasis [<xref ref-type="bibr" rid="CR237">237</xref>]</td></tr><tr><td align="left" rowspan="3">Cryptococcosis</td><td align="left" rowspan="3">20–70% [<xref ref-type="bibr" rid="CR228">228</xref>]</td><td align="left" rowspan="3"><p><italic>C. neoformans</italic></p><p><italic>C. gattii</italic></p></td><td align="left">Pulmonary</td><td align="left">Cryptococcoma, pneumonia [<xref ref-type="bibr" rid="CR239">239</xref>]</td></tr><tr><td align="left">CNS</td><td align="left">Meningitis, cerebral cryptococcoma [<xref ref-type="bibr" rid="CR232">232</xref>]</td></tr><tr><td align="left">Cutaneous</td><td align="left">Nodules, ulcerated lesion [<xref ref-type="bibr" rid="CR239">239</xref>]</td></tr><tr><td align="left" rowspan="4">Mucormycosis</td><td align="left" rowspan="4"><p>46–96%</p><p>[<xref ref-type="bibr" rid="CR241">241</xref>]</p></td><td align="left" rowspan="4"><p><italic>Rhizopus</italic> spp.</p><p><italic>Mucor</italic> spp.</p><p><italic>Rhizomucor</italic> spp.</p><p><italic>Lichtheimia</italic> spp.</p></td><td align="left">Rhino-cerebral</td><td align="left">Sinusitis, meningitis, orbital oedema, cellulitis, nasal necrotic/ulcerative lesion [<xref ref-type="bibr" rid="CR242">242</xref>]</td></tr><tr><td align="left">Pulmonary</td><td align="left">Pneumonia, cavity, nodules, mass [<xref ref-type="bibr" rid="CR243">243</xref>]</td></tr><tr><td align="left">Cutaneous</td><td align="left">Nodules, ulcer, scaly plaques, cellulitis, necrotic eschar [<xref ref-type="bibr" rid="CR244">244</xref>]</td></tr><tr><td align="left">GIT</td><td align="left">Necrotising enterocolitis, intestinal perforation, ulceration [<xref ref-type="bibr" rid="CR245">245</xref>]</td></tr><tr><td align="left" rowspan="2">Pneumocystis</td><td align="left" rowspan="2">20–80% [<xref ref-type="bibr" rid="CR228">228</xref>]</td><td align="left" rowspan="2"><italic>P. jirovecii</italic></td><td align="left">Pulmonary</td><td align="left">Pneumonia [<xref ref-type="bibr" rid="CR9">9</xref>]</td></tr><tr><td align="left">Extra-pulmonary</td><td align="left">Eye, ear, thyroid, GIT, bone marrow, muscle, lymph node involvement [<xref ref-type="bibr" rid="CR247">247</xref>, <xref ref-type="bibr" rid="CR248">248</xref>]</td></tr><tr><td align="left" rowspan="5">Blastomycosis</td><td align="left" rowspan="5">0.06–68% [<xref ref-type="bibr" rid="CR228">228</xref>, <xref ref-type="bibr" rid="CR249">249</xref>]</td><td align="left" rowspan="5"><p><italic>B. dermatitidis</italic></p><p><italic>B. gilchristii</italic></p></td><td align="left">CNS</td><td align="left">Meningitis, brain and epidural abscess [<xref ref-type="bibr" rid="CR250">250</xref>]</td></tr><tr><td align="left">Cutaneous</td><td align="left">Papulopustular, ulcerative, verrucous, crusted lesions</td></tr><tr><td align="left">GUT</td><td align="left">Prostatitis, epididymitis, tubo-ovarian abscess, endometritis, salpingitis</td></tr><tr><td align="left">Pulmonary</td><td align="left">Pneumonia</td></tr><tr><td align="left">Bone</td><td align="left">Osteomyelitis</td></tr><tr><td align="left" rowspan="4">Histoplasmosis</td><td align="left" rowspan="4">5–60% [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR228">228</xref>, <xref ref-type="bibr" rid="CR252">252</xref>]</td><td align="left" rowspan="4"><italic>H. capsulatum</italic></td><td align="left">Pulmonary</td><td align="left">Pneumonia, nodule, cavity, fibrosing mediastinitis, broncholithiasis [<xref ref-type="bibr" rid="CR225">225</xref>, <xref ref-type="bibr" rid="CR253">253</xref>, <xref ref-type="bibr" rid="CR254">254</xref>]</td></tr><tr><td align="left">Cutaneous</td><td align="left">Erythema nodosum, erythema multiforme [<xref ref-type="bibr" rid="CR227">227</xref>]</td></tr><tr><td align="left">CNS</td><td align="left">Meningitis, parenchymal lesion [<xref ref-type="bibr" rid="CR227">227</xref>, <xref ref-type="bibr" rid="CR232">232</xref>]</td></tr><tr><td align="left">GIT</td><td align="left">Ulceration, stricture [<xref ref-type="bibr" rid="CR227">227</xref>]</td></tr><tr><td align="left" rowspan="4">Coccidioidomycosis</td><td align="left" rowspan="4">1–70% [<xref ref-type="bibr" rid="CR228">228</xref>]</td><td align="left" rowspan="4"><p>Coccidioides immitis</p><p><italic>Coccidioides posadasii</italic></p></td><td align="left">Pulmonary</td><td align="left">Pneumonia, nodules, cavity [<xref ref-type="bibr" rid="CR256">256</xref>]</td></tr><tr><td align="left">Cutaneous</td><td align="left">Erythema nodosum, erythema multiforme, nodule, plaque, papules [<xref ref-type="bibr" rid="CR258">258</xref>]</td></tr><tr><td align="left">Bone and Joint</td><td align="left">Osteomyelitis, arthritis, abscess [<xref ref-type="bibr" rid="CR259">259</xref>, <xref ref-type="bibr" rid="CR260">260</xref>]</td></tr><tr><td align="left">CNS</td><td align="left">Meningitis [<xref ref-type="bibr" rid="CR256">256</xref>]</td></tr><tr><td align="left" rowspan="5">Paracoccidioidomycosis</td><td align="left" rowspan="5">65–27% [<xref ref-type="bibr" rid="CR228">228</xref>, <xref ref-type="bibr" rid="CR261">261</xref>]</td><td align="left" rowspan="5"><p><italic>P. brasiliensis</italic></p><p><italic>P. lutzii</italic></p></td><td align="left">Pulmonary</td><td align="left">Pneumonia, nodule, cavity, emphysema, fibrosis, pleural effusion, miliary-like shadow [<xref ref-type="bibr" rid="CR262">262</xref>, <xref ref-type="bibr" rid="CR263">263</xref>]</td></tr><tr><td align="left">Cutaneous</td><td align="left">Ulcerated lesion, abscess [<xref ref-type="bibr" rid="CR227">227</xref>]</td></tr><tr><td align="left">Mucosa</td><td align="left">Oral ulcer, gingivostomatitis [<xref ref-type="bibr" rid="CR227">227</xref>]</td></tr><tr><td align="left">Lymph node</td><td align="left">Lymphadenopathy [<xref ref-type="bibr" rid="CR227">227</xref>]</td></tr><tr><td align="left">CNS</td><td align="left">Meningitis, CNS granuloma, abscess [<xref ref-type="bibr" rid="CR227">227</xref>, <xref ref-type="bibr" rid="CR232">232</xref>]</td></tr><tr><td align="left" rowspan="4">Talaromycosis</td><td align="left" rowspan="4">2–75% (6)</td><td align="left" rowspan="4"><italic>T. marneffe</italic></td><td align="left">Cutaneous</td><td align="left">Subcutaneous abscesses, papule-like ulcers, molluscum-contagiosum-like lesion [<xref ref-type="bibr" rid="CR264">264</xref>]</td></tr><tr><td align="left">Lymph node</td><td align="left">Lymphadenopathy [<xref ref-type="bibr" rid="CR9">9</xref>]</td></tr><tr><td align="left">Pulmonary</td><td align="left">Diffuse reticular infiltrates, cavity, localised alveolar infiltrates [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR264">264</xref>]</td></tr><tr><td align="left">GIT</td><td align="left">Hepatosplenomegaly, Intestinal [<xref ref-type="bibr" rid="CR267">267</xref>, <xref ref-type="bibr" rid="CR268">268</xref>]</td></tr></tbody></table><table frame="hsides" rules="groups"><thead><tr><th align="left">Fungal infection</th><th align="left">Susceptible host</th><th align="left">Diagnosis (specific assays) [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR225">225</xref>–<xref ref-type="bibr" rid="CR227">227</xref>]</th><th align="left">Diagnosis (general assays) [<xref ref-type="bibr" rid="CR28">28</xref>]</th><th align="left">Treatment</th></tr></thead><tbody><tr><td align="left">Aspergillosis</td><td align="left"><p>Immuno-compromised</p><p>ICU/critically ill</p><p>COPD</p></td><td align="left"><p>Galactomannan (serum, BAL, CSF)</p><p>Lateral-flow device antigen detection (serum, BAL)</p><p>PCR</p></td><td align="left"><p>Serum beta glucan</p><p>Histopathology</p><p>Culture</p></td><td align="left"><p>First line: voriconazole [<xref ref-type="bibr" rid="CR230">230</xref>], isavuconazole [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR231">231</xref>]</p><p>Severe: liposomal amphotericin</p><p>Alternative: itraconazole, posaconazole, micafungin [<xref ref-type="bibr" rid="CR230">230</xref>]</p></td></tr><tr><td align="left">Candidiasis</td><td align="left"><p>Immuno-compromise</p><p>Invasive procedure and surgery</p><p>Trauma or burn</p><p>Prolong ICU stay</p></td><td align="left"><p><italic>Candida albicans</italic> germ tube antibody (CAGTA) assay</p><p>Mannan-Ag and mannan-Ab</p><p>PCR</p></td><td align="left"><p>Histopathology</p><p>Culture</p><p>Serum beta glucan</p></td><td align="left"><p>First line: echinocandin [<xref ref-type="bibr" rid="CR30">30</xref>]</p><p>Alternative: fluconazole, voriconazole, amphotericin [<xref ref-type="bibr" rid="CR30">30</xref>]</p></td></tr><tr><td align="left">Cryptococcosis</td><td align="left">Both immune-compromised and immunocompetent host</td><td align="left">Cryptococcal antigen test (CSF, serum)</td><td align="left"><p>Histopathology</p><p>Culture</p></td><td align="left"><p>First line: amphotericin +flucytosine, fluconazole [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR240">240</xref>]</p><p>Alternative: itraconazole</p></td></tr><tr><td align="left">Mucormycosis</td><td align="left"><p>Diabetes</p><p>Immuno-compromised</p><p>Trauma or burn</p></td><td align="left">PCR</td><td align="left"><p>Histopathology</p><p>Culture</p></td><td align="left"><p>First line: liposomal amphotericin</p><p>Alternative: posaconazole [<xref ref-type="bibr" rid="CR226">226</xref>], isavuconazole [<xref ref-type="bibr" rid="CR237">237</xref>]</p></td></tr><tr><td align="left">Pneumocystis</td><td align="left">Immuno-compromised</td><td align="left">PCR</td><td align="left"><p>Histopathology</p><p>Serum Beta glucan</p></td><td align="left"><p>First line: trimethoprim/sulfamethoxazole [<xref ref-type="bibr" rid="CR9">9</xref>]</p><p>Alternative: primaquine + clindamycin, pentamidine [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR246">246</xref>]</p></td></tr><tr><td align="left">Blastomycosis</td><td align="left">Both immune-compromised and immunocompetent host at the endemic region</td><td align="left"><p>Antibody test (serum)</p><p>Antigen test (urine)</p></td><td align="left"><p>Histopathology</p><p>Culture</p></td><td align="left"><p>Severe: amphotericin</p><p>Mild to moderate: itraconazole [<xref ref-type="bibr" rid="CR251">251</xref>]</p></td></tr><tr><td align="left">Histoplasmosis</td><td align="left">Both immune-compromised and immunocompetent host at the endemic region</td><td align="left"><p>Antibody test (serum)</p><p>Antigen test (urine, serum)</p></td><td align="left"><p>Histopathology</p><p>Culture</p></td><td align="left"><p>Severe: liposomal amphotericin [<xref ref-type="bibr" rid="CR225">225</xref>]</p><p>Mild to moderate: itraconazole [<xref ref-type="bibr" rid="CR255">255</xref>]</p><p>Mild disease treatment is usually not require [<xref ref-type="bibr" rid="CR255">255</xref>]</p></td></tr><tr><td align="left">Coccidioidomycosis</td><td align="left">Both immune-compromised and immunocompetent host at the endemic region</td><td align="left">Antibody test (serum)</td><td align="left"><p>Histopathology</p><p>Culture</p></td><td align="left"><p>First line: fluconazole/itraconazole [<xref ref-type="bibr" rid="CR257">257</xref>]</p><p>Severe: amphotericin [<xref ref-type="bibr" rid="CR257">257</xref>]</p></td></tr><tr><td align="left">Paracoccidioidomycosis</td><td align="left">Both immune-compromised and immunocompetent host at the endemic region</td><td align="left">Antibody test (serum)</td><td align="left"><p>Histopathology</p><p>Culture</p></td><td align="left"><p>First line: itraconazole [<xref ref-type="bibr" rid="CR225">225</xref>, <xref ref-type="bibr" rid="CR227">227</xref>]</p><p>Severe: amphotericin [<xref ref-type="bibr" rid="CR225">225</xref>, <xref ref-type="bibr" rid="CR227">227</xref>]</p><p>Alternative: trimethoprim/sulfamethoxazole, voriconazole, posaconazole, isavuconazole [<xref ref-type="bibr" rid="CR227">227</xref>]</p></td></tr><tr><td align="left">Talaromycosis</td><td align="left">Immuno-compromised</td><td align="left"><p>PCR</p><p>Serology (not widely available)</p></td><td align="left"><p>Histopathology</p><p>Culture</p><p>Galactomannan</p></td><td align="left"><p>First line: liposomal amphotericin and itraconazole [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR265">265</xref>]</p><p>Alternative: voriconazole [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR266">266</xref>]</p></td></tr></tbody></table><table-wrap-foot><p><italic>CNS</italic> central nervous system, <italic>GIT</italic> gastrointestinal tract, <italic>ICU</italic> intensive care unit, <italic>COPD</italic> chronic obstructive pulmonary disease, <italic>BAL</italic> bronchoalveolar lavage, <italic>CSF</italic> cerebrospinal fluid, <italic>PCR</italic> polymerase chain reaction</p></table-wrap-foot></table-wrap><fig id="Fig1"><label>Fig. 1</label><caption><p>Overview of the mycobiome in healthy and diseased states. Purple arrow: cross-talk between lung and gut; grey arrow: dysbiosis. COPD: chronic obstructive pulmonary disease; HIV: human immunodeficiency virus; IBD: inflammatory bowel disease; IBS: irritable bowel syndrome; down arrow: decreased abundance</p></caption><graphic id="MO1" xlink:href="11046_2019_413_Fig1_HTML"></graphic></fig></p>
</sec>
<sec id="Sec2">
<title>Diagnostic and Treatment Challenges in Fungal Infection</title>
<p>The early diagnosis and initiation of therapy for fungal infection is critical, influencing outcome and mortality, particularly in the immuno-compromised [<xref ref-type="bibr" rid="CR8">8</xref>–<xref ref-type="bibr" rid="CR10">10</xref>]. Current available diagnostic modalities lack sensitivity and specificity, and therefore the diagnosis of invasive fungal disease relies on a combined clinical, microbiological and radiological approach with empirical treatment often initiated based on clinical judgment alone pending diagnostic confirmation [<xref ref-type="bibr" rid="CR11">11</xref>]. Patient characteristics including the presence or absence of neutropenia or use of antifungal prophylaxis impact the diagnostic accuracy of tests, adding additional uncertainty [<xref ref-type="bibr" rid="CR12">12</xref>–<xref ref-type="bibr" rid="CR14">14</xref>]. The ability to distinguish infection from colonisation poses an additional and important clinical challenge. Conventional culture methods provide species-level identification and information on antifungal susceptibility. However, culture-based methods are poorly sensitive and delay time to diagnosis [<xref ref-type="bibr" rid="CR15">15</xref>–<xref ref-type="bibr" rid="CR17">17</xref>]. Their accuracy is contingent on sample source, type of fungus, as well as disease and host immune status. For instance, <italic>Pneumocystis</italic> species are unable to grow on culture media [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>] and isolation of <italic>Aspergillus</italic> in blood is uncommon and ineffective for the diagnosis of invasive aspergillosis [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR20">20</xref>]. In addition, positive cultures obtained from non-sterile body sites may not be representative and should be interpreted with caution. Direct microscopic examination is useful in providing rapid and more accurate diagnosis of fungal infection allowing differentiation by their morphology and staining [<xref ref-type="bibr" rid="CR21">21</xref>]. However, as with culture, the diagnostic yield is contingent on several factors and exhibits variable accuracy [<xref ref-type="bibr" rid="CR22">22</xref>]. Non-culture-based techniques are increasingly employed to aid the diagnosis of invasive fungal disease. For example, detection of β-glucan, a component of the fungal cell wall, identifies patients with invasive disease with sensitivities ranging from 50–100% and specificities of 44–98% [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR24">24</xref>]. The high false positive rate, however, limits the usefulness of this approach particularly in high-risk patient groups including patients with haematological malignancy, stem cell and lung transplant recipients, where co-existing bacterial infection is present and in those receiving haemodialysis [<xref ref-type="bibr" rid="CR25">25</xref>–<xref ref-type="bibr" rid="CR27">27</xref>]. While β-glucan is a useful diagnostic target, it is not specific to any single fungal species and may be detectable across a range of fungal infections including invasive aspergillosis, candidiasis, and cryptococcosis. Galactomannan (GM) is another commonly used marker for the diagnosis of invasive aspergillosis in patients with haematological malignancy and/or neutropenia with sensitivities and specificities of 79–96% and 74–99%, respectively [<xref ref-type="bibr" rid="CR23">23</xref>]. However, sensitivity decreases with use of antifungal agents and among non-neutropenic patients [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR24">24</xref>]. Serological testing is another option available for a range of fungal infections including candidiasis, cryptococcosis and endemic mycoses with diagnostic accuracies varying based on the type of fungal organism and sample source. While providing a good diagnostic yield for histoplasmosis and coccidioidomycosis, it is not particularly useful for the diagnosis of invasive aspergillosis [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR28">28</xref>]. Polymerase chain reaction (PCR) provides an alternative, more rapid and accurate diagnostic tool for the detection of fungal infection [<xref ref-type="bibr" rid="CR29">29</xref>]. Numerous PCR assays are described with variations in primer sequence, DNA extraction method, positivity thresholds and assay performance, which coupled with limited multi-centre clinical validation, has curtailed widespread adoption [<xref ref-type="bibr" rid="CR28">28</xref>–<xref ref-type="bibr" rid="CR31">31</xref>]. Importantly, false positive results are common as fungi are ubiquitous and contamination possible at various sample processing stages necessitating rigorous and costly quality control processes [<xref ref-type="bibr" rid="CR32">32</xref>]. Next-generation sequencing (NGS) is increasingly used in epidemiological studies and during infectious disease outbreaks for resolution of species, virulence and antibiotic resistance, to assist infection control and its management [<xref ref-type="bibr" rid="CR33">33</xref>–<xref ref-type="bibr" rid="CR35">35</xref>]. In addition, NGS may be employed in the resolution of cryptic epidemiological cases where it has demonstrated superiority to traditional diagnostic methods in the detection of rare infections [<xref ref-type="bibr" rid="CR36">36</xref>–<xref ref-type="bibr" rid="CR38">38</xref>]. However, demonstration of its utility within the medical diagnostic setting is currently limited. Low abundance of fungi in relation to the overall microbial community (≤ 0.1%) poses challenges to their detection via metagenomic sequencing in human samples, necessitating targeted amplicon sequencing approaches, which are still in their infancy [<xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR40">40</xref>]. Further refinement and standardisation of reproducible wet-lab and bioinformatic workflows coupled to automated and scalable user-friendly reporting systems remain key challenges for the field, which unless addressed, will continue to impede widespread adoption and translation into clinical practice [<xref ref-type="bibr" rid="CR41">41</xref>–<xref ref-type="bibr" rid="CR43">43</xref>].</p>
<p id="Par4">Four distinct classes of antifungal drugs are currently prescribed: the polyenes, flucytosines, azoles and echinocandins. Despite treatment, mortality rates for invasive fungal disease remain high with factors contributing to poor prognosis including delayed diagnosis and initiation of antifungal treatment, host factors, site of infection, emerging antifungal resistance and drug toxicity. Clinical presentation of fungal infection is largely non-specific, and therefore a high index of suspicion is necessary for early diagnosis and initiation of treatment, particularly in the immuno-compromised population. Host factors of relevance include underlying comorbidities and long-term medications that interact with antifungal treatment. This is most marked in concomitant antifungal and antiviral treatments in HIV-related cryptococcus infection, which results in life-threatening inflammation secondary to immune reconstitution. The available tissue concentrations of antifungals also differ according to their chemical and pharmacokinetic properties leading to sub-optimal concentrations, therapeutic failure and the development of resistance in many settings, highlighting the importance of infection site to the appropriate selection of antifungal agent [<xref ref-type="bibr" rid="CR44">44</xref>]. Drug toxicity is a further consideration as treatment is often prolonged and, in those with other comorbidities, increases the risk of drug–drug interactions [<xref ref-type="bibr" rid="CR45">45</xref>]. Antifungal resistance is emerging rapidly, both intrinsic resistance and that driven by the widespread use of antifungal and environmental fungicides [<xref ref-type="bibr" rid="CR46">46</xref>]. Resistance, however, varies based on geographic location, patient demographics and prior drug exposure [<xref ref-type="bibr" rid="CR47">47</xref>, <xref ref-type="bibr" rid="CR48">48</xref>]. Azole resistance in <italic>Candida</italic> and <italic>Aspergillus</italic> spp. ranges from 2.3–40 to 0.85–28%, respectively [<xref ref-type="bibr" rid="CR47">47</xref>, <xref ref-type="bibr" rid="CR49">49</xref>–<xref ref-type="bibr" rid="CR52">52</xref>]. Resistance to echinocandins—first-line antifungal agents for invasive candidiasis—is also described in invasive <italic>Candida glabrata</italic> infections [<xref ref-type="bibr" rid="CR48">48</xref>, <xref ref-type="bibr" rid="CR51">51</xref>, <xref ref-type="bibr" rid="CR53">53</xref>–<xref ref-type="bibr" rid="CR55">55</xref>]. The development of new antifungals with decreased toxicity and broad-spectrum coverage is urgently required to reduce mortality rates, and a better understanding of host–fungal interaction is necessary to facilitate future therapeutic development pipelines. Furthermore, advances in NGS enable identification of antifungal resistance genes, informing our understanding of the resistome and guiding antifungal drug development [<xref ref-type="bibr" rid="CR56">56</xref>–<xref ref-type="bibr" rid="CR58">58</xref>]. In the following sections, we aim to describe our current understanding of the mycobiome in the context of recent NGS advances and the methodological challenges and barriers that exist in terms of its clinical implementation.</p>
</sec>
<sec id="Sec3">
<title>Mycobiome Analysis: Methodologies and Challenges</title>
<sec id="Sec4">
<title>Sample Processing</title>
<p id="Par5">Sample processing including storage conditions and various DNA extraction protocols may inadvertently introduce confounders that affect experimental results (Fig. <xref ref-type="fig" rid="Fig2">2</xref>). To date, studies comparing various methodologies of sample processing demonstrate conflicting results and varying efficacies, with implications for cross-comparisons of published mycobiome research. Freezing samples within 12 h to prevent overgrowth by fast-growing fungi and avoiding multiple freeze–thaw cycles has been advocated [<xref ref-type="bibr" rid="CR59">59</xref>, <xref ref-type="bibr" rid="CR60">60</xref>]. The addition of RNAlater decreases the relative abundance of certain fungal taxa particularly in faecal samples suggesting possible introduction of bias in relative abundance assessments [<xref ref-type="bibr" rid="CR61">61</xref>]. Nevertheless, taxonomic diversity generally remains assessable and largely unaffected by the freezing process [<xref ref-type="bibr" rid="CR61">61</xref>–<xref ref-type="bibr" rid="CR63">63</xref>]. When extracting fungal DNA for mycobiome sequencing, the highly rigid fungal cell wall, rich in glucans, chitin, mannans and glycoproteins, has necessitated additional steps that involve rigorous bead-beating or enzymatic lysis prior to DNA extraction [<xref ref-type="bibr" rid="CR61">61</xref>, <xref ref-type="bibr" rid="CR62">62</xref>, <xref ref-type="bibr" rid="CR64">64</xref>–<xref ref-type="bibr" rid="CR67">67</xref>]. Notably, enzymatic lysis provides an alternative option for increasing DNA yields [<xref ref-type="bibr" rid="CR68">68</xref>–<xref ref-type="bibr" rid="CR70">70</xref>]. The harsher bead-beating method, however, is observed to have conflicting efficacies likely due to DNA degradation [<xref ref-type="bibr" rid="CR71">71</xref>]. Various DNA extraction methods also significantly affect fungal DNA yield and quality with phenol/chloroform extraction often outperforming the various available commercial kits (Fig. <xref ref-type="fig" rid="Fig2">2</xref>) [<xref ref-type="bibr" rid="CR61">61</xref>, <xref ref-type="bibr" rid="CR62">62</xref>, <xref ref-type="bibr" rid="CR65">65</xref>, <xref ref-type="bibr" rid="CR70">70</xref>, <xref ref-type="bibr" rid="CR71">71</xref>]. This loss of DNA using commercial kits is likely related to use of silica column purification [<xref ref-type="bibr" rid="CR71">71</xref>]. DNA extraction kits illustrate inconsistent results when performed with different sample types and produce variable fungal DNA yields [<xref ref-type="bibr" rid="CR70">70</xref>, <xref ref-type="bibr" rid="CR72">72</xref>]. While extraction methods affect DNA yield and quality, their impact on mycobiome composition and diversity appears minor [<xref ref-type="bibr" rid="CR62">62</xref>, <xref ref-type="bibr" rid="CR65">65</xref>, <xref ref-type="bibr" rid="CR71">71</xref>]. However, recent work from our group, using spontaneous induced sputum, has demonstrated more consistent amplification of the ITS region from samples subjected to mechanical disruption as compared to enzymatic lysis [<xref ref-type="bibr" rid="CR40">40</xref>]. This was observed despite higher overall DNA yields achieved by enzymatic lysis suggesting preferential liberation of fungal DNA by mechanical lysis [<xref ref-type="bibr" rid="CR40">40</xref>]. Extraction methods are critical and must be applied consistently and carefully both within and between mycobiome studies. Ultimately, sample-specific mycobiome protocols are required and a need exists to incorporate specific methods adjusted to sample type or disease-specific application, importantly, with validation for routine use in future mycobiome research.<fig id="Fig2"><label>Fig. 2</label><caption><p>Diagram summarising the key challenges in mycobiome sequencing and analysis. PCR: polymerase chain reaction, rRNA: ribosomal ribonucleic acid, ITS: internal transcribed spacer, DNA: deoxyribonucleic acid, OTU: operational taxonomic unit</p></caption><graphic id="MO2" xlink:href="11046_2019_413_Fig2_HTML"></graphic></fig></p>
</sec>
<sec id="Sec5">
<title>Amplicon Sequencing</title>
<p id="Par6">In contrast to high-throughput sequencing (HTS) of the bacterial microbiome, taxonomic classification and primer choice are not well established for the fungal mycobiome (Fig. <xref ref-type="fig" rid="Fig2">2</xref>) [<xref ref-type="bibr" rid="CR60">60</xref>, <xref ref-type="bibr" rid="CR73">73</xref>]. As amplicon sequencing is well recognised to be subject to selective amplification bias, careful consideration of primer selection is crucial [<xref ref-type="bibr" rid="CR74">74</xref>]. Key factors include taxonomic resolution, coverage, accuracy and amplicon length [<xref ref-type="bibr" rid="CR74">74</xref>]. The ITS region, located between genes encoding ribosomal subunits 18S and 23S, has been proposed as the universal genetic fungal barcode, primarily because these regions have high evolutionary rates and are flanked by highly conserved regions serving as suitable target sites for universal primers [<xref ref-type="bibr" rid="CR60">60</xref>, <xref ref-type="bibr" rid="CR73">73</xref>, <xref ref-type="bibr" rid="CR75">75</xref>, <xref ref-type="bibr" rid="CR76">76</xref>]. The ITS region typically spans 500–700 bps, and consists of two sub-regions, ITS1 and ITS2, which are separated by the conserved 5.8S region [<xref ref-type="bibr" rid="CR77">77</xref>]. Although primers targeting ITS1 (i.e. ITS1F and ITS2) have been used for decades in several large-scale microbiome projects, to date, it is still unclear which ITS fragment is optimal. Recent findings demonstrate that these primers suffer from primer bias, amplification bias and fail to accurately profile mock communities analysed, leading to inconsistent representation of synthetic fungal communities of known taxonomic abundance [<xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR74">74</xref>, <xref ref-type="bibr" rid="CR78">78</xref>–<xref ref-type="bibr" rid="CR82">82</xref>]. Based on these observations, Nilsson and colleagues provide a list of fungus specific, HTS-oriented primers for amplification of ITS region, and recommend targeting the ITS2 sub-region by using degenerate forward primers gITS7ngs and the reverse primer ITS4ng owing to their superior coverage of the fungal kingdom [<xref ref-type="bibr" rid="CR60">60</xref>]. Advantages of the ITS2 sub-region include a more universal primer site and lower length variation, leading to less taxonomic bias compared to ITS1 [<xref ref-type="bibr" rid="CR60">60</xref>, <xref ref-type="bibr" rid="CR83">83</xref>, <xref ref-type="bibr" rid="CR84">84</xref>]. While this primer set (gITS7ngs and ITS4ng) has a superior coverage of fungal kingdoms, its accurate taxonomic resolution has yet to be evaluated experimentally [<xref ref-type="bibr" rid="CR82">82</xref>]. Further confirmatory studies are required before the field can advance and eventually reach consensus on methodology for targeted amplicon sequencing of the mycobiome, as has been the case for 16 s rRNA sequencing of bacterial microbiomes. In addition to primer choice, care must be taken to yield fewer compromised amplicon sequences. These include careful consideration of number of PCR cycles and dilution of DNA samples where possible (Fig. <xref ref-type="fig" rid="Fig2">2</xref>) [<xref ref-type="bibr" rid="CR85">85</xref>, <xref ref-type="bibr" rid="CR86">86</xref>]. High fidelity proofreading PCR polymerase with low GC content bias is also necessary to reduce chimeras and random errors that accumulate in later cycles [<xref ref-type="bibr" rid="CR85">85</xref>, <xref ref-type="bibr" rid="CR86">86</xref>]. It is also essential to include appropriate negative controls and a mock community into the analysis. The former indicates sources of potential contamination, while the latter allows assessment of chimera formation, quantification of index switching and operational taxonomic unit (OTU) inference stringency (Fig. <xref ref-type="fig" rid="Fig2">2</xref>) [<xref ref-type="bibr" rid="CR85">85</xref>, <xref ref-type="bibr" rid="CR87">87</xref>, <xref ref-type="bibr" rid="CR88">88</xref>].</p>
</sec>
<sec id="Sec6">
<title>Metagenomic Shotgun Sequencing</title>
<p id="Par7">An alternative approach to targeted amplicon sequencing is the use of whole-genome shotgun (WGS) metagenomics to study the mycobiome. This entails the sequencing of all extracted DNA in a given sample without the use of targeted PCR amplification of the ITS or other specific target sequences. Here, all DNA from resident microbes and host cells present in a sample is assessed. Sequence reads are processed and classified relative to a reference database through either assembly-based or assembly-free methods [<xref ref-type="bibr" rid="CR89">89</xref>]. Analysis will usually also include steps for removal of host DNA sequences, which may contribute to a significant proportion of sequence data if removal of human cells is not attempted prior to DNA extraction [<xref ref-type="bibr" rid="CR90">90</xref>]. While, in principle, metagenomic sequencing should provide a superior, unbiased assessment of the mycobiome, studies to date employing WGS metagenomics highlight the low abundance of fungi relative to bacterial DNA across a variety of human samples (Fig. <xref ref-type="fig" rid="Fig2">2</xref>) [<xref ref-type="bibr" rid="CR39">39</xref>]. This represents a significant cost barrier given the sequencing depth therefore required to detect fungi in samples where bacteria predominate while lower sequencing coverage also hinders assembly-based analysis of fungi [<xref ref-type="bibr" rid="CR89">89</xref>]. Currently, it appears that low fungal abundance in human samples hinders the widespread application of metagenomic WGS in human samples, a finding that appears unrelated to DNA extraction methods and reflects a genuinely low overall in vivo fungal abundance [<xref ref-type="bibr" rid="CR63">63</xref>].</p>
</sec>
<sec id="Sec7">
<title>Bioinformatic Challenges</title>
<p id="Par8">The development of tools for the analysis of ITS-derived amplicon sequences is still a nascent area of research, and many options are available for the analysis of metabarcoding amplicon data sets [<xref ref-type="bibr" rid="CR29">29</xref>]. While the field still has no consensus on standards and best practices, further studies are clearly required, and no optimal, broadly applicable protocol has been yet established. Further, it is probable that amplicon sequencing and its accompanying analysis largely depend on the samples under investigation due to variable primer coverage, as demonstrated for comparable bacterial microbiome analysis targeting the 16 s rRNA gene [<xref ref-type="bibr" rid="CR91">91</xref>]. The increased variability of the fungal ITS region exacerbates this problem in the case of mycobiome research, and this requires careful consideration when interpreting ITS-derived mycobiome profiles. A further analytic hurdle of mycobiome metagenomic analyses remains the sparsely populated fungal databases on which read classifications are based (Fig. <xref ref-type="fig" rid="Fig2">2</xref>). This leads to large numbers of unclassified reads or unidentified operational taxonomic units (OTUs), which may be addressed by generation of more high-quality metagenomic and whole-fungal genome assemblies [<xref ref-type="bibr" rid="CR63">63</xref>, <xref ref-type="bibr" rid="CR92">92</xref>]. Major fungal ITS reference databases include the INSDC, UNITE and Warcup ITS [<xref ref-type="bibr" rid="CR60">60</xref>]. Although accurate species-level classification is not possible using the ITS regions, there are currently no known alternate markers offering comparable lineage separation, while reported taxonomic thresholds for filamentous fungal identification at the genus, family, order and class levels are estimated at 94.3%, 88.5%, 81.2% and 80.9%, respectively [<xref ref-type="bibr" rid="CR60">60</xref>, <xref ref-type="bibr" rid="CR93">93</xref>]. The increased accessibility of third-generation long-read sequencing offers promise in this regard as the large stretches of repetitive and non-coding DNA as well as intron-containing genes found in fungal genomes can be resolved by these technologies which may also be applied to targeted sequencing of the ITS [<xref ref-type="bibr" rid="CR60">60</xref>, <xref ref-type="bibr" rid="CR63">63</xref>]. Although the literature on fungal metagenomics is lacking, two key studies (Nash et al. and Donovan et al.) represent the most in-depth assessment to date in terms of metagenomic identification of fungi in human samples [<xref ref-type="bibr" rid="CR63">63</xref>, <xref ref-type="bibr" rid="CR94">94</xref>]. Nash et al. performed a large assessment of gut samples from the human microbiome project, performing both metagenomic analysis and comparative ITS sequencing. Importantly, they showed that DNA extraction methods did not have appreciable effects on the levels of fungi detected, re-affirming the apparent low abundance of fungi in these samples. Secondly, they performed a comparative analysis of ITS and 18 s targeted sequencing protocols demonstrating that ITS2-targeting primers showed greater resolution of low-abundance taxa [<xref ref-type="bibr" rid="CR63">63</xref>]. The work of Donovan and colleagues is notable for their bioinformatic dissection of the challenges inherent to analysis of the fungal metagenome. They present a solution in the form of the ‘FindFungi’ pipeline, which highlights the challenges of fungal metagenomic analysis including false positive detection, for which they developed an important step to identify uneven read distribution across reference genomes indicating spurious fungal detection [<xref ref-type="bibr" rid="CR94">94</xref>]. Finally, an additional challenge that remains is the implementation of these bioinformatic pipelines, which, necessitates execution on high-performance computing clusters due to the requirement to hold large genomic databases in memory (Fig. <xref ref-type="fig" rid="Fig2">2</xref>). Such computation requires domain expertise that may not be widely available to fungal research laboratories and remains an operational and logistical challenge.</p>
</sec>
<sec id="Sec8">
<title>Comparison with Culture and Other Fungal Detection Methodologies</title>
<p id="Par9">Culture-based methods of detection require a priori selection of fungal growth conditions and are susceptible to bacterial overgrowth hindering the proliferation of selected fungi leading to bias. In addition, culture-based methods are prone to cross-contamination of spore-producing fungi, which can be minimised by the use of horizontal laminar flow clean bench [<xref ref-type="bibr" rid="CR95">95</xref>, <xref ref-type="bibr" rid="CR96">96</xref>]. While the addition of antibiotics to culture media is commonly employed to prevent bacterial contamination, its drawbacks include limited antibacterial spectrum, and its potential inhibitory effect on fungi [<xref ref-type="bibr" rid="CR97">97</xref>–<xref ref-type="bibr" rid="CR99">99</xref>]. Results from culture methods may be difficult to cross compare with the existing literature given heterogeneity of methodology and study designs as well as sample pre-processing protocols, thereby requiring a standardised protocol for detecting key fungal pathogens [<xref ref-type="bibr" rid="CR100">100</xref>, <xref ref-type="bibr" rid="CR101">101</xref>]. However, culture-based methods do allow for an assessment of antifungal susceptibilities and the isolates obtained by culture provides scope for further molecular characterisation. Numerous culture-independent approaches have been developed to overcome the limitations of culture-based methodology but are not without their disadvantages. Internal transcribed spacer-polymerase chain reaction (ITS-PCR) approaches could be used to detect mixed infections; however, careful target selection is necessary [<xref ref-type="bibr" rid="CR76">76</xref>, <xref ref-type="bibr" rid="CR102">102</xref>–<xref ref-type="bibr" rid="CR104">104</xref>]. In some cases, ITS-PCR may appear even less reliable than culture for fungal detection [<xref ref-type="bibr" rid="CR95">95</xref>]. Multiplex PCR assays allow for greater efficiency but require strict primer design [<xref ref-type="bibr" rid="CR101">101</xref>]. However, PCR-based approaches are susceptible to false-negative results where sub-optimal sample storage or DNA extraction methods are employed or where PCR inhibitors are present. The use of oligonucleotide array platforms represents a possible alternative but is expensive and subject to batch effects [<xref ref-type="bibr" rid="CR101">101</xref>]. Arguably, sequencing of individual amplified ITS regions remains the gold standard for fungal identification, allowing for sensitive detection of unculturable or low-abundance fungi but may not be practical for all laboratories [<xref ref-type="bibr" rid="CR105">105</xref>]. The use of mycobiome profiling as an alternative to culture-based and molecular diagnostic detection methods represents potentially valuable applications for this technology, but one that requires further validation and research [<xref ref-type="bibr" rid="CR95">95</xref>].</p>
</sec>
</sec>
<sec id="Sec9">
<title>The Mycobiome in Health and Disease</title>
<sec id="Sec10">
<title>Host–Fungal Interaction</title>
<p id="Par10">The term mycobiome is used to describe the fungal component of the microbiome. It is yet unclear whether a core mycobiome, analogous to the bacteriome, exists in humans [<xref ref-type="bibr" rid="CR106">106</xref>]. Relative to the bacteriome (&gt; 99% of the total microbiota), the human mycobiome is less diverse (generally &lt; 20 OTUs per sample) and present at a lower abundance (≤ 0.1% of the total microbiota) [<xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR63">63</xref>]. Targeted sequencing approaches reveal that infants are colonised by fungi shortly after birth, predominantly by members of the genera <italic>Candida</italic>, <italic>Saccharomyces, Cladosporium</italic>, <italic>Cryptococcus</italic> and <italic>Malassezia</italic> [<xref ref-type="bibr" rid="CR107">107</xref>, <xref ref-type="bibr" rid="CR108">108</xref>]. Where correlated, stool mycobiomes from healthy adults reveal profiles predominated by <italic>Saccharomyces</italic>, <italic>Malassezia</italic> and <italic>Candida</italic> suggesting that these genera are the key constituents of a healthy mycobiome throughout life. Critically, however, and in contrast to human bacteriome studies, little correlation with host phenotype metadata is firmly established in healthy individuals and, as such, our knowledge of fungal mycobiome–host interaction remains limited to that in fungal colonisation and/or disease. It is clear from existing studies and their subsequent molecular analysis that intricate immunological systems have evolved to regulate fungal homoeostasis and, when perturbed, lead to infection or other pathologies [<xref ref-type="bibr" rid="CR109">109</xref>]. Immunity to fungi is underpinned by innate signalling pathways recognising both spores and fungal cell wall components and include adaptive T cell responses that orchestrate tolerance and appropriate immune surveillance of ubiquitous fungi encountered daily [<xref ref-type="bibr" rid="CR109">109</xref>, <xref ref-type="bibr" rid="CR110">110</xref>]. Immune responses to fungi are protective when functioning, however, where over-zealous, can manifest as allergy. Consequently, the evolution of immuno-regulatory mechanisms in vivo is perturbed across a range of fungal-driven allergy. Given the parallels with the human bacteriome, where host immunity acts as gatekeeper, it is arguable that similar ecological interactions occur with fungi [<xref ref-type="bibr" rid="CR111">111</xref>]. Perhaps the strongest evidence for a conserved human mycobiome is evidenced by the restricted numbers of fungi that actually inhabit the human body, suggestive of niche specialisation [<xref ref-type="bibr" rid="CR112">112</xref>]. Despite over 50 described bacterial phyla, the human bacteriome is characterised by four: <italic>Actinobacteria</italic>, <italic>Bacteroidetes</italic>, <italic>Firmicutes</italic> and <italic>Proteobacteria</italic>. In corollary, fungal taxa exhibit lower diversity in vivo compared to that seen environmentally and associations between fungi and specific body sites indicate the likely existence of selection and adaptation [<xref ref-type="bibr" rid="CR113">113</xref>, <xref ref-type="bibr" rid="CR114">114</xref>]. Given the limited available data, formal meta-analysis of clinical mycobiome studies, while important, is currently challenging to perform. However, emerging associations based on culture-independent mycobiome studies in humans are summarised in Fig. <xref ref-type="fig" rid="Fig1">1</xref>.</p>
</sec>
<sec id="Sec11">
<title>The Lung Mycobiome</title>
<p id="Par11">While fungal lung disease is now widespread and a growing global concern, the lack of dedicated mycobiome studies assessing the effects of fungi in chronic lung disease is hampering the field. In this particular organ system, the prior presupposition of sterility in a healthy lung puts back microbiome studies in this area for a number of years, and consequently, our understanding of the respiratory microbiome lags significantly behind that at other anatomical sites [<xref ref-type="bibr" rid="CR115">115</xref>]. The advent of culture-independent sequencing technologies has uncovered the diversity of organisms inhabiting the lung, including that in the healthy state [<xref ref-type="bibr" rid="CR116">116</xref>, <xref ref-type="bibr" rid="CR117">117</xref>]. Through the use of internal transcribed spacer (ITS) sequencing, it was reported that <italic>Ceriporia lacerata</italic>, <italic>Saccaromyces cerevisiae</italic> and <italic>Penicillium brevicompactum</italic> were possible pulmonary fungi, with the main pathogen being <italic>Aspergillus fumigatus</italic> [<xref ref-type="bibr" rid="CR118">118</xref>, <xref ref-type="bibr" rid="CR119">119</xref>]. Lung-dwelling microbiota include bacteria, fungi and viruses, which together maintain a cross-kingdom ecological network [<xref ref-type="bibr" rid="CR120">120</xref>]. Interactions between lung and gut microbiomes, through the lung–gut axis, have further immunological consequence, and changes in the gut mycobiome can influence allergic airway disease [<xref ref-type="bibr" rid="CR121">121</xref>–<xref ref-type="bibr" rid="CR125">125</xref>]. The healthy lung mycobiome differs from that observed in patients suffering with chronic inflammatory respiratory disease such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF) and bronchiectasis [<xref ref-type="bibr" rid="CR126">126</xref>, <xref ref-type="bibr" rid="CR127">127</xref>]. The lungs in asthma, COPD and CF all exhibit lower fungal diversity, which in turn is linked to poorer lung function postulated to be influenced by fungal overgrowth and/or loss of some fungal species [<xref ref-type="bibr" rid="CR128">128</xref>]. In asthma, higher loads with increase percentages of <italic>Psathyrella candolleana, Malassezia pachydermatis, Termitomyces clypeatus</italic> and <italic>Grifola sordulenta</italic> and a greater fungal diversity were observed compared to that of a healthy airway [<xref ref-type="bibr" rid="CR129">129</xref>, <xref ref-type="bibr" rid="CR130">130</xref>]. In children with severe asthma, a higher abundance of <italic>Rhodosporidium, Pneumocystis, Leucosporidium</italic> and <italic>Rhodotorula</italic> was detected when compared to those without asthma [<xref ref-type="bibr" rid="CR131">131</xref>]. Bronchiectasis, a permanent and irreversible dilatation of airways, places patients at the higher risks of fungal acquisition and colonisation [<xref ref-type="bibr" rid="CR132">132</xref>]. This is reflected by airway mycobiomes demonstrating a higher abundance of potentially pathogenic taxa including <italic>Aspergillus, Penicillium</italic> and <italic>Cryptococcus</italic> and the detection, in many patients, of an unfavourable allergic sensitisation and immune response profile associated with <italic>Aspergillus</italic> [<xref ref-type="bibr" rid="CR117">117</xref>, <xref ref-type="bibr" rid="CR133">133</xref>]. In view of the dysfunctional mucociliary clearance inherent in bronchiectasis, the airway is susceptible to inhaled airborne fungi and therefore colonisation [<xref ref-type="bibr" rid="CR134">134</xref>]. In COPD, <italic>Aspergillus</italic> spp. has been isolated in 17% of patients and particular fungal taxa such as <italic>Pneumocystis jirovecii</italic> associated with a COPD airway have also been found in HIV and COPD-associated HIV suggestive of immunological predisposition [<xref ref-type="bibr" rid="CR135">135</xref>, <xref ref-type="bibr" rid="CR136">136</xref>]. The overrepresentation of <italic>Pneumocystis</italic> and other fungal species in HIV-related COPD further illustrates the relationship between fungal communities in the lung and corresponding lung function and homoeostasis, warranting more detailed investigation by culture-independent sequencing [<xref ref-type="bibr" rid="CR137">137</xref>]. Significant fungal variability is seen in cystic fibrosis (CF), a genetic disease caused by abnormal Cystic Fibrosis Transmembrane conductance Regulator (CFTR) function, where fungal colonisation and infection for <italic>A. fumigatus</italic> range between 6 and 60% [<xref ref-type="bibr" rid="CR138">138</xref>]. While dedicated CF mycobiome research is nascent, a number of groups have nevertheless started to characterise its main components. Stable fungal communities are detected and exist in parallel to the more ephemeral fungal species that remain transient when assessed longitudinally [<xref ref-type="bibr" rid="CR95">95</xref>, <xref ref-type="bibr" rid="CR127">127</xref>, <xref ref-type="bibr" rid="CR128">128</xref>, <xref ref-type="bibr" rid="CR139">139</xref>–<xref ref-type="bibr" rid="CR143">143</xref>]. Targeted sequencing studies of the CF mycobiome reveal that in addition to the fungi detected by mycological culture alone, that (unculturable) fungal taxa are also present [<xref ref-type="bibr" rid="CR95">95</xref>, <xref ref-type="bibr" rid="CR139">139</xref>, <xref ref-type="bibr" rid="CR142">142</xref>]. Overall, an increased abundance of <italic>Aspergillus</italic> species (particularly <italic>A. fumigatus</italic>), <italic>C. albicans</italic>, <italic>C. parapsilosis</italic> and <italic>Malassezia</italic> is identified [<xref ref-type="bibr" rid="CR127">127</xref>]. In both asthma and CF, an allergic response may be induced when <italic>Aspergillus</italic> is encountered, with the key form being allergic bronchopulmonary aspergillosis (ABPA) [<xref ref-type="bibr" rid="CR144">144</xref>]. The application of mycobiome sequencing approaches to the lung has started to gain significant traction and research interest with the transition from smaller pilot-scale optimisation studies to a more detailed and comprehensive assessment in well-phenotyped cohorts of patients with respiratory disease [<xref ref-type="bibr" rid="CR117">117</xref>, <xref ref-type="bibr" rid="CR139">139</xref>, <xref ref-type="bibr" rid="CR145">145</xref>, <xref ref-type="bibr" rid="CR146">146</xref>].</p>
</sec>
<sec id="Sec12">
<title>The Gut Mycobiome</title>
<p id="Par12">Efforts to examine gut mycobiomes have largely focused on gastrointestinal (GI)-associated disease, and key findings echo trends of mycobiome alteration in other non-GI diseased states. In inflammatory bowel disease (IBD), for instance, initial work using 18S rRNA and rDNA sequencing showed an increased fungal diversity in Crohn’s disease (CD) but not ulcerative colitis (UC) [<xref ref-type="bibr" rid="CR147">147</xref>, <xref ref-type="bibr" rid="CR148">148</xref>]. Further differences were also identified between inflamed and non-inflamed tissue [<xref ref-type="bibr" rid="CR147">147</xref>]. More recently, however, application of ITS2 sequencing has found distinct fungal microbial dysbiosis in IBD with increased Basidiomycota/Ascomycota ratios accompanied by higher proportions of <italic>C. albicans</italic> but reduced levels of <italic>S. cerevisiae</italic> [<xref ref-type="bibr" rid="CR149">149</xref>]. In CD, ITS2 pyrosequencing also confirms increases to overall fungal load during disease flares and a higher prevalence of the Cystofilobasidiaceae family and <italic>C. glabrata</italic> species. In correlation, the application of ITS1 sequencing in another study revealed an increased <italic>Candida tropicalis</italic> in CD as compared to non-CD relatives [<xref ref-type="bibr" rid="CR150">150</xref>]. Interestingly, <italic>S. cerevisiae</italic> and <italic>Filobasidium uniguttulatum</italic> are associated with non-inflamed tissue in CD [<xref ref-type="bibr" rid="CR151">151</xref>]. <italic>Malassezia restricta</italic> was found to increase CD severity in a subset of patients with <italic>CARD9</italic> polymorphisms, suggesting that the targeting of specific fungi in certain patient phenotypes may have value [<xref ref-type="bibr" rid="CR152">152</xref>]. It is further demonstrated that antifungal drugs lead to increases in colitis severity in animal models where ITS1 amplicon sequencing revealed gut fungal dysbiosis characterised by a reduction in <italic>Candida</italic> spp. and concurrent increase in <italic>Aspergillus, Wallemia</italic> and <italic>Epicoccum</italic> spp. [<xref ref-type="bibr" rid="CR153">153</xref>]. Similarly, antibiotics influence gut inflammation through modification of the gut bacteriome with a consequential impact on fungal colonisation [<xref ref-type="bibr" rid="CR154">154</xref>]. Here, alteration in <italic>Enterobacteriaceae</italic> modulates fungal colonisation and colitis severity [<xref ref-type="bibr" rid="CR154">154</xref>]. Although the mouse gut mycobiome does not fully represent that in humans, these findings lend support to the implication of fungal dysbiosis in IBD. Paediatric IBD has also been assessed providing insight into potential age-associated effects, and 18S rDNA pyrosequencing illustrates Basidiomycota dominance [<xref ref-type="bibr" rid="CR155">155</xref>]. In other paediatric IBD works, ITS1 pyrosequencing reveals high <italic>Candida</italic> burdens and a reduced fungal diversity [<xref ref-type="bibr" rid="CR156">156</xref>]. While dedicated study of the healthy gut mycobiome is limited and much required, Nash et al. observed the healthy human gut mycobiome to be lacking in diversity and dominated by yeast genera such as <italic>Saccharomyces</italic>, <italic>Malassezia</italic> and <italic>Candida</italic>, albeit with significant inter- and intra-individual variability [<xref ref-type="bibr" rid="CR63">63</xref>]. This suggests active and dynamic change to the gut mycobiome over time, further influenced by host immunity, even in the absence of disease. In Irritable Bowel Syndrome (IBS), a functional gastrointestinal disease, ITS1-based metabarcoding of faecal samples reveals a gut mycobiome dysbiosis with a significant loss of diversity. <italic>Saccharomyces</italic> and <italic>Candida</italic> were dominant in IBS and healthy controls, but higher proportions were observed in the former [<xref ref-type="bibr" rid="CR157">157</xref>]. Visceral hypersensitivity is linked to IBS with fungi implicated in animal models, suggesting that targeted manipulation of the mycobiome may provide scope for therapeutic intervention [<xref ref-type="bibr" rid="CR158">158</xref>, <xref ref-type="bibr" rid="CR159">159</xref>]. Mycobiome signatures clearly differ between hypersensitive and normally sensitive IBS [<xref ref-type="bibr" rid="CR158">158</xref>]. While these findings are clearly of clinical interest, more compelling evidence and biological validation is required to further clarify mechanistic underpinnings of these early observations [<xref ref-type="bibr" rid="CR157">157</xref>]. Interestingly, in the oncological setting, antifungal treatment is associated with decreased tumour progression in pancreatic ductal carcinoma, while post-therapeutic repopulation by <italic>Malassezia</italic> accelerates tumour growth [<xref ref-type="bibr" rid="CR160">160</xref>]. In addition, an increased abundance of <italic>Malassezia</italic> is described in colorectal cancer by faecal shotgun metagenomic sequencing, along-with <italic>Moniliophthtora</italic>, <italic>Rhodotorula</italic>, <italic>Acremonium</italic>, <italic>Thielaviopsis</italic> and <italic>Pisolithus</italic>, while a higher abundance of <italic>Basidiomycota</italic> is associated with more advance disease [<xref ref-type="bibr" rid="CR161">161</xref>, <xref ref-type="bibr" rid="CR162">162</xref>]. The gut mycobiome may additionally influence other organ systems such as the lung and central nervous system through their respective axes, but the precise mechanisms are poorly understood. In particular, the lung-gut axis, which includes the mycobiome, is highlighted as a key and emerging player in determining susceptibility to chronic lung disease, and the gut microbiome composition in itself has also been independently associated with several chronic inflammatory lung diseases [<xref ref-type="bibr" rid="CR118">118</xref>]. For instance, the presence of <italic>C. albicans</italic> in the gut influences Th17-related immune pathways, which in turn has implications for <italic>Aspergillus</italic>-associated pathology in chronic airways disease supporting a role for lung–gut cross-talk in the pathogenesis of respiratory disease [<xref ref-type="bibr" rid="CR124">124</xref>]. Gut mycobiome dysbiosis is reported in multiple neurological disorders, where a higher abundance of <italic>Candida</italic> occurs in schizophrenia, autism and Rett Syndrome [<xref ref-type="bibr" rid="CR163">163</xref>–<xref ref-type="bibr" rid="CR166">166</xref>]. This has prompted the investigation of gut fungi in the microbiome–gut–brain axis, an emerging biological concept already firmly established with respect to bacteria [<xref ref-type="bibr" rid="CR167">167</xref>]. While recent studies describe associations between fungal dysbiosis and IBS, the association with neurological symptoms such as anxiety and depression in IBS sufferers is intriguing, results that further support the role of gut fungi in the microbiome–gut–brain axis [<xref ref-type="bibr" rid="CR168">168</xref>]. While these findings remain speculative at present requiring more study to explain clearer biological mechanism, they nevertheless do illustrate the importance and emergence of the fungal mycobiome in human disease.</p>
</sec>
<sec id="Sec13">
<title>The Skin Mycobiome</title>
<p id="Par13">The skin remains a key organ and provides barrier protection against pathogens but is also home to resident fungi [<xref ref-type="bibr" rid="CR169">169</xref>, <xref ref-type="bibr" rid="CR170">170</xref>]. Different skin components demonstrate differing fungal patterns, and fungal species also vary by age and gender. For instance, children have greater numbers and variety of fungi on their skin compared to adults, who are dominated by lipophilic <italic>Malassezia</italic> [<xref ref-type="bibr" rid="CR115">115</xref>, <xref ref-type="bibr" rid="CR171">171</xref>]. This is likely explained by the changes in sebum composition and sebaceous gland activation [<xref ref-type="bibr" rid="CR171">171</xref>]. Most work reveals that healthy skin (across many body sites) is characterised by <italic>Malassezia</italic>, which produces an aryl hydrocarbon receptor (Ahr) ligand beneficial for epithelial cell health and UV protection [<xref ref-type="bibr" rid="CR114">114</xref>, <xref ref-type="bibr" rid="CR115">115</xref>, <xref ref-type="bibr" rid="CR172">172</xref>]. Diverse domains of the skin mycobiome interact with one another, promoting connectivity and providing network stability. Comparable to lung mycobiomes, the communities in skin mycobiomes help maintain ecological network structure [<xref ref-type="bibr" rid="CR120">120</xref>]. As with other organ systems and their microbiomes, the skin mycobiome associates with skin disease: <italic>Malassezia</italic>, when in higher abundance or where an inappropriate immune response is observed is seen in association with seborrhoeic or atopic dermatitis [<xref ref-type="bibr" rid="CR115">115</xref>, <xref ref-type="bibr" rid="CR173">173</xref>]. Conversely in psoriasis, which involves the multiplication of skin cells at much higher rates, patients had a lower abundance of <italic>Malassezia</italic> when compared to healthy skin despite <italic>Malassezia</italic> remaining the dominant phylum in both groups [<xref ref-type="bibr" rid="CR174">174</xref>]. Relationships between the skin mycobiome and systemic diseases demonstrating dermatological manifestations are established: for example, the role of fungi in systemic sclerosis (SSc), an autoimmune disease characterised by skin thickening where <italic>Rhodotorula glutinis</italic> is highly abundant. Average <italic>R. glutinis</italic> abundance in normal subjects compared to SSc patients was 0.02 and 5.04 per million reads, respectively, supporting this association [<xref ref-type="bibr" rid="CR175">175</xref>]. Tinea versicolor (<italic>Pityriasis versicolor</italic>), a skin fungal infection, attributed to <italic>Malassezia</italic> and a consequence of <italic>Malassezia</italic> protein-induced melanocyte apoptosis and UV exposure has also been the subject of multiple investigations [<xref ref-type="bibr" rid="CR115">115</xref>]. Affected lesions illustrate high burdens of <italic>M. globosa, M. sympodialis</italic> and <italic>M. furfur</italic>, and mycelial fungal forms predominate in contrast to yeast forms commonly seen in healthy skin [<xref ref-type="bibr" rid="CR176">176</xref>]. A role for the mycobiome has been established in seborrhoeic dermatitis, a condition where scaly patches, red skin and persistent dandruff ensue. While Ascomycota and Basidiomycota are prevalent in both healthy and dandruff-affected human scalps, the latter illustrates higher densities of <italic>Acremonium</italic>, <italic>Penicillium and Malassezia</italic> [<xref ref-type="bibr" rid="CR176">176</xref>, <xref ref-type="bibr" rid="CR177">177</xref>]<italic>. Malassezia restricta</italic> and <italic>Malassezia globosa</italic> are identified in seborrhoeic dermatitis, and the presence of new colonising strains when compared to the healthy scalp is indicative of disease onset [<xref ref-type="bibr" rid="CR173">173</xref>]. <italic>Malassezia</italic> may also more directly cause dandruff as antifungal agents are particularly effective as treatment [<xref ref-type="bibr" rid="CR176">176</xref>]. Atopic dermatitis (AD) (eczema) is another important skin condition with established mycobiome associations: significant intra- and inter-individual variation is observed in AD where taxonomic diversity has been examined. However, consistently, as is the case in other skin conditions, <italic>M. sympodialis</italic>, <italic>M. sloofiae</italic> and <italic>M. dermatis</italic> all characterise disease and sometimes exacerbate it. AD patients demonstrate circulating IgE to <italic>Malassezia</italic> and on closer examination, secreted <italic>Malassezia</italic> vesicles from AD patients differ in their RNA content when compared to healthy individuals [<xref ref-type="bibr" rid="CR115">115</xref>, <xref ref-type="bibr" rid="CR176">176</xref>, <xref ref-type="bibr" rid="CR178">178</xref>–<xref ref-type="bibr" rid="CR180">180</xref>]. In addition, <italic>Malassezia</italic> may induce cutaneous inflammation via a Th-17 response, with increased CCR6 + Th17 memory T cells (<italic>M.</italic> specific) observed in AD [<xref ref-type="bibr" rid="CR181">181</xref>]. While <italic>Malassezia</italic> is a key AD correlate, it is important to recognise that non-<italic>Malassezia</italic> fungi are also described [<xref ref-type="bibr" rid="CR179">179</xref>]. Different methodologies have been employed to characterise and describe skin mycobiomes: ion-torrent sequencing has been used in AD, while other approaches include targeted amplicon sequencing of various fungal regions, such as the fungal 28S rRNA large subunit D1/D2 and the 18S rRNA, internal transcribed spacer (ITS) regions ITS1 and ITS2 [<xref ref-type="bibr" rid="CR108">108</xref>, <xref ref-type="bibr" rid="CR114">114</xref>, <xref ref-type="bibr" rid="CR171">171</xref>, <xref ref-type="bibr" rid="CR173">173</xref>, <xref ref-type="bibr" rid="CR175">175</xref>, <xref ref-type="bibr" rid="CR176">176</xref>, <xref ref-type="bibr" rid="CR179">179</xref>, <xref ref-type="bibr" rid="CR182">182</xref>–<xref ref-type="bibr" rid="CR184">184</xref>].</p>
</sec>
<sec id="Sec14">
<title>The Mycobiome and Neurological Disorders</title>
<p id="Par14">Increasing evidence suggests the importance of the microbiome in neurological disease. Changes to gut bacteria are linked to multiple sclerosis (MS), a neuro-inflammatory disease characterised by demyelination and neurodegeneration, suggesting cross-talk via gut–brain microbiota in its pathogenesis [<xref ref-type="bibr" rid="CR185">185</xref>–<xref ref-type="bibr" rid="CR190">190</xref>]. Higher abundance of <italic>Candida, Malassezia</italic> and <italic>Trichosporon</italic> by targeted ITS1 sequencing is reported in MS compared to control brain tissue [<xref ref-type="bibr" rid="CR187">187</xref>]. Similarly, metagenomic analyses of cerebrospinal fluid (CSF) from MS patients reveal that the presence of <italic>Malassezia, Ascomycota, Funneliformis, Glomus, Cladosporium, Candida</italic> and <italic>Alternaria,</italic> however as concluded by these works, likely reflects environmental contaminants [<xref ref-type="bibr" rid="CR191">191</xref>]. In contrast, Jovel et al. using CSF from MS patients did not report any detection of fungal reads [<xref ref-type="bibr" rid="CR192">192</xref>]. In Alzheimer’s disease, fungal cells are detected in neurons through immunohistochemistry and confocal microscopy within brain tissue and these fungal species are further identified by nested PCR, where <italic>Candida, Cladosporium, Malassezia, Neosartorya, Phoma and Sacharomyces</italic> are detected [<xref ref-type="bibr" rid="CR193">193</xref>]. Using targeted amplicon sequencing, <italic>Alternaria</italic> and <italic>Malassezia</italic> are higher in Alzheimer’s compared to normal brain tissue [<xref ref-type="bibr" rid="CR194">194</xref>]. In other works, brain tissue from individuals with amyotrophic lateral sclerosis (ALS), a neurodegenerative disease with progressive motor neuron dysfunction, contains an increased abundance of <italic>Candida</italic>, <italic>Malassezia</italic>, <italic>Fusarium</italic>, <italic>Botrytis</italic>, <italic>Trichoderma</italic> and <italic>Cryptococcus</italic> [<xref ref-type="bibr" rid="CR185">185</xref>, <xref ref-type="bibr" rid="CR195">195</xref>]. The strong association between seborrhoeic dermatitis and Parkinson disease (PD) also raises the suspicion of specific <italic>Malassezia</italic> contribution to both disease states. Importantly, genetic polymorphisms associated with PD and levodopa use are known to promote <italic>Malassezia</italic> growth and invasiveness, and hence this fungal association is of clinical relevance [<xref ref-type="bibr" rid="CR196">196</xref>]. Collectively, these studies implicate fungi in the pathogenesis of several neurological diseases underlining the importance of fungal biology and host–microbe interaction to overall human health and the inter-organ axis communication networks posited to promote disease onset.</p>
</sec>
<sec id="Sec15">
<title>The Environmental Mycobiome</title>
<p id="Par15">Fungi are ubiquitous and present in indoor (built) and outdoor environments [<xref ref-type="bibr" rid="CR197">197</xref>]. While indoor and outdoor fungal communities are similar, indoor fungal particles are passively distributed and dominated by spores, hyphal fragments and other dormant fungi [<xref ref-type="bibr" rid="CR198">198</xref>]. Fungi from indoor air may originate from outdoor air with air exchanges when windows are opened [<xref ref-type="bibr" rid="CR199">199</xref>]. Outdoor airborne fungal composition is affected by location, temperature and humidity, with large numbers of fungi identified by metagenomic sequencing, with consequent and significant impact on indoor fungal communities [<xref ref-type="bibr" rid="CR200">200</xref>]. Other sources of indoor fungi include humans, pets, plants, plumbing systems, heating ventilation and air conditioning systems (HVAC), and also dust re-suspension [<xref ref-type="bibr" rid="CR201">201</xref>, <xref ref-type="bibr" rid="CR202">202</xref>]. Exposure to indoor fungi and fungal particles is linked to health-related outcomes including allergies, fatigue and asthma [<xref ref-type="bibr" rid="CR197">197</xref>, <xref ref-type="bibr" rid="CR203">203</xref>]. In addition, damp dwellings pose an additional health risk due to fungal exposure [<xref ref-type="bibr" rid="CR204">204</xref>]. The built mycobiome is therefore of interest from microbiological, environmental and clinical perspectives. Traditionally, morphology-based studies of fungal cultures and their spores, derived from indoor sampling, have recognised many common indoor fungal species; however, with the application of high-throughput sequencing in the built environment, the much larger scale and depth of the indoor fungal diversity have been demonstrated [<xref ref-type="bibr" rid="CR203">203</xref>, <xref ref-type="bibr" rid="CR205">205</xref>]. Using pyrosequencing of ITS2 and D1/D2 of the large ribosomal subunit (LSU), Amend et al. recovered approximately 4400 fungal OTUs at the species level in a global study of indoor dust samples, while Nonnenmann et al. applied the combination of quantitative PCR with the fungal tag-encoded flexible amplicon pyrosequencing technique and describe 450 fungal species from fifty indoor dust samples in the Yakima valley, WA (USA) [<xref ref-type="bibr" rid="CR206">206</xref>, <xref ref-type="bibr" rid="CR207">207</xref>]. In other works, 986 fungal OTUs were detected in a homogeneous set of houses in a Californian family housing complex [<xref ref-type="bibr" rid="CR199">199</xref>]. Considering culture-dependent and culture-independent approaches (including next-generation sequencing; NGS), substantial fungal diversity is now associated with the built environment. These indoor fungi, whether persistent residents or transient visitors, likely hold clues to the increasing numbers of human allergies and other health problems observed globally in previously healthy individuals [<xref ref-type="bibr" rid="CR208">208</xref>]. One such example is ‘sick building syndrome’: associated with poor indoor air quality and fungal exposure and experienced by building occupants, with symptoms including headache, dizziness, nausea, eye, nose or throat irritation [<xref ref-type="bibr" rid="CR209">209</xref>–<xref ref-type="bibr" rid="CR211">211</xref>]. As part of the effort in reducing harmful exposure of indoor fungi, source-tracking of airborne fungi is necessary to locate and eliminate contaminated building surfaces that may serve as potential reservoirs, a major challenge given the highly dynamic movement of aerosols. Fungal growth on building surfaces may also be invisible to the naked eye, and it is impractical to swab all surfaces for examination. Therefore, future studies must instead attempt source-tracking by swabbing potential source surfaces in homes, classrooms and offices to compare them against air samples using probabilistic models [<xref ref-type="bibr" rid="CR201">201</xref>, <xref ref-type="bibr" rid="CR212">212</xref>]. Some early works have reported mould and yeasts from the genera <italic>Alternaria</italic>, <italic>Aspergillus</italic>, <italic>Cladosporium</italic>, <italic>Penicillium</italic>, <italic>Rhodotorula</italic> and <italic>Wallemia</italic>, where <italic>Rhodotorula mucilaginosa</italic> generally dominate moist spaces such as toilets, <italic>A. fumigatus</italic> in drier spaces such as the living rooms and <italic>Cladosporium</italic> in almost every living space [<xref ref-type="bibr" rid="CR212">212</xref>, <xref ref-type="bibr" rid="CR213">213</xref>]. Besides source-tracking, engineered building materials and surface coatings that prevent or minimise fungal colonisation are another area of active research [<xref ref-type="bibr" rid="CR214">214</xref>, <xref ref-type="bibr" rid="CR215">215</xref>]. These solutions, however, are expensive, and it is almost impossible to maintain sterility in a built environment unless medically warranted, for example, in the intensive care units of healthcare facilities, which in themselves poses a challenge [<xref ref-type="bibr" rid="CR216">216</xref>]. Alternatively, buildings should be constructed using sustainable fungal-resistant materials complemented with architectural designs that consider operating factors such as heating, ventilation and air conditioning (HVAC) systems for controlling indoor temperature and relative humidity, as well as plumbing designs with accessible sites for addressing water leaks, all of which can contribute to a safer indoor environment, minimal fungal contamination and potentially improved human health outcomes.</p>
</sec>
<sec id="Sec16">
<title>Translation of Mycobiome Research to Clinical Practice</title>
<p id="Par16">The number of reported microbiome-related publications has increased exponentially in recent years and now includes numerous studies of the mycobiome [<xref ref-type="bibr" rid="CR94">94</xref>, <xref ref-type="bibr" rid="CR185">185</xref>]. In parallel, a better understanding of the role of microbes in health and disease has emerged with studies increasingly investigating the importance of the mycobiome and its contribution to disease [<xref ref-type="bibr" rid="CR117">117</xref>, <xref ref-type="bibr" rid="CR124">124</xref>, <xref ref-type="bibr" rid="CR133">133</xref>, <xref ref-type="bibr" rid="CR217">217</xref>–<xref ref-type="bibr" rid="CR219">219</xref>]. It is likely that these organisms co-exist in the same environment and that interaction between bacterial, fungal and viral microbiomes achieves homoeostasis among healthy individuals, while dysbiosis leads to disease. Although increasingly investigated in association with pathological states, it is still too early to make conclusions about the true clinical importance and relevance of the mycobiome. Several challenges do remain including the validation and standardisation of robust sampling and analytic methodologies, which must be examined in larger-scale studies. Currently, there is no standardised method in mycobiome sequencing with variation in DNA extraction methods, primer selection, sequencing, reference databases and analytical pipelines (Fig. <xref ref-type="fig" rid="Fig2">2</xref>), precluding robust meta-analysis of clinical studies performed to date, which continue to increase, but remain limited in number. Nevertheless, the field of mycobiome research is evolving and the rapid adoption of sequencing and computational technologies may overcome current limitations and allow a better definition of the mycobiome from a clinical context [<xref ref-type="bibr" rid="CR29">29</xref>]. With an improved understanding of resident mycobiomes and their interaction with host immunity, as correlated with disease at difference stages, this potentially opens avenues for early diagnosis and more targeted therapeutic approaches. Moreover, the use of NGS to characterise resistome pathways may have relevance for surveillance, antifungal stewardship and the development of new antifungal drug approaches. Newer treatment approaches may emerge from better patient stratification based on mycobiome profiles, while manipulating or restoring a ‘healthy’ mycobiome also represents a potentially viable approach for precision medicine. These technological advancements combined with sequencing and analysis may be simplified and evolve into point of care diagnostics for fungal disease in the future.</p>
</sec>
</sec>
<sec id="Sec17">
<title>Future Directions</title>
<p id="Par17">The number of microbiome studies focused on bacteria far exceeds that of the fungal mycobiome (and virome). This is largely attributed to pioneering efforts towards the standardisation of methodologies for bacterial 16 s rRNA gene sequencing and analysis, allowing scalability. A standardised and reliable method of mycobiome sequencing combined with more comprehensive fungal database coverage is crucial to achieve similar scalability for fungal microbiomes [<xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR92">92</xref>]. Despite known interaction between various microbes, studies integrating bacterial microbiomes, fungal mycobiomes, viromes and parasites are limited. Interaction between members of microbial kingdoms likely results in an alteration of function and behaviour of individual microbes, which in turn play important roles for disease pathogenesis. Microbes housed at key body sites exhibit cross-talk and interaction with host immunity resulting in systemic manifestations of disease outside the initial site of dysbiosis. Dysregulation of intestinal microbiome has been implicated in allergic airways disease, with increased intestinal <italic>Clostridium</italic> spp. in asthmatics and an emerging role for the gut mycobiome in regulating fungal airway responses through the lung–gut axis [<xref ref-type="bibr" rid="CR118">118</xref>, <xref ref-type="bibr" rid="CR124">124</xref>, <xref ref-type="bibr" rid="CR220">220</xref>–<xref ref-type="bibr" rid="CR222">222</xref>]. Such insight provides explanations for clinical phenomena including how disruption of the healthy intestinal mycobiome composition with oral antifungals can lead to exacerbations of allergy airway disease [<xref ref-type="bibr" rid="CR173">173</xref>]. Changes in the composition of intestinal microbiota are also implicated in diseases of the central nervous system including autism spectrum disorder, Parkinson disease and schizophrenia, further substantiating the key role of microbiome cross-talk, which is likely to include major fungal in addition to established bacterial players [<xref ref-type="bibr" rid="CR165">165</xref>, <xref ref-type="bibr" rid="CR223">223</xref>, <xref ref-type="bibr" rid="CR224">224</xref>]. To better understand the precise role of the mycobiome and its contribution to disease pathogenesis, future studies must assess interactions between the various microbial kingdoms in tandem with host immunity across multiple body sites in a holistic systems-based approach. Across such complex and interlinked microbial systems, the mycobiome is clearly a recognised and emerging factor that contributes to a range of diseases and their pathogenesis, which if harnessed appropriately can represent an opportunity, one that improves disease prognosis and future approaches to precision medicine using the microbiome.</p>
</sec>
</body>
<back>
<fn-group>
<fn>
<p>Handling Editor: J. P. Xu.</p>
</fn>
<fn>
<p>
<bold>Publisher's Note</bold>
</p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</fn>
<fn>
<p>Pei Yee Tiew and Micheál Mac Aogáin contributed equally.</p>
</fn>
</fn-group>
<ack>
<title>Acknowledgements</title>
<p>The authors would like to acknowledge The Academic Respiratory Initiative for Pulmonary Health (TARIPH) for collaboration support.</p>
</ack>
<notes notes-type="author-contribution">
<title>Author Contribution</title>
<p>PYT and MMA contributed to conception, literature review, final manuscript writing and editing, NABMA contributed to literature review, manuscript writing, drawing of figures; KT, KG and KL contributed to literature review, manuscript writing, SHC contributed to conception, literature review, manuscript writing and editing.</p>
</notes>
<notes notes-type="funding-information">
<title>Funding</title>
<p>This research is supported by the Singapore Ministry of Health’s National Medical Research Council under its Research Training Fellowship (NMRC/Fellowship/0049/2017) (P.Y.T) and a Clinician-Scientist Individual Research Grant (MOH-000141) (S.H.C); the Singapore Ministry of Education under its Singapore Ministry of Education Academic Research Fund Tier 1 (2016-T1-001-050) (S.H.C); the NTU Integrated Medical, Biological and Environmental Life Sciences (NIMBELS), Nanyang Technological University, Singapore [NIM/03/2018] (S.H.C) and the Ageing Research Institute for Society and Education (ARISE), Nanyang Technological University, Singapore [ARISE/2017/6] (S.H.C).</p>
</notes>
<notes>
<title>Compliance with Ethical Standards</title>
<notes id="FPar1" notes-type="COI-statement">
<title>Conflict of interest</title>
<p id="Par18">The authors declare that they have no conflict of interest.</p>
</notes>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<mixed-citation publication-type="other">Stop neglecting fungi. Nat Microbiol. 2017;2:17120.</mixed-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bongomin</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Gago</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Oladele</surname>
<given-names>RO</given-names>
</name>
<name>
<surname>Denning</surname>
<given-names>DW</given-names>
</name>
</person-group>
<article-title>Global and multi-national prevalence of fungal diseases-estimate precision</article-title>
<source/>J Fungi (Basel)
          <year>2017</year>
<volume>3</volume>
<issue>4</issue>
<fpage>57</fpage>
<pub-id pub-id-type="doi">10.3390/jof3040057</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garcia-Solache</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Casadevall</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Global warming will bring new fungal diseases for mammals</article-title>
<source/>MBio
          <year>2010</year>
<volume>1</volume>
<issue>1</issue>
<fpage>1</fpage>
<lpage>3</lpage>
<pub-id pub-id-type="doi">10.1128/mBio.00061-10</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garber</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>An overview of fungal infections</article-title>
<source/>Drugs.
          <year>2001</year>
<volume>61</volume>
<issue>Suppl 1</issue>
<fpage>1</fpage>
<lpage>12</lpage>
<pub-id pub-id-type="doi">10.2165/00003495-200161001-00001</pub-id>
<pub-id pub-id-type="pmid">11219546</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meyer</surname>
<given-names>KC</given-names>
</name>
<name>
<surname>Raghu</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Baughman</surname>
<given-names>RP</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>KK</given-names>
</name>
<name>
<surname>Costabel</surname>
<given-names>U</given-names>
</name>
<name>
<surname>du Bois</surname>
<given-names>RM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease</article-title>
<source/>Am J Respir Crit Care Med
          <year>2012</year>
<volume>185</volume>
<issue>9</issue>
<fpage>1004</fpage>
<lpage>1014</lpage>
<pub-id pub-id-type="doi">10.1164/rccm.201202-0320ST</pub-id>
<pub-id pub-id-type="pmid">22550210</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Sigel</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Vaz</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Komatsu</surname>
<given-names>K</given-names>
</name>
<name>
<surname>McRill</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Phelan</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>An epidemic of coccidioidomycosis in Arizona associated with climatic changes, 1998–2001</article-title>
<source/>J Infect Dis
          <year>2005</year>
<volume>191</volume>
<issue>11</issue>
<fpage>1981</fpage>
<lpage>1987</lpage>
<pub-id pub-id-type="doi">10.1086/430092</pub-id>
<pub-id pub-id-type="pmid">15871133</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Byrnes</surname>
<given-names>EJ</given-names>
<suffix>3rd</suffix>
</name>
<name>
<surname>Bildfell</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Frank</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Mitchell</surname>
<given-names>TG</given-names>
</name>
<name>
<surname>Marr</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Heitman</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Molecular evidence that the range of the Vancouver Island outbreak of <italic>Cryptococcus gattii</italic> infection has expanded into the Pacific Northwest in the United States</article-title>
<source/>J Infect Dis
          <year>2009</year>
<volume>199</volume>
<issue>7</issue>
<fpage>1081</fpage>
<lpage>1086</lpage>
<pub-id pub-id-type="doi">10.1086/597306</pub-id>
<pub-id pub-id-type="pmid">19220140</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perlin</surname>
<given-names>DS</given-names>
</name>
<name>
<surname>Rautemaa-Richardson</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Alastruey-Izquierdo</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>The global problem of antifungal resistance: prevalence, mechanisms, and management</article-title>
<source/>Lancet Infect Dis
          <year>2017</year>
<volume>17</volume>
<issue>12</issue>
<fpage>e383</fpage>
<lpage>e392</lpage>
<pub-id pub-id-type="doi">10.1016/S1473-3099(17)30316-X</pub-id>
<pub-id pub-id-type="pmid">28774698</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Limper</surname>
<given-names>AH</given-names>
</name>
<name>
<surname>Adenis</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Le</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Harrison</surname>
<given-names>TS</given-names>
</name>
</person-group>
<article-title>Fungal infections in HIV/AIDS</article-title>
<source/>Lancet Infect Dis
          <year>2017</year>
<volume>17</volume>
<issue>11</issue>
<fpage>e334</fpage>
<lpage>e343</lpage>
<pub-id pub-id-type="doi">10.1016/S1473-3099(17)30303-1</pub-id>
<pub-id pub-id-type="pmid">28774701</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barnes</surname>
<given-names>RA</given-names>
</name>
</person-group>
<article-title>Early diagnosis of fungal infection in immunocompromised patients</article-title>
<source/>J Antimicrob Chemother
          <year>2008</year>
<volume>61</volume>
<issue>Suppl 1</issue>
<fpage>i3</fpage>
<lpage>i6</lpage>
<pub-id pub-id-type="doi">10.1093/jac/dkm424</pub-id>
<pub-id pub-id-type="pmid">18063601</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Pauw</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Walsh</surname>
<given-names>TJ</given-names>
</name>
<name>
<surname>Donnelly</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Stevens</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Edwards</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Calandra</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group</article-title>
<source/>Clin Infect Dis
          <year>2008</year>
<volume>46</volume>
<issue>12</issue>
<fpage>1813</fpage>
<lpage>1821</lpage>
<pub-id pub-id-type="doi">10.1086/588660</pub-id>
<pub-id pub-id-type="pmid">18462102</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>He</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Diagnostic value of galactomannan antigen test in serum and bronchoalveolar lavage fluid samples from patients with nonneutropenic invasive pulmonary aspergillosis</article-title>
<source/>J Clin Microbiol
          <year>2017</year>
<volume>55</volume>
<issue>7</issue>
<fpage>2153</fpage>
<lpage>2161</lpage>
<pub-id pub-id-type="doi">10.1128/JCM.00345-17</pub-id>
<pub-id pub-id-type="pmid">28446576</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Duarte</surname>
<given-names>RF</given-names>
</name>
<name>
<surname>Sanchez-Ortega</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Cuesta</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Arnan</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Patino</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Fernandez de Sevilla</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Serum galactomannan-based early detection of invasive aspergillosis in hematology patients receiving effective antimold prophylaxis</article-title>
<source/>Clin Infect Dis
          <year>2014</year>
<volume>59</volume>
<issue>12</issue>
<fpage>1696</fpage>
<lpage>1702</lpage>
<pub-id pub-id-type="doi">10.1093/cid/ciu673</pub-id>
<pub-id pub-id-type="pmid">25165088</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nguyen</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Jaber</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Leather</surname>
<given-names>HL</given-names>
</name>
<name>
<surname>Wingard</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Staley</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Wheat</surname>
<given-names>LJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Use of bronchoalveolar lavage to detect galactomannan for diagnosis of pulmonary aspergillosis among nonimmunocompromised hosts</article-title>
<source/>J Clin Microbiol
          <year>2007</year>
<volume>45</volume>
<issue>9</issue>
<fpage>2787</fpage>
<lpage>2792</lpage>
<pub-id pub-id-type="doi">10.1128/JCM.00716-07</pub-id>
<pub-id pub-id-type="pmid">17596367</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clancy</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>MH</given-names>
</name>
</person-group>
<article-title>Finding the “missing 50%” of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care</article-title>
<source/>Clin Infect Dis
          <year>2013</year>
<volume>56</volume>
<issue>9</issue>
<fpage>1284</fpage>
<lpage>1292</lpage>
<pub-id pub-id-type="doi">10.1093/cid/cit006</pub-id>
<pub-id pub-id-type="pmid">23315320</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Simoneau</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Kelly</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Labbe</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Roy</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Laverdiere</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>What is the clinical significance of positive blood cultures with <italic>Aspergillus</italic> sp. in hematopoietic stem cell transplant recipients? A 23 year experience</article-title>
<source/>Bone Marrow Transpl
          <year>2005</year>
<volume>35</volume>
<issue>3</issue>
<fpage>303</fpage>
<lpage>306</lpage>
<pub-id pub-id-type="doi">10.1038/sj.bmt.1704793</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tarrand</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Lichterfeld</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Warraich</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Luna</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>XY</given-names>
</name>
<name>
<surname>May</surname>
<given-names>GS</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Diagnosis of invasive septate mold infections. A correlation of microbiological culture and histologic or cytologic examination</article-title>
<source/>Am J Clin Pathol
          <year>2003</year>
<volume>119</volume>
<issue>6</issue>
<fpage>854</fpage>
<lpage>858</lpage>
<pub-id pub-id-type="doi">10.1309/EXBVYAUPENBM285Y</pub-id>
<pub-id pub-id-type="pmid">12817433</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sloand</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Laughon</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Armstrong</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bartlett</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Blumenfeld</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Cushion</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The challenge of Pneumocystis carinii culture</article-title>
<source/>J Eukaryot Microbiol
          <year>1993</year>
<volume>40</volume>
<issue>2</issue>
<fpage>188</fpage>
<lpage>195</lpage>
<pub-id pub-id-type="doi">10.1111/j.1550-7408.1993.tb04902.x</pub-id>
<pub-id pub-id-type="pmid">8461892</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Fahle</surname>
<given-names>GA</given-names>
</name>
<name>
<surname>Kovacs</surname>
<given-names>JA</given-names>
</name>
</person-group>
<article-title>Inability to culture <italic>Pneumocystis jirovecii</italic></article-title>
<source/>MBio.
          <year>2018</year>
<volume>9</volume>
<issue>3</issue>
<fpage>e00939-18</fpage>
<pub-id pub-id-type="doi">10.1128/mBio.00939-18</pub-id>
<pub-id pub-id-type="pmid">29895638</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kami</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Murashige</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Fujihara</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Sakagami</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Tanaka</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>The mechanism for low yield of blood culture in invasive aspergillosis; the clinical importance of antigen detection tests revisited</article-title>
<source/>Bone Marrow Transpl
          <year>2005</year>
<volume>36</volume>
<issue>1</issue>
<fpage>85</fpage>
<lpage>86</lpage>
<pub-id pub-id-type="doi">10.1038/sj.bmt.1704997</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Denning</surname>
<given-names>DW</given-names>
</name>
<name>
<surname>Kibbler</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Barnes</surname>
<given-names>RA</given-names>
</name>
</person-group>
<article-title>British Society for Medical M. British Society for Medical Mycology proposed standards of care for patients with invasive fungal infections</article-title>
<source/>Lancet Infect Dis
          <year>2003</year>
<volume>3</volume>
<issue>4</issue>
<fpage>230</fpage>
<lpage>240</lpage>
<pub-id pub-id-type="doi">10.1016/S1473-3099(03)00580-2</pub-id>
<pub-id pub-id-type="pmid">12679266</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Limper</surname>
<given-names>AH</given-names>
</name>
</person-group>
<article-title>Clinical approach and management for selected fungal infections in pulmonary and critical care patients</article-title>
<source/>Chest
          <year>2014</year>
<volume>146</volume>
<issue>6</issue>
<fpage>1658</fpage>
<lpage>1666</lpage>
<pub-id pub-id-type="doi">10.1378/chest.14-0305</pub-id>
<pub-id pub-id-type="pmid">25451352</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wheat</surname>
<given-names>LJ</given-names>
</name>
</person-group>
<article-title>Approach to the diagnosis of invasive aspergillosis and candidiasis</article-title>
<source/>Clin Chest Med
          <year>2009</year>
<volume>30</volume>
<issue>2</issue>
<fpage>367</fpage>
<lpage>377</lpage>
<pub-id pub-id-type="doi">10.1016/j.ccm.2009.02.012</pub-id>
<pub-id pub-id-type="pmid">19375641</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ullmann</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Aguado</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Arikan-Akdagli</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Denning</surname>
<given-names>DW</given-names>
</name>
<name>
<surname>Groll</surname>
<given-names>AH</given-names>
</name>
<name>
<surname>Lagrou</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID–ECMM–ERS guideline</article-title>
<source/>Clin Microbiol Infect
          <year>2018</year>
<volume>24</volume>
<issue>Suppl 1</issue>
<fpage>e1</fpage>
<lpage>e38</lpage>
<pub-id pub-id-type="doi">10.1016/j.cmi.2018.01.002</pub-id>
<pub-id pub-id-type="pmid">29544767</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alexander</surname>
<given-names>BD</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>PB</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>RD</given-names>
</name>
<name>
<surname>Perfect</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Reller</surname>
<given-names>LB</given-names>
</name>
</person-group>
<article-title>The (1,3){beta}-<sc>d</sc>-glucan test as an aid to early diagnosis of invasive fungal infections following lung transplantation</article-title>
<source/>J Clin Microbiol
          <year>2010</year>
<volume>48</volume>
<issue>11</issue>
<fpage>4083</fpage>
<lpage>4088</lpage>
<pub-id pub-id-type="doi">10.1128/JCM.01183-10</pub-id>
<pub-id pub-id-type="pmid">20720025</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koo</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bryar</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Page</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Baden</surname>
<given-names>LR</given-names>
</name>
<name>
<surname>Marty</surname>
<given-names>FM</given-names>
</name>
</person-group>
<article-title>Diagnostic performance of the (1 → 3)-beta-<sc>d</sc>-glucan assay for invasive fungal disease</article-title>
<source/>Clin Infect Dis
          <year>2009</year>
<volume>49</volume>
<issue>11</issue>
<fpage>1650</fpage>
<lpage>1659</lpage>
<pub-id pub-id-type="doi">10.1086/647942</pub-id>
<pub-id pub-id-type="pmid">19863452</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Racil</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Kocmanova</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Lengerova</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Weinbergerova</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Buresova</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Toskova</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Difficulties in using 1,3-{beta}-<sc>d</sc>-glucan as the screening test for the early diagnosis of invasive fungal infections in patients with haematological malignancies–high frequency of false-positive results and their analysis</article-title>
<source/>J Med Microbiol
          <year>2010</year>
<volume>59</volume>
<issue>Pt 9</issue>
<fpage>1016</fpage>
<lpage>1022</lpage>
<pub-id pub-id-type="doi">10.1099/jmm.0.019299-0</pub-id>
<pub-id pub-id-type="pmid">20488937</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arvanitis</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Anagnostou</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Fuchs</surname>
<given-names>BB</given-names>
</name>
<name>
<surname>Caliendo</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Mylonakis</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Molecular and nonmolecular diagnostic methods for invasive fungal infections</article-title>
<source/>Clin Microbiol Rev
          <year>2014</year>
<volume>27</volume>
<issue>3</issue>
<fpage>490</fpage>
<lpage>526</lpage>
<pub-id pub-id-type="doi">10.1128/CMR.00091-13</pub-id>
<pub-id pub-id-type="pmid">24982319</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<collab>Consortium O, Gabaldon T</collab>
</person-group>
<article-title>Recent trends in molecular diagnostics of yeast infections: from PCR to NGS</article-title>
<source/>FEMS Microbiol Rev
          <year>2019</year>
<volume>43</volume>
<issue>5</issue>
<fpage>517</fpage>
<lpage>547</lpage>
<pub-id pub-id-type="pmid">31158289</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pappas</surname>
<given-names>PG</given-names>
</name>
<name>
<surname>Kauffman</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Andes</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Clancy</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Marr</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Ostrosky-Zeichner</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America</article-title>
<source/>Clin Infect Dis
          <year>2016</year>
<volume>62</volume>
<issue>4</issue>
<fpage>e1</fpage>
<lpage>e50</lpage>
<pub-id pub-id-type="doi">10.1093/cid/civ1194</pub-id>
<pub-id pub-id-type="pmid">26679628</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morton</surname>
<given-names>CO</given-names>
</name>
<name>
<surname>White</surname>
<given-names>PL</given-names>
</name>
<name>
<surname>Barnes</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Klingspor</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Cuenca-Estrella</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lagrou</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Determining the analytical specificity of PCR-based assays for the diagnosis of IA: What is Aspergillus?</article-title>
<source/>Med Mycol
          <year>2017</year>
<volume>55</volume>
<issue>4</issue>
<fpage>402</fpage>
<lpage>413</lpage>
<pub-id pub-id-type="pmid">28339744</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khot</surname>
<given-names>PD</given-names>
</name>
<name>
<surname>Fredricks</surname>
<given-names>DN</given-names>
</name>
</person-group>
<article-title>PCR-based diagnosis of human fungal infections</article-title>
<source/>Expert Rev Anti Infect Ther
          <year>2009</year>
<volume>7</volume>
<issue>10</issue>
<fpage>1201</fpage>
<lpage>1221</lpage>
<pub-id pub-id-type="doi">10.1586/eri.09.104</pub-id>
<pub-id pub-id-type="pmid">19968513</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Snitkin</surname>
<given-names>ES</given-names>
</name>
<name>
<surname>Zelazny</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Stock</surname>
<given-names>F</given-names>
</name>
<collab>Group NCS</collab>
<name>
<surname>Henderson</surname>
<given-names>DK</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Tracking a hospital outbreak of carbapenem-resistant <italic>Klebsiella pneumoniae</italic> with whole-genome sequencing</article-title>
<source/>Sci Transl Med
          <year>2012</year>
<volume>4</volume>
<issue>148</issue>
<fpage>148ra16</fpage>
<pub-id pub-id-type="doi">10.1126/scitranslmed.3004129</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lewis</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Loman</surname>
<given-names>NJ</given-names>
</name>
<name>
<surname>Bingle</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Jumaa</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Weinstock</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Mortiboy</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>High-throughput whole-genome sequencing to dissect the epidemiology of <italic>Acinetobacter baumannii</italic> isolates from a hospital outbreak</article-title>
<source/>J Hosp Infect
          <year>2010</year>
<volume>75</volume>
<issue>1</issue>
<fpage>37</fpage>
<lpage>41</lpage>
<pub-id pub-id-type="doi">10.1016/j.jhin.2010.01.012</pub-id>
<pub-id pub-id-type="pmid">20299126</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weterings</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Rossen</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>van Stenis</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Thewessen</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Kluytmans</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>An outbreak of colistin-resistant <italic>Klebsiella pneumoniae</italic> carbapenemase-producing <italic>Klebsiella pneumoniae</italic> in the Netherlands (July to December 2013), with inter-institutional spread</article-title>
<source/>Eur J Clin Microbiol Infect Dis
          <year>2015</year>
<volume>34</volume>
<issue>8</issue>
<fpage>1647</fpage>
<lpage>1655</lpage>
<pub-id pub-id-type="doi">10.1007/s10096-015-2401-2</pub-id>
<pub-id pub-id-type="pmid">26067658</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wilson</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Naccache</surname>
<given-names>SN</given-names>
</name>
<name>
<surname>Samayoa</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Biagtan</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bashir</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Actionable diagnosis of neuroleptospirosis by next-generation sequencing</article-title>
<source/>N Engl J Med
          <year>2014</year>
<volume>370</volume>
<issue>25</issue>
<fpage>2408</fpage>
<lpage>2417</lpage>
<pub-id pub-id-type="doi">10.1056/NEJMoa1401268</pub-id>
<pub-id pub-id-type="pmid">24896819</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thoendel</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Jeraldo</surname>
<given-names>PR</given-names>
</name>
<name>
<surname>Greenwood-Quaintance</surname>
<given-names>KE</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>JZ</given-names>
</name>
<name>
<surname>Chia</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Hanssen</surname>
<given-names>AD</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Identification of prosthetic joint infection pathogens using a shotgun metagenomics approach</article-title>
<source/>Clin Infect Dis
          <year>2018</year>
<volume>67</volume>
<issue>9</issue>
<fpage>1333</fpage>
<lpage>1338</lpage>
<pub-id pub-id-type="doi">10.1093/cid/ciy303</pub-id>
<pub-id pub-id-type="pmid">29648630</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wilson</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>O’Donovan</surname>
<given-names>BD</given-names>
</name>
<name>
<surname>Gelfand</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Sample</surname>
<given-names>HA</given-names>
</name>
<name>
<surname>Chow</surname>
<given-names>FC</given-names>
</name>
<name>
<surname>Betjemann</surname>
<given-names>JP</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Chronic meningitis investigated via metagenomic next-generation sequencing</article-title>
<source/>JAMA Neurol
          <year>2018</year>
<volume>75</volume>
<issue>8</issue>
<fpage>947</fpage>
<lpage>955</lpage>
<pub-id pub-id-type="doi">10.1001/jamaneurol.2018.0463</pub-id>
<pub-id pub-id-type="pmid">29710329</pub-id>
</element-citation>
</ref>
<ref id="CR39">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qin</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Raes</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Arumugam</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Burgdorf</surname>
<given-names>KS</given-names>
</name>
<name>
<surname>Manichanh</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A human gut microbial gene catalogue established by metagenomic sequencing</article-title>
<source/>Nature
          <year>2010</year>
<volume>464</volume>
<issue>7285</issue>
<fpage>59</fpage>
<lpage>65</lpage>
<pub-id pub-id-type="doi">10.1038/nature08821</pub-id>
<pub-id pub-id-type="pmid">20203603</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ali</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Mac Aogain</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Morales</surname>
<given-names>RF</given-names>
</name>
<name>
<surname>Tiew</surname>
<given-names>PY</given-names>
</name>
<name>
<surname>Chotirmall</surname>
<given-names>SH</given-names>
</name>
</person-group>
<article-title>Optimisation and benchmarking of targeted amplicon sequencing for mycobiome analysis of respiratory specimens</article-title>
<source/>Int J Mol Sci
          <year>2019</year>
<volume>20</volume>
<issue>20</issue>
<fpage>4991</fpage>
<pub-id pub-id-type="doi">10.3390/ijms20204991</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fricke</surname>
<given-names>WF</given-names>
</name>
<name>
<surname>Rasko</surname>
<given-names>DA</given-names>
</name>
</person-group>
<article-title>Bacterial genome sequencing in the clinic: bioinformatic challenges and solutions</article-title>
<source/>Nat Rev Genet
          <year>2014</year>
<volume>15</volume>
<issue>1</issue>
<fpage>49</fpage>
<lpage>55</lpage>
<pub-id pub-id-type="doi">10.1038/nrg3624</pub-id>
<pub-id pub-id-type="pmid">24281148</pub-id>
</element-citation>
</ref>
<ref id="CR42">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lawlor</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Walsh</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Engineering bioinformatics: building reliability, performance and productivity into bioinformatics software</article-title>
<source/>Bioengineered
          <year>2015</year>
<volume>6</volume>
<issue>4</issue>
<fpage>193</fpage>
<lpage>203</lpage>
<pub-id pub-id-type="doi">10.1080/21655979.2015.1050162</pub-id>
<pub-id pub-id-type="pmid">25996054</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Walsh</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Carroll</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Sleator</surname>
<given-names>RD</given-names>
</name>
</person-group>
<article-title>Accelerating in silico research with workflows: a lesson in simplicity</article-title>
<source/>Comput Biol Med
          <year>2013</year>
<volume>43</volume>
<issue>12</issue>
<fpage>2028</fpage>
<lpage>2035</lpage>
<pub-id pub-id-type="doi">10.1016/j.compbiomed.2013.09.011</pub-id>
<pub-id pub-id-type="pmid">24290918</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Felton</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Troke</surname>
<given-names>PF</given-names>
</name>
<name>
<surname>Hope</surname>
<given-names>WW</given-names>
</name>
</person-group>
<article-title>Tissue penetration of antifungal agents</article-title>
<source/>Clin Microbiol Rev
          <year>2014</year>
<volume>27</volume>
<issue>1</issue>
<fpage>68</fpage>
<lpage>88</lpage>
<pub-id pub-id-type="doi">10.1128/CMR.00046-13</pub-id>
<pub-id pub-id-type="pmid">24396137</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gubbins</surname>
<given-names>PO</given-names>
</name>
<name>
<surname>Amsden</surname>
<given-names>JR</given-names>
</name>
</person-group>
<article-title>Drug–drug interactions of antifungal agents and implications for patient care</article-title>
<source/>Expert Opin Pharmacother
          <year>2005</year>
<volume>6</volume>
<issue>13</issue>
<fpage>2231</fpage>
<lpage>2243</lpage>
<pub-id pub-id-type="doi">10.1517/14656566.6.13.2231</pub-id>
<pub-id pub-id-type="pmid">16218884</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Verweij</surname>
<given-names>PE</given-names>
</name>
<name>
<surname>Snelders</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Kema</surname>
<given-names>GH</given-names>
</name>
<name>
<surname>Mellado</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Melchers</surname>
<given-names>WJ</given-names>
</name>
</person-group>
<article-title>Azole resistance in <italic>Aspergillus fumigatus</italic>: a side-effect of environmental fungicide use?</article-title>
<source/>Lancet Infect Dis
          <year>2009</year>
<volume>9</volume>
<issue>12</issue>
<fpage>789</fpage>
<lpage>795</lpage>
<pub-id pub-id-type="doi">10.1016/S1473-3099(09)70265-8</pub-id>
<pub-id pub-id-type="pmid">19926038</pub-id>
</element-citation>
</ref>
<ref id="CR47">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rivero-Menendez</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Alastruey-Izquierdo</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mellado</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Cuenca-Estrella</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Triazole resistance in <italic>Aspergillus</italic> spp.: a worldwide problem?</article-title>
<source/>J Fungi (Basel)
          <year>2016</year>
<volume>2</volume>
<issue>3</issue>
<fpage>21</fpage>
<pub-id pub-id-type="doi">10.3390/jof2030021</pub-id>
</element-citation>
</ref>
<ref id="CR48">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wiederhold</surname>
<given-names>NP</given-names>
</name>
</person-group>
<article-title>Antifungal resistance: current trends and future strategies to combat</article-title>
<source/>Infect Drug Resist
          <year>2017</year>
<volume>10</volume>
<fpage>249</fpage>
<lpage>259</lpage>
<pub-id pub-id-type="doi">10.2147/IDR.S124918</pub-id>
<pub-id pub-id-type="pmid">28919789</pub-id>
</element-citation>
</ref>
<ref id="CR49">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lockhart</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Iqbal</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Cleveland</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Farley</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Harrison</surname>
<given-names>LH</given-names>
</name>
<name>
<surname>Bolden</surname>
<given-names>CB</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Species identification and antifungal susceptibility testing of Candida bloodstream isolates from population-based surveillance studies in two U.S. cities from 2008 to 2011</article-title>
<source/>J Clin Microbiol
          <year>2012</year>
<volume>50</volume>
<issue>11</issue>
<fpage>3435</fpage>
<lpage>3442</lpage>
<pub-id pub-id-type="doi">10.1128/JCM.01283-12</pub-id>
<pub-id pub-id-type="pmid">22875889</pub-id>
</element-citation>
</ref>
<ref id="CR50">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liao</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Qiu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Risk factors for fluconazole-resistant invasive candidiasis in intensive care unit patients: an analysis from the China Survey of Candidiasis study</article-title>
<source/>J Crit Care
          <year>2015</year>
<volume>30</volume>
<issue>4</issue>
<fpage>862 e1-5</fpage>
<pub-id pub-id-type="doi">10.1016/j.jcrc.2015.04.088</pub-id>
<pub-id pub-id-type="pmid">26002430</pub-id>
</element-citation>
</ref>
<ref id="CR51">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>YC</given-names>
</name>
<name>
<surname>Hsueh</surname>
<given-names>PR</given-names>
</name>
</person-group>
<article-title>Epidemiology of candidemia and antifungal susceptibility in invasive Candida species in the Asia-Pacific region</article-title>
<source/>Future Microbiol
          <year>2016</year>
<volume>11</volume>
<fpage>1461</fpage>
<lpage>1477</lpage>
<pub-id pub-id-type="doi">10.2217/fmb-2016-0099</pub-id>
<pub-id pub-id-type="pmid">27750452</pub-id>
</element-citation>
</ref>
<ref id="CR52">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Verweij</surname>
<given-names>PE</given-names>
</name>
<name>
<surname>Chowdhary</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Melchers</surname>
<given-names>WJ</given-names>
</name>
<name>
<surname>Meis</surname>
<given-names>JF</given-names>
</name>
</person-group>
<article-title>Azole resistance in <italic>Aspergillus fumigatus</italic>: can we retain the clinical use of mold-active antifungal azoles?</article-title>
<source/>Clin Infect Dis
          <year>2016</year>
<volume>62</volume>
<issue>3</issue>
<fpage>362</fpage>
<lpage>368</lpage>
<pub-id pub-id-type="doi">10.1093/cid/civ885</pub-id>
<pub-id pub-id-type="pmid">26486705</pub-id>
</element-citation>
</ref>
<ref id="CR53">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vallabhaneni</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Cleveland</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Farley</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Harrison</surname>
<given-names>LH</given-names>
</name>
<name>
<surname>Schaffner</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Beldavs</surname>
<given-names>ZG</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Epidemiology and risk factors for echinocandin nonsusceptible <italic>Candida glabrata</italic> bloodstream infections: data from a large multisite population-based candidemia surveillance program, 2008–2014</article-title>
<source/>Open Forum Infect Dis
          <year>2015</year>
<volume>2</volume>
<issue>4</issue>
<fpage>ofv163</fpage>
<pub-id pub-id-type="doi">10.1093/ofid/ofv163</pub-id>
<pub-id pub-id-type="pmid">26677456</pub-id>
</element-citation>
</ref>
<ref id="CR54">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alexander</surname>
<given-names>BD</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Pfeiffer</surname>
<given-names>CD</given-names>
</name>
<name>
<surname>Jimenez-Ortigosa</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Catania</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Booker</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Increasing echinocandin resistance in <italic>Candida glabrata</italic>: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations</article-title>
<source/>Clin Infect Dis
          <year>2013</year>
<volume>56</volume>
<issue>12</issue>
<fpage>1724</fpage>
<lpage>1732</lpage>
<pub-id pub-id-type="doi">10.1093/cid/cit136</pub-id>
<pub-id pub-id-type="pmid">23487382</pub-id>
</element-citation>
</ref>
<ref id="CR55">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beyda</surname>
<given-names>ND</given-names>
</name>
<name>
<surname>John</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kilic</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Alam</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Lasco</surname>
<given-names>TM</given-names>
</name>
<name>
<surname>Garey</surname>
<given-names>KW</given-names>
</name>
</person-group>
<article-title>FKS mutant <italic>Candida glabrata</italic>: risk factors and outcomes in patients with candidemia</article-title>
<source/>Clin Infect Dis
          <year>2014</year>
<volume>59</volume>
<issue>6</issue>
<fpage>819</fpage>
<lpage>825</lpage>
<pub-id pub-id-type="doi">10.1093/cid/ciu407</pub-id>
<pub-id pub-id-type="pmid">24879785</pub-id>
</element-citation>
</ref>
<ref id="CR56">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Biswas</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Halliday</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Martinez</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Rockett</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Q</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Whole genome sequencing of <italic>Candida glabrata</italic> for detection of markers of antifungal drug resistance</article-title>
<source/>J VisExp JoVE
          <year>2017</year>
<volume>130</volume>
<fpage>e56714</fpage>
</element-citation>
</ref>
<ref id="CR57">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Biswas</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Halliday</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Kennedy</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Playford</surname>
<given-names>EG</given-names>
</name>
<name>
<surname>Marriott</surname>
<given-names>DJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Identification of genetic markers of resistance to echinocandins, azoles and 5-fluorocytosine in <italic>Candida glabrata</italic> by next-generation sequencing: a feasibility study</article-title>
<source/>Clin Microbiol Infect
          <year>2017</year>
<volume>23</volume>
<issue>9</issue>
<fpage>676 e7–e10</fpage>
<pub-id pub-id-type="doi">10.1016/j.cmi.2017.03.014</pub-id>
</element-citation>
</ref>
<ref id="CR58">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garnaud</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Botterel</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Sertour</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Bougnoux</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Dannaoui</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Larrat</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Next-generation sequencing offers new insights into the resistance of <italic>Candida</italic> spp. to echinocandins and azoles</article-title>
<source/>J Antimicrob Chemother
          <year>2015</year>
<volume>70</volume>
<issue>9</issue>
<fpage>2556</fpage>
<lpage>2565</lpage>
<pub-id pub-id-type="doi">10.1093/jac/dkv139</pub-id>
<pub-id pub-id-type="pmid">26017039</pub-id>
</element-citation>
</ref>
<ref id="CR59">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cuthbertson</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Rogers</surname>
<given-names>GB</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>AW</given-names>
</name>
<name>
<surname>Oliver</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hoffman</surname>
<given-names>LR</given-names>
</name>
<name>
<surname>Carroll</surname>
<given-names>MP</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Implications of multiple freeze-thawing on respiratory samples for culture-independent analyses</article-title>
<source/>J Cyst Fibros
          <year>2015</year>
<volume>14</volume>
<issue>4</issue>
<fpage>464</fpage>
<lpage>467</lpage>
<pub-id pub-id-type="doi">10.1016/j.jcf.2014.10.004</pub-id>
<pub-id pub-id-type="pmid">25459563</pub-id>
</element-citation>
</ref>
<ref id="CR60">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nilsson</surname>
<given-names>RH</given-names>
</name>
<name>
<surname>Anslan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bahram</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wurzbacher</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Baldrian</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Tedersoo</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Mycobiome diversity: high-throughput sequencing and identification of fungi</article-title>
<source/>Nat Rev Microbiol
          <year>2019</year>
<volume>17</volume>
<issue>2</issue>
<fpage>95</fpage>
<lpage>109</lpage>
<pub-id pub-id-type="doi">10.1038/s41579-018-0116-y</pub-id>
<pub-id pub-id-type="pmid">30442909</pub-id>
</element-citation>
</ref>
<ref id="CR61">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Angebault</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Ghozlane</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Volant</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Botterel</surname>
<given-names>F</given-names>
</name>
<name>
<surname>d’Enfert</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Bougnoux</surname>
<given-names>ME</given-names>
</name>
</person-group>
<article-title>Combined bacterial and fungal intestinal microbiota analyses: impact of storage conditions and DNA extraction protocols</article-title>
<source/>PLoS ONE
          <year>2018</year>
<volume>13</volume>
<issue>8</issue>
<fpage>e0201174</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0201174</pub-id>
<pub-id pub-id-type="pmid">30074988</pub-id>
</element-citation>
</ref>
<ref id="CR62">
<label>62.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huseyin</surname>
<given-names>CE</given-names>
</name>
<name>
<surname>Rubio</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>O’Sullivan</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Cotter</surname>
<given-names>PD</given-names>
</name>
<name>
<surname>Scanlan</surname>
<given-names>PD</given-names>
</name>
</person-group>
<article-title>The fungal frontier: a comparative analysis of methods used in the study of the human gut mycobiome</article-title>
<source/>Front Microbiol
          <year>2017</year>
<volume>8</volume>
<fpage>1432</fpage>
<pub-id pub-id-type="doi">10.3389/fmicb.2017.01432</pub-id>
<pub-id pub-id-type="pmid">28824566</pub-id>
</element-citation>
</ref>
<ref id="CR63">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nash</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Auchtung</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>DP</given-names>
</name>
<name>
<surname>Gesell</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Ross</surname>
<given-names>MC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The gut mycobiome of the Human Microbiome Project healthy cohort</article-title>
<source/>Microbiome
          <year>2017</year>
<volume>5</volume>
<issue>1</issue>
<fpage>153</fpage>
<pub-id pub-id-type="doi">10.1186/s40168-017-0373-4</pub-id>
<pub-id pub-id-type="pmid">29178920</pub-id>
</element-citation>
</ref>
<ref id="CR64">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>van Burik</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Schreckhise</surname>
<given-names>RW</given-names>
</name>
<name>
<surname>White</surname>
<given-names>TC</given-names>
</name>
<name>
<surname>Bowden</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Myerson</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Comparison of six extraction techniques for isolation of DNA from filamentous fungi</article-title>
<source/>Med Mycol
          <year>1998</year>
<volume>36</volume>
<issue>5</issue>
<fpage>299</fpage>
<lpage>303</lpage>
<pub-id pub-id-type="doi">10.1080/02681219880000471</pub-id>
<pub-id pub-id-type="pmid">10075499</pub-id>
</element-citation>
</ref>
<ref id="CR65">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Henderson</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Cox</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Kittelmann</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Miri</surname>
<given-names>VH</given-names>
</name>
<name>
<surname>Zethof</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Noel</surname>
<given-names>SJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Effect of DNA extraction methods and sampling techniques on the apparent structure of cow and sheep rumen microbial communities</article-title>
<source/>PLoS ONE
          <year>2013</year>
<volume>8</volume>
<issue>9</issue>
<fpage>e74787</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0074787</pub-id>
<pub-id pub-id-type="pmid">24040342</pub-id>
</element-citation>
</ref>
<ref id="CR66">
<label>66.</label>
<mixed-citation publication-type="other">Gow NA, Latge J-P, Munro CA. The fungal cell wall: structure, biosynthesis, and function. Microbiology spectrum. 2017.</mixed-citation>
</ref>
<ref id="CR67">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smits</surname>
<given-names>GJ</given-names>
</name>
<name>
<surname>Kapteyn</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>van den Ende</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Klis</surname>
<given-names>FM</given-names>
</name>
</person-group>
<article-title>Cell wall dynamics in yeast</article-title>
<source/>Curr Opin Microbiol
          <year>1999</year>
<volume>2</volume>
<issue>4</issue>
<fpage>348</fpage>
<lpage>352</lpage>
<pub-id pub-id-type="doi">10.1016/S1369-5274(99)80061-7</pub-id>
<pub-id pub-id-type="pmid">10458981</pub-id>
</element-citation>
</ref>
<ref id="CR68">
<label>68.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Muñoz-Cadavid</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Rudd</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zaki</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Moser</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Brandt</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Improving molecular detection of fungal DNA in formalin-fixed paraffin-embedded tissues: comparison of five tissue DNA extraction methods using panfungal PCR</article-title>
<source/>J Clin Microbiol
          <year>2010</year>
<volume>48</volume>
<issue>6</issue>
<fpage>2147</fpage>
<lpage>2153</lpage>
<pub-id pub-id-type="doi">10.1128/JCM.00459-10</pub-id>
<pub-id pub-id-type="pmid">20392915</pub-id>
</element-citation>
</ref>
<ref id="CR69">
<label>69.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goldschmidt</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Degorge</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Merabet</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Chaumeil</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Enzymatic treatment of specimens before DNA extraction directly influences molecular detection of infectious agents</article-title>
<source/>PLoS ONE
          <year>2014</year>
<volume>9</volume>
<issue>6</issue>
<fpage>e94886</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0094886</pub-id>
<pub-id pub-id-type="pmid">24936792</pub-id>
</element-citation>
</ref>
<ref id="CR70">
<label>70.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vesty</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Biswas</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>MW</given-names>
</name>
<name>
<surname>Gear</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Douglas</surname>
<given-names>RG</given-names>
</name>
</person-group>
<article-title>Evaluating the impact of DNA extraction method on the representation of human oral bacterial and fungal communities</article-title>
<source/>PLoS ONE
          <year>2017</year>
<volume>12</volume>
<issue>1</issue>
<fpage>e0169877</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0169877</pub-id>
<pub-id pub-id-type="pmid">28099455</pub-id>
</element-citation>
</ref>
<ref id="CR71">
<label>71.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rosenbaum</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Usyk</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Zolnik</surname>
<given-names>CP</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>HE</given-names>
</name>
<name>
<surname>Waldron</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Evaluation of oral cavity DNA extraction methods on bacterial and fungal microbiota</article-title>
<source/>Sci Rep
          <year>2019</year>
<volume>9</volume>
<issue>1</issue>
<fpage>1531</fpage>
<pub-id pub-id-type="doi">10.1038/s41598-018-38049-6</pub-id>
<pub-id pub-id-type="pmid">30728424</pub-id>
</element-citation>
</ref>
<ref id="CR72">
<label>72.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fredricks</surname>
<given-names>DN</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Meier</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Comparison of six DNA extraction methods for recovery of fungal DNA as assessed by quantitative PCR</article-title>
<source/>J Clin Microbiol
          <year>2005</year>
<volume>43</volume>
<issue>10</issue>
<fpage>5122</fpage>
<lpage>5128</lpage>
<pub-id pub-id-type="doi">10.1128/JCM.43.10.5122-5128.2005</pub-id>
<pub-id pub-id-type="pmid">16207973</pub-id>
</element-citation>
</ref>
<ref id="CR73">
<label>73.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huseyin</surname>
<given-names>CE</given-names>
</name>
<name>
<surname>O’Toole</surname>
<given-names>PW</given-names>
</name>
<name>
<surname>Cotter</surname>
<given-names>PD</given-names>
</name>
<name>
<surname>Scanlan</surname>
<given-names>PD</given-names>
</name>
</person-group>
<article-title>Forgotten fungi-the gut mycobiome in human health and disease</article-title>
<source/>FEMS Microbiol Rev
          <year>2017</year>
<volume>41</volume>
<issue>4</issue>
<fpage>479</fpage>
<lpage>511</lpage>
<pub-id pub-id-type="doi">10.1093/femsre/fuw047</pub-id>
<pub-id pub-id-type="pmid">28430946</pub-id>
</element-citation>
</ref>
<ref id="CR74">
<label>74.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bokulich</surname>
<given-names>NA</given-names>
</name>
<name>
<surname>Mills</surname>
<given-names>DA</given-names>
</name>
</person-group>
<article-title>Improved selection of internal transcribed spacer-specific primers enables quantitative, ultra-high-throughput profiling of fungal communities</article-title>
<source/>Appl Environ Microbiol
          <year>2013</year>
<volume>79</volume>
<issue>8</issue>
<fpage>2519</fpage>
<lpage>2526</lpage>
<pub-id pub-id-type="doi">10.1128/AEM.03870-12</pub-id>
<pub-id pub-id-type="pmid">23377949</pub-id>
</element-citation>
</ref>
<ref id="CR75">
<label>75.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Begerow</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Nilsson</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Unterseher</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Maier</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>Current state and perspectives of fungal DNA barcoding and rapid identification procedures</article-title>
<source/>Appl Microbiol Biotechnol
          <year>2010</year>
<volume>87</volume>
<issue>1</issue>
<fpage>99</fpage>
<lpage>108</lpage>
<pub-id pub-id-type="doi">10.1007/s00253-010-2585-4</pub-id>
<pub-id pub-id-type="pmid">20405123</pub-id>
</element-citation>
</ref>
<ref id="CR76">
<label>76.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schoch</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Seifert</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Huhndorf</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Robert</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Spouge</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Levesque</surname>
<given-names>CA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Nuclear ribosomal internal transcribed spacer (ITS) region as a universal DNA barcode marker for Fungi</article-title>
<source/>Proc Natl Acad Sci USA
          <year>2012</year>
<volume>109</volume>
<issue>16</issue>
<fpage>6241</fpage>
<lpage>6246</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1117018109</pub-id>
<pub-id pub-id-type="pmid">22454494</pub-id>
</element-citation>
</ref>
<ref id="CR77">
<label>77.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tedersoo</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Anslan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bahram</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Põlme</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Riit</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Liiv</surname>
<given-names>I</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Shotgun metagenomes and multiple primer pair-barcode combinations of amplicons reveal biases in metabarcoding analyses of fungi</article-title>
<source/>MycoKeys
          <year>2015</year>
<volume>10</volume>
<fpage>1</fpage>
<lpage>43</lpage>
<pub-id pub-id-type="doi">10.3897/mycokeys.10.4852</pub-id>
</element-citation>
</ref>
<ref id="CR78">
<label>78.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Filippis</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Laiola</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Blaiotta</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Ercolini</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Different amplicon targets for sequencing-based studies of fungal diversity</article-title>
<source/>Appl Environ Microbiol
          <year>2017</year>
<volume>83</volume>
<issue>17</issue>
<fpage>e00905</fpage>
<lpage>e00917</lpage>
<pub-id pub-id-type="doi">10.1128/AEM.00905-17</pub-id>
<pub-id pub-id-type="pmid">28625991</pub-id>
</element-citation>
</ref>
<ref id="CR79">
<label>79.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Iliev</surname>
<given-names>ID</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Underhill</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Funari</surname>
<given-names>VA</given-names>
</name>
</person-group>
<article-title>Mycobiome: approaches to analysis of intestinal fungi</article-title>
<source/>J Immunol Methods
          <year>2015</year>
<volume>421</volume>
<fpage>112</fpage>
<lpage>121</lpage>
<pub-id pub-id-type="doi">10.1016/j.jim.2015.04.004</pub-id>
<pub-id pub-id-type="pmid">25891793</pub-id>
</element-citation>
</ref>
<ref id="CR80">
<label>80.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bellemain</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Carlsen</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Brochmann</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Coissac</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Taberlet</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Kauserud</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>ITS as an environmental DNA barcode for fungi: an in silico approach reveals potential PCR biases</article-title>
<source/>BMC Microbiol
          <year>2010</year>
<volume>10</volume>
<fpage>189</fpage>
<pub-id pub-id-type="doi">10.1186/1471-2180-10-189</pub-id>
<pub-id pub-id-type="pmid">20618939</pub-id>
</element-citation>
</ref>
<ref id="CR81">
<label>81.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Op De Beeck</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lievens</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Busschaert</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Declerck</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Vangronsveld</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Colpaert</surname>
<given-names>JV</given-names>
</name>
</person-group>
<article-title>Comparison and validation of some ITS primer pairs useful for fungal metabarcoding studies</article-title>
<source/>PLoS ONE
          <year>2014</year>
<volume>9</volume>
<issue>6</issue>
<fpage>e97629</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0097629</pub-id>
<pub-id pub-id-type="pmid">24933453</pub-id>
</element-citation>
</ref>
<ref id="CR82">
<label>82.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tedersoo</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Lindahl</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Fungal identification biases in microbiome projects</article-title>
<source/>Environ Microbiol Rep
          <year>2016</year>
<volume>8</volume>
<issue>5</issue>
<fpage>774</fpage>
<lpage>779</lpage>
<pub-id pub-id-type="doi">10.1111/1758-2229.12438</pub-id>
<pub-id pub-id-type="pmid">27348848</pub-id>
</element-citation>
</ref>
<ref id="CR83">
<label>83.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heisel</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Podgorski</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Staley</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Knights</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Sadowsky</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Gale</surname>
<given-names>CA</given-names>
</name>
</person-group>
<article-title>Complementary amplicon-based genomic approaches for the study of fungal communities in humans</article-title>
<source/>PLoS ONE
          <year>2015</year>
<volume>10</volume>
<issue>2</issue>
<fpage>e0116705</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0116705</pub-id>
<pub-id pub-id-type="pmid">25706290</pub-id>
</element-citation>
</ref>
<ref id="CR84">
<label>84.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ihrmark</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Bodeker</surname>
<given-names>IT</given-names>
</name>
<name>
<surname>Cruz-Martinez</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Friberg</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kubartova</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Schenck</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>New primers to amplify the fungal ITS2 region–evaluation by 454-sequencing of artificial and natural communities</article-title>
<source/>FEMS Microbiol Ecol
          <year>2012</year>
<volume>82</volume>
<issue>3</issue>
<fpage>666</fpage>
<lpage>677</lpage>
<pub-id pub-id-type="doi">10.1111/j.1574-6941.2012.01437.x</pub-id>
<pub-id pub-id-type="pmid">22738186</pub-id>
</element-citation>
</ref>
<ref id="CR85">
<label>85.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bakker</surname>
<given-names>MG</given-names>
</name>
</person-group>
<article-title>A fungal mock community control for amplicon sequencing experiments</article-title>
<source/>Mol Ecol Resour
          <year>2018</year>
<volume>18</volume>
<issue>3</issue>
<fpage>541</fpage>
<lpage>556</lpage>
<pub-id pub-id-type="doi">10.1111/1755-0998.12760</pub-id>
<pub-id pub-id-type="pmid">29389073</pub-id>
</element-citation>
</ref>
<ref id="CR86">
<label>86.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>D’Amore</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Ijaz</surname>
<given-names>UZ</given-names>
</name>
<name>
<surname>Schirmer</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kenny</surname>
<given-names>JG</given-names>
</name>
<name>
<surname>Gregory</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Darby</surname>
<given-names>AC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A comprehensive benchmarking study of protocols and sequencing platforms for 16S rRNA community profiling</article-title>
<source/>BMC Genom
          <year>2016</year>
<volume>17</volume>
<issue>1</issue>
<fpage>55</fpage>
<pub-id pub-id-type="doi">10.1186/s12864-015-2194-9</pub-id>
</element-citation>
</ref>
<ref id="CR87">
<label>87.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Salter</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Cox</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Turek</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Calus</surname>
<given-names>ST</given-names>
</name>
<name>
<surname>Cookson</surname>
<given-names>WO</given-names>
</name>
<name>
<surname>Moffatt</surname>
<given-names>MF</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Reagent and laboratory contamination can critically impact sequence-based microbiome analyses</article-title>
<source/>BMC Biol
          <year>2014</year>
<volume>12</volume>
<fpage>87</fpage>
<pub-id pub-id-type="doi">10.1186/s12915-014-0087-z</pub-id>
<pub-id pub-id-type="pmid">25387460</pub-id>
</element-citation>
</ref>
<ref id="CR88">
<label>88.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nguyen</surname>
<given-names>NH</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Bates</surname>
<given-names>ST</given-names>
</name>
<name>
<surname>Branco</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tedersoo</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Menke</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>FUNGuild: an open annotation tool for parsing fungal community datasets by ecological guild</article-title>
<source/>Fungal Ecol
          <year>2016</year>
<volume>20</volume>
<fpage>241</fpage>
<lpage>248</lpage>
<pub-id pub-id-type="doi">10.1016/j.funeco.2015.06.006</pub-id>
</element-citation>
</ref>
<ref id="CR89">
<label>89.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Quince</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>AW</given-names>
</name>
<name>
<surname>Simpson</surname>
<given-names>JT</given-names>
</name>
<name>
<surname>Loman</surname>
<given-names>NJ</given-names>
</name>
<name>
<surname>Segata</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Shotgun metagenomics, from sampling to analysis</article-title>
<source/>Nat Biotechnol
          <year>2017</year>
<volume>35</volume>
<issue>9</issue>
<fpage>833</fpage>
<lpage>844</lpage>
<pub-id pub-id-type="doi">10.1038/nbt.3935</pub-id>
<pub-id pub-id-type="pmid">28898207</pub-id>
</element-citation>
</ref>
<ref id="CR90">
<label>90.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marotz</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Sanders</surname>
<given-names>JG</given-names>
</name>
<name>
<surname>Zuniga</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Zaramela</surname>
<given-names>LS</given-names>
</name>
<name>
<surname>Knight</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Zengler</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Improving saliva shotgun metagenomics by chemical host DNA depletion</article-title>
<source/>Microbiome
          <year>2018</year>
<volume>6</volume>
<issue>1</issue>
<fpage>42</fpage>
<pub-id pub-id-type="doi">10.1186/s40168-018-0426-3</pub-id>
<pub-id pub-id-type="pmid">29482639</pub-id>
</element-citation>
</ref>
<ref id="CR91">
<label>91.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Soergel</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Dey</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Knight</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Brenner</surname>
<given-names>SE</given-names>
</name>
</person-group>
<article-title>Selection of primers for optimal taxonomic classification of environmental 16S rRNA gene sequences</article-title>
<source/>ISME J
          <year>2012</year>
<volume>6</volume>
<issue>7</issue>
<fpage>1440</fpage>
<lpage>1444</lpage>
<pub-id pub-id-type="doi">10.1038/ismej.2011.208</pub-id>
<pub-id pub-id-type="pmid">22237546</pub-id>
</element-citation>
</ref>
<ref id="CR92">
<label>92.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mac Aogain</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Chaturvedi</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Chotirmall</surname>
<given-names>SH</given-names>
</name>
</person-group>
<article-title>MycopathologiaGENOMES: the New ‘Home’ for the Publication of Fungal Genomes</article-title>
<source/>Mycopathologia
          <year>2019</year>
<volume>184</volume>
<issue>5</issue>
<fpage>551</fpage>
<lpage>554</lpage>
<pub-id pub-id-type="doi">10.1007/s11046-019-00366-3</pub-id>
<pub-id pub-id-type="pmid">31399887</pub-id>
</element-citation>
</ref>
<ref id="CR93">
<label>93.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vu</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Groenewald</surname>
<given-names>M</given-names>
</name>
<name>
<surname>de Vries</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gehrmann</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Stielow</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Eberhardt</surname>
<given-names>U</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Large-scale generation and analysis of filamentous fungal DNA barcodes boosts coverage for kingdom fungi and reveals thresholds for fungal species and higher taxon delimitation</article-title>
<source/>Stud Mycol
          <year>2019</year>
<volume>92</volume>
<fpage>135</fpage>
<lpage>154</lpage>
<pub-id pub-id-type="doi">10.1016/j.simyco.2018.05.001</pub-id>
<pub-id pub-id-type="pmid">29955203</pub-id>
</element-citation>
</ref>
<ref id="CR94">
<label>94.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Donovan</surname>
<given-names>PD</given-names>
</name>
<name>
<surname>Gonzalez</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Higgins</surname>
<given-names>DG</given-names>
</name>
<name>
<surname>Butler</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Ito</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Identification of fungi in shotgun metagenomics datasets</article-title>
<source/>PLoS ONE
          <year>2018</year>
<volume>13</volume>
<issue>2</issue>
<fpage>e0192898</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0192898</pub-id>
<pub-id pub-id-type="pmid">29444186</pub-id>
</element-citation>
</ref>
<ref id="CR95">
<label>95.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Botterel</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Angebault</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Cabaret</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Stressmann</surname>
<given-names>FA</given-names>
</name>
<name>
<surname>Costa</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Wallet</surname>
<given-names>F</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Fungal and Bacterial Diversity of Airway Microbiota in Adults with Cystic Fibrosis: concordance Between Conventional Methods and Ultra-Deep Sequencing, and Their Practical use in the Clinical Laboratory</article-title>
<source/>Mycopathologia
          <year>2018</year>
<volume>183</volume>
<issue>1</issue>
<fpage>171</fpage>
<lpage>183</lpage>
<pub-id pub-id-type="doi">10.1007/s11046-017-0185-x</pub-id>
<pub-id pub-id-type="pmid">28766039</pub-id>
</element-citation>
</ref>
<ref id="CR96">
<label>96.</label>
<mixed-citation publication-type="other">Cote RJ. Aseptic technique for cell culture. Curr Protoc Cell Biol. 2001;Chapter 1:Unit 1:3.</mixed-citation>
</ref>
<ref id="CR97">
<label>97.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Day</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lalitha</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Haug</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Fothergill</surname>
<given-names>AW</given-names>
</name>
<name>
<surname>Cevallos</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Vijayakumar</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Activity of antibiotics against Fusarium and Aspergillus</article-title>
<source/>Br J Ophthalmol
          <year>2009</year>
<volume>93</volume>
<issue>1</issue>
<fpage>116</fpage>
<lpage>119</lpage>
<pub-id pub-id-type="doi">10.1136/bjo.2008.142364</pub-id>
<pub-id pub-id-type="pmid">18952649</pub-id>
</element-citation>
</ref>
<ref id="CR98">
<label>98.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kerr</surname>
<given-names>JR</given-names>
</name>
</person-group>
<article-title>Bacterial inhibition of fungal growth and pathogenicity</article-title>
<source/>Microbial Ecol Health Dis
          <year>1999</year>
<volume>11</volume>
<issue>3</issue>
<fpage>129</fpage>
<lpage>142</lpage>
<pub-id pub-id-type="doi">10.1080/089106099435709</pub-id>
</element-citation>
</ref>
<ref id="CR99">
<label>99.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shi</surname>
<given-names>X-X</given-names>
</name>
<name>
<surname>Qiu</surname>
<given-names>H-P</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J-y</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y-L</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>G-C</given-names>
</name>
</person-group>
<article-title>A handy method to remove bacterial contamination from fungal cultures</article-title>
<source/>PLoS ONE
          <year>2019</year>
<volume>14</volume>
<issue>11</issue>
<fpage>e0224635</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0224635</pub-id>
<pub-id pub-id-type="pmid">31693673</pub-id>
</element-citation>
</ref>
<ref id="CR100">
<label>100.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coron</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Pihet</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Fréalle</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Lemeille</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Pinel</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Pelloux</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Toward the standardization of mycological examination of sputum samples in cystic fibrosis: results from a French multicenter prospective study</article-title>
<source/>Mycopathologia
          <year>2018</year>
<volume>183</volume>
<issue>1</issue>
<fpage>101</fpage>
<lpage>117</lpage>
<pub-id pub-id-type="doi">10.1007/s11046-017-0173-1</pub-id>
<pub-id pub-id-type="pmid">28748285</pub-id>
</element-citation>
</ref>
<ref id="CR101">
<label>101.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>SC-A</given-names>
</name>
<name>
<surname>Meyer</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Pashley</surname>
<given-names>CH</given-names>
</name>
</person-group>
<article-title>Challenges in laboratory detection of fungal pathogens in the airways of cystic fibrosis patients</article-title>
<source/>Mycopathologia
          <year>2018</year>
<volume>183</volume>
<issue>1</issue>
<fpage>89</fpage>
<lpage>100</lpage>
<pub-id pub-id-type="doi">10.1007/s11046-017-0150-8</pub-id>
<pub-id pub-id-type="pmid">28589247</pub-id>
</element-citation>
</ref>
<ref id="CR102">
<label>102.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gilgado</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Cano</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gene</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Sutton</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Guarro</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Molecular and phenotypic data supporting distinct species statuses for <italic>Scedosporium apiospermum</italic> and <italic>Pseudallescheria boydii</italic> and the proposed new species <italic>Scedosporium dehoogii</italic></article-title>
<source/>J Clin Microbiol
          <year>2008</year>
<volume>46</volume>
<issue>2</issue>
<fpage>766</fpage>
<lpage>771</lpage>
<pub-id pub-id-type="doi">10.1128/JCM.01122-07</pub-id>
<pub-id pub-id-type="pmid">18077629</pub-id>
</element-citation>
</ref>
<ref id="CR103">
<label>103.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lawrence</surname>
<given-names>DP</given-names>
</name>
<name>
<surname>Gannibal</surname>
<given-names>PB</given-names>
</name>
<name>
<surname>Peever</surname>
<given-names>TL</given-names>
</name>
<name>
<surname>Pryor</surname>
<given-names>BM</given-names>
</name>
</person-group>
<article-title>The sections of Alternaria: formalizing species-group concepts</article-title>
<source/>Mycologia
          <year>2013</year>
<volume>105</volume>
<issue>3</issue>
<fpage>530</fpage>
<lpage>546</lpage>
<pub-id pub-id-type="doi">10.3852/12-249</pub-id>
<pub-id pub-id-type="pmid">23687125</pub-id>
</element-citation>
</ref>
<ref id="CR104">
<label>104.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abliz</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Fukushima</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Takizawa</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Nishimura</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Identification of pathogenic dematiaceous fungi and related taxa based on large subunit ribosomal DNA D1/D2 domain sequence analysis</article-title>
<source/>FEMS Immunol Med Microbiol
          <year>2004</year>
<volume>40</volume>
<issue>1</issue>
<fpage>41</fpage>
<lpage>49</lpage>
<pub-id pub-id-type="doi">10.1016/S0928-8244(03)00275-X</pub-id>
<pub-id pub-id-type="pmid">14734185</pub-id>
</element-citation>
</ref>
<ref id="CR105">
<label>105.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perlin</surname>
<given-names>DS</given-names>
</name>
<name>
<surname>Wiederhold</surname>
<given-names>NP</given-names>
</name>
</person-group>
<article-title>Culture-independent molecular methods for detection of antifungal resistance mechanisms and fungal identification</article-title>
<source/>J Infect Dis
          <year>2017</year>
<volume>216</volume>
<issue>suppl_3</issue>
<fpage>S458</fpage>
<lpage>S465</lpage>
<pub-id pub-id-type="doi">10.1093/infdis/jix121</pub-id>
<pub-id pub-id-type="pmid">28911041</pub-id>
</element-citation>
</ref>
<ref id="CR106">
<label>106.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<collab>Human Microbiome Project C</collab>
</person-group>
<article-title>Structure function and diversity of the healthy human microbiome</article-title>
<source/>Nature
          <year>2012</year>
<volume>486</volume>
<issue>7402</issue>
<fpage>207</fpage>
<lpage>214</lpage>
<pub-id pub-id-type="doi">10.1038/nature11234</pub-id>
<pub-id pub-id-type="pmid">22699609</pub-id>
</element-citation>
</ref>
<ref id="CR107">
<label>107.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stewart</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Nelson</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Scribbins</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Marrs</surname>
<given-names>EC</given-names>
</name>
<name>
<surname>Lanyon</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Perry</surname>
<given-names>JD</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Bacterial and fungal viability in the preterm gut: NEC and sepsis</article-title>
<source/>Arch Dis Child Fetal Neonatal Ed
          <year>2013</year>
<volume>98</volume>
<issue>4</issue>
<fpage>F298</fpage>
<lpage>F303</lpage>
<pub-id pub-id-type="doi">10.1136/archdischild-2012-302119</pub-id>
<pub-id pub-id-type="pmid">23426613</pub-id>
</element-citation>
</ref>
<ref id="CR108">
<label>108.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ward</surname>
<given-names>TL</given-names>
</name>
<name>
<surname>Dominguez-Bello</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Heisel</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Al-Ghalith</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Knights</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Gale</surname>
<given-names>CA</given-names>
</name>
</person-group>
<article-title>Development of the human mycobiome over the first month of life and across body sites</article-title>
<source/>mSystems
          <year>2018</year>
<volume>3</volume>
<issue>3</issue>
<fpage>e00140-17</fpage>
<pub-id pub-id-type="doi">10.1128/mSystems.00140-17</pub-id>
<pub-id pub-id-type="pmid">29546248</pub-id>
</element-citation>
</ref>
<ref id="CR109">
<label>109.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Romani</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Immunity to fungal infections</article-title>
<source/>Nat Rev Immunol
          <year>2011</year>
<volume>11</volume>
<issue>4</issue>
<fpage>275</fpage>
<lpage>288</lpage>
<pub-id pub-id-type="doi">10.1038/nri2939</pub-id>
<pub-id pub-id-type="pmid">21394104</pub-id>
</element-citation>
</ref>
<ref id="CR110">
<label>110.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>van de Veerdonk</surname>
<given-names>FL</given-names>
</name>
<name>
<surname>Gresnigt</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Romani</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Netea</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Latge</surname>
<given-names>JP</given-names>
</name>
</person-group>
<article-title><italic>Aspergillus fumigatus</italic> morphology and dynamic host interactions</article-title>
<source/>Nat Rev Microbiol
          <year>2017</year>
<volume>15</volume>
<issue>11</issue>
<fpage>661</fpage>
<lpage>674</lpage>
<pub-id pub-id-type="doi">10.1038/nrmicro.2017.90</pub-id>
<pub-id pub-id-type="pmid">28919635</pub-id>
</element-citation>
</ref>
<ref id="CR111">
<label>111.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harvill</surname>
<given-names>ET</given-names>
</name>
</person-group>
<article-title>Cultivating our “frienemies”: viewing immunity as microbiome management</article-title>
<source/>MBio
          <year>2013</year>
<volume>4</volume>
<issue>2</issue>
<fpage>e00027-13</fpage>
<pub-id pub-id-type="doi">10.1128/mBio.00027-13</pub-id>
<pub-id pub-id-type="pmid">23532974</pub-id>
</element-citation>
</ref>
<ref id="CR112">
<label>112.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cho</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Blaser</surname>
<given-names>MJ</given-names>
</name>
</person-group>
<article-title>The human microbiome: at the interface of health and disease</article-title>
<source/>Nat Rev Genet
          <year>2012</year>
<volume>13</volume>
<issue>4</issue>
<fpage>260</fpage>
<lpage>270</lpage>
<pub-id pub-id-type="doi">10.1038/nrg3182</pub-id>
<pub-id pub-id-type="pmid">22411464</pub-id>
</element-citation>
</ref>
<ref id="CR113">
<label>113.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peay</surname>
<given-names>KG</given-names>
</name>
<name>
<surname>Kennedy</surname>
<given-names>PG</given-names>
</name>
<name>
<surname>Talbot</surname>
<given-names>JM</given-names>
</name>
</person-group>
<article-title>Dimensions of biodiversity in the Earth mycobiome</article-title>
<source/>Nat Rev Microbiol
          <year>2016</year>
<volume>14</volume>
<issue>7</issue>
<fpage>434</fpage>
<lpage>447</lpage>
<pub-id pub-id-type="doi">10.1038/nrmicro.2016.59</pub-id>
<pub-id pub-id-type="pmid">27296482</pub-id>
</element-citation>
</ref>
<ref id="CR114">
<label>114.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Findley</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Oh</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Conlan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Deming</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Meyer</surname>
<given-names>JA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Topographic diversity of fungal and bacterial communities in human skin</article-title>
<source/>Nature
          <year>2013</year>
<volume>498</volume>
<fpage>367</fpage>
<pub-id pub-id-type="doi">10.1038/nature12171</pub-id>
<pub-id pub-id-type="pmid">23698366</pub-id>
</element-citation>
</ref>
<ref id="CR115">
<label>115.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Limon</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Skalski</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Underhill</surname>
<given-names>DM</given-names>
</name>
</person-group>
<article-title>Commensal fungi in health and disease</article-title>
<source/>Cell Host Microbe
          <year>2017</year>
<volume>22</volume>
<issue>2</issue>
<fpage>156</fpage>
<lpage>165</lpage>
<pub-id pub-id-type="doi">10.1016/j.chom.2017.07.002</pub-id>
<pub-id pub-id-type="pmid">28799901</pub-id>
</element-citation>
</ref>
<ref id="CR116">
<label>116.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ghannoum</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Jurevic</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Mukherjee</surname>
<given-names>PK</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Sikaroodi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Naqvi</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Characterization of the oral fungal microbiome (mycobiome) in healthy individuals</article-title>
<source/>PLoS Pathog
          <year>2010</year>
<volume>6</volume>
<issue>1</issue>
<fpage>e1000713</fpage>
<pub-id pub-id-type="doi">10.1371/journal.ppat.1000713</pub-id>
<pub-id pub-id-type="pmid">20072605</pub-id>
</element-citation>
</ref>
<ref id="CR117">
<label>117.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mac Aogain</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Chandrasekaran</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>AYH</given-names>
</name>
<name>
<surname>Low</surname>
<given-names>TB</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>GL</given-names>
</name>
<name>
<surname>Hassan</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Immunological corollary of the pulmonary mycobiome in bronchiectasis: the CAMEB study</article-title>
<source/>Eur Respir J
          <year>2018</year>
<volume>52</volume>
<issue>1</issue>
<fpage>1800766</fpage>
<pub-id pub-id-type="doi">10.1183/13993003.00766-2018</pub-id>
<pub-id pub-id-type="pmid">29880655</pub-id>
</element-citation>
</ref>
<ref id="CR118">
<label>118.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Budden</surname>
<given-names>KF</given-names>
</name>
<name>
<surname>Shukla</surname>
<given-names>SD</given-names>
</name>
<name>
<surname>Rehman</surname>
<given-names>SF</given-names>
</name>
<name>
<surname>Bowerman</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>Keely</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hugenholtz</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Functional effects of the microbiota in chronic respiratory disease</article-title>
<source/>Lancet Respir Med
          <year>2019</year>
<volume>7</volume>
<fpage>907</fpage>
<lpage>920</lpage>
<pub-id pub-id-type="doi">10.1016/S2213-2600(18)30510-1</pub-id>
<pub-id pub-id-type="pmid">30975495</pub-id>
</element-citation>
</ref>
<ref id="CR119">
<label>119.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kong</surname>
<given-names>HH</given-names>
</name>
<name>
<surname>Morris</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>The emerging importance and challenges of the human mycobiome</article-title>
<source/>Virulence
          <year>2017</year>
<volume>8</volume>
<issue>3</issue>
<fpage>310</fpage>
<lpage>312</lpage>
<pub-id pub-id-type="doi">10.1080/21505594.2017.1279780</pub-id>
<pub-id pub-id-type="pmid">28102762</pub-id>
</element-citation>
</ref>
<ref id="CR120">
<label>120.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tipton</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Müller</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Kurtz</surname>
<given-names>ZD</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Kleerup</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Morris</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Fungi stabilize connectivity in the lung and skin microbial ecosystems</article-title>
<source/>Microbiome
          <year>2018</year>
<volume>6</volume>
<issue>1</issue>
<fpage>12</fpage>
<pub-id pub-id-type="doi">10.1186/s40168-017-0393-0</pub-id>
<pub-id pub-id-type="pmid">29335027</pub-id>
</element-citation>
</ref>
<ref id="CR121">
<label>121.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lyon</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>The lung microbiome: key to respiratory Ills?</article-title>
<source/>JAMA
          <year>2017</year>
<volume>317</volume>
<issue>17</issue>
<fpage>1713</fpage>
<lpage>1714</lpage>
<pub-id pub-id-type="doi">10.1001/jama.2017.3023</pub-id>
<pub-id pub-id-type="pmid">28403451</pub-id>
</element-citation>
</ref>
<ref id="CR122">
<label>122.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Leonardi</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Semon</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Doron</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>IH</given-names>
</name>
<name>
<surname>Putzel</surname>
<given-names>GG</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Response to fungal dysbiosis by gut-resident CX3CR1 + mononuclear phagocytes aggravates allergic airway disease</article-title>
<source/>Cell Host Microbe
          <year>2018</year>
<volume>24</volume>
<issue>6</issue>
<fpage>847</fpage>
<lpage>856</lpage>
<pub-id pub-id-type="doi">10.1016/j.chom.2018.11.003</pub-id>
<pub-id pub-id-type="pmid">30503509</pub-id>
</element-citation>
</ref>
<ref id="CR123">
<label>123.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Skalski</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Limon</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Gargus</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Expansion of commensal fungus <italic>Wallemia mellicola</italic> in the gastrointestinal mycobiota enhances the severity of allergic airway disease in mice</article-title>
<source/>PLoS Pathog
          <year>2018</year>
<volume>14</volume>
<issue>9</issue>
<fpage>e1007260-e</fpage>
<pub-id pub-id-type="doi">10.1371/journal.ppat.1007260</pub-id>
<pub-id pub-id-type="pmid">30235351</pub-id>
</element-citation>
</ref>
<ref id="CR124">
<label>124.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bacher</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Hohnstein</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Beerbaum</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Rocker</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Blango</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Kaufmann</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Human anti-fungal Th17 immunity and pathology rely on cross-reactivity against <italic>Candida albicans</italic></article-title>
<source/>Cell
          <year>2019</year>
<volume>176</volume>
<issue>6</issue>
<fpage>1340–55 e15</fpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2019.01.041</pub-id>
<pub-id pub-id-type="pmid">30799037</pub-id>
</element-citation>
</ref>
<ref id="CR125">
<label>125.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Noverr</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Falkowski</surname>
<given-names>NR</given-names>
</name>
<name>
<surname>McDonald</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>McKenzie</surname>
<given-names>AN</given-names>
</name>
<name>
<surname>Huffnagle</surname>
<given-names>GB</given-names>
</name>
</person-group>
<article-title>Development of allergic airway disease in mice following antibiotic therapy and fungal microbiota increase: role of host genetics, antigen, and interleukin-13</article-title>
<source/>Infect Immun
          <year>2005</year>
<volume>73</volume>
<issue>1</issue>
<fpage>30</fpage>
<lpage>38</lpage>
<pub-id pub-id-type="doi">10.1128/IAI.73.1.30-38.2005</pub-id>
<pub-id pub-id-type="pmid">15618138</pub-id>
</element-citation>
</ref>
<ref id="CR126">
<label>126.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krause</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Moissl-Eichinger</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Halwachs</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Gorkiewicz</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Berg</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Valentin</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mycobiome in the lower respiratory tract—a clinical perspective</article-title>
<source/>Front Microbiol
          <year>2017</year>
<volume>7</volume>
<fpage>2169</fpage>
<pub-id pub-id-type="doi">10.3389/fmicb.2016.02169</pub-id>
<pub-id pub-id-type="pmid">28119685</pub-id>
</element-citation>
</ref>
<ref id="CR127">
<label>127.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nguyen</surname>
<given-names>LD</given-names>
</name>
<name>
<surname>Viscogliosi</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Delhaes</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>The lung mycobiome: an emerging field of the human respiratory microbiome</article-title>
<source/>Front Microbiol
          <year>2015</year>
<volume>6</volume>
<fpage>89</fpage>
<pub-id pub-id-type="pmid">25762987</pub-id>
</element-citation>
</ref>
<ref id="CR128">
<label>128.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tipton</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Ghedin</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Morris</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>The lung mycobiome in the next-generation sequencing era</article-title>
<source/>Virulence
          <year>2017</year>
<volume>8</volume>
<issue>3</issue>
<fpage>334</fpage>
<lpage>341</lpage>
<pub-id pub-id-type="doi">10.1080/21505594.2016.1235671</pub-id>
<pub-id pub-id-type="pmid">27687858</pub-id>
</element-citation>
</ref>
<ref id="CR129">
<label>129.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fraczek</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Chishimba</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Niven</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Bromley</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Simpson</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Smyth</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Corticosteroid treatment is associated with increased filamentous fungal burden in allergic fungal disease</article-title>
<source/>J Allergy Clin Immunol
          <year>2018</year>
<volume>142</volume>
<issue>2</issue>
<fpage>407</fpage>
<lpage>414</lpage>
<pub-id pub-id-type="doi">10.1016/j.jaci.2017.09.039</pub-id>
<pub-id pub-id-type="pmid">29122659</pub-id>
</element-citation>
</ref>
<ref id="CR130">
<label>130.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>van Woerden</surname>
<given-names>HC</given-names>
</name>
<name>
<surname>Gregory</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Marchesi</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Hoogendoorn</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Matthews</surname>
<given-names>IP</given-names>
</name>
</person-group>
<article-title>Differences in fungi present in induced sputum samples from asthma patients and non-atopic controls: a community based case control study</article-title>
<source/>BMC Infect Dis
          <year>2013</year>
<volume>13</volume>
<fpage>69</fpage>
<pub-id pub-id-type="doi">10.1186/1471-2334-13-69</pub-id>
<pub-id pub-id-type="pmid">23384395</pub-id>
</element-citation>
</ref>
<ref id="CR131">
<label>131.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goldman</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Shankar</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Tyberg</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Vicencio</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Burk</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Lower airway microbiota and mycobiota in children with severe asthma</article-title>
<source/>J Allergy Clin Immunol
          <year>2018</year>
<volume>141</volume>
<issue>2</issue>
<fpage>808–11 e7</fpage>
<pub-id pub-id-type="doi">10.1016/j.jaci.2017.09.018</pub-id>
<pub-id pub-id-type="pmid">29031597</pub-id>
</element-citation>
</ref>
<ref id="CR132">
<label>132.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chandrasekaran</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Mac Aogáin</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Chalmers</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Elborn</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Chotirmall</surname>
<given-names>SH</given-names>
</name>
</person-group>
<article-title>Geographic variation in the aetiology, epidemiology and microbiology of bronchiectasis</article-title>
<source/>BMC Pulm Med
          <year>2018</year>
<volume>18</volume>
<issue>1</issue>
<fpage>83</fpage>
<pub-id pub-id-type="doi">10.1186/s12890-018-0638-0</pub-id>
<pub-id pub-id-type="pmid">29788932</pub-id>
</element-citation>
</ref>
<ref id="CR133">
<label>133.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mac Aogain</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tiew</surname>
<given-names>PY</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>AYH</given-names>
</name>
<name>
<surname>Low</surname>
<given-names>TB</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>GL</given-names>
</name>
<name>
<surname>Hassan</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Distinct ‘immuno-allertypes’ of disease and high frequencies of sensitisation in non-cystic-fibrosis bronchiectasis</article-title>
<source/>Am J Respir Crit Care Med
          <year>2018</year>
<volume>199</volume>
<fpage>842</fpage>
<lpage>853</lpage>
<pub-id pub-id-type="doi">10.1164/rccm.201807-1355OC</pub-id>
</element-citation>
</ref>
<ref id="CR134">
<label>134.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Máiz</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Nieto</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Cantón</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Gómez</surname>
<given-names>G</given-names>
</name>
<name>
<surname>de la Pedrosa</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Martinez-García</surname>
<given-names>MÁ</given-names>
</name>
</person-group>
<article-title>Fungi in bronchiectasis: a concise review</article-title>
<source/>Int J Mol Sci
          <year>2018</year>
<volume>19</volume>
<issue>1</issue>
<fpage>142</fpage>
<pub-id pub-id-type="doi">10.3390/ijms19010142</pub-id>
</element-citation>
</ref>
<ref id="CR135">
<label>135.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Veerdonk</surname>
<given-names>EKFLvd</given-names>
</name>
</person-group>
<article-title>The potential impact of the pulmonary microbiome on immunopathogenesis of <italic>Aspergillus</italic> related lung disease</article-title>
<source/>Eur J Immunol
          <year>2014</year>
<volume>44</volume>
<issue>11</issue>
<fpage>3156</fpage>
<lpage>3165</lpage>
<pub-id pub-id-type="doi">10.1002/eji.201344404</pub-id>
<pub-id pub-id-type="pmid">25256637</pub-id>
</element-citation>
</ref>
<ref id="CR136">
<label>136.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lawani</surname>
<given-names>MB</given-names>
</name>
<name>
<surname>Morris</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>The respiratory microbiome of HIV-infected individuals</article-title>
<source/>Expert Rev Anti infect Ther
          <year>2016</year>
<volume>14</volume>
<issue>8</issue>
<fpage>719</fpage>
<lpage>729</lpage>
<pub-id pub-id-type="doi">10.1080/14787210.2016.1206469</pub-id>
<pub-id pub-id-type="pmid">27348261</pub-id>
</element-citation>
</ref>
<ref id="CR137">
<label>137.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cui</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Lucht</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Tipton</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Rogers</surname>
<given-names>MB</given-names>
</name>
<name>
<surname>Fitch</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kessinger</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Topographic diversity of the respiratory tract mycobiome and alteration in HIV and lung disease</article-title>
<source/>Am J Respir Crit Care Med
          <year>2015</year>
<volume>191</volume>
<issue>8</issue>
<fpage>932</fpage>
<lpage>942</lpage>
<pub-id pub-id-type="doi">10.1164/rccm.201409-1583OC</pub-id>
<pub-id pub-id-type="pmid">25603113</pub-id>
</element-citation>
</ref>
<ref id="CR138">
<label>138.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lipuma</surname>
<given-names>JJ</given-names>
</name>
</person-group>
<article-title>The changing microbial epidemiology in cystic fibrosis</article-title>
<source/>Clin Microbiol Rev
          <year>2010</year>
<volume>23</volume>
<issue>2</issue>
<fpage>299</fpage>
<lpage>323</lpage>
<pub-id pub-id-type="doi">10.1128/CMR.00068-09</pub-id>
<pub-id pub-id-type="pmid">20375354</pub-id>
</element-citation>
</ref>
<ref id="CR139">
<label>139.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Delhaes</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Monchy</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Frealle</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Hubans</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Salleron</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Leroy</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The airway microbiota in cystic fibrosis: a complex fungal and bacterial community–implications for therapeutic management</article-title>
<source/>PLoS ONE
          <year>2012</year>
<volume>7</volume>
<issue>4</issue>
<fpage>e36313</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0036313</pub-id>
<pub-id pub-id-type="pmid">22558432</pub-id>
</element-citation>
</ref>
<ref id="CR140">
<label>140.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mounier</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gouello</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Keravec</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Le Gal</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Pacini</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Debaets</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Use of denaturing high-performance liquid chromatography (DHPLC) to characterize the bacterial and fungal airway microbiota of cystic fibrosis patients</article-title>
<source/>J Microbiol
          <year>2014</year>
<volume>52</volume>
<issue>4</issue>
<fpage>307</fpage>
<lpage>314</lpage>
<pub-id pub-id-type="doi">10.1007/s12275-014-3425-5</pub-id>
<pub-id pub-id-type="pmid">24535743</pub-id>
</element-citation>
</ref>
<ref id="CR141">
<label>141.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Willger</surname>
<given-names>SD</given-names>
</name>
<name>
<surname>Grim</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Dolben</surname>
<given-names>EL</given-names>
</name>
<name>
<surname>Shipunova</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hampton</surname>
<given-names>TH</given-names>
</name>
<name>
<surname>Morrison</surname>
<given-names>HG</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Characterization and quantification of the fungal microbiome in serial samples from individuals with cystic fibrosis</article-title>
<source/>Microbiome
          <year>2014</year>
<volume>2</volume>
<fpage>40</fpage>
<pub-id pub-id-type="doi">10.1186/2049-2618-2-40</pub-id>
<pub-id pub-id-type="pmid">25408892</pub-id>
</element-citation>
</ref>
<ref id="CR142">
<label>142.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Clark</surname>
<given-names>ST</given-names>
</name>
<name>
<surname>Surendra</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Copeland</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>PW</given-names>
</name>
<name>
<surname>Ammar</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Global analysis of the fungal microbiome in cystic fibrosis patients reveals loss of function of the transcriptional repressor Nrg1 as a mechanism of pathogen adaptation</article-title>
<source/>PLoS Pathog
          <year>2015</year>
<volume>11</volume>
<issue>11</issue>
<fpage>e1005308</fpage>
<pub-id pub-id-type="doi">10.1371/journal.ppat.1005308</pub-id>
<pub-id pub-id-type="pmid">26588216</pub-id>
</element-citation>
</ref>
<ref id="CR143">
<label>143.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kramer</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Sauer-Heilborn</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Welte</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Guzman</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Abraham</surname>
<given-names>WR</given-names>
</name>
<name>
<surname>Hofle</surname>
<given-names>MG</given-names>
</name>
</person-group>
<article-title>Cohort Study of Airway Mycobiome in Adult Cystic Fibrosis Patients: differences in Community Structure between Fungi and Bacteria Reveal Predominance of Transient Fungal Elements</article-title>
<source/>J Clin Microbiol
          <year>2015</year>
<volume>53</volume>
<issue>9</issue>
<fpage>2900</fpage>
<lpage>2907</lpage>
<pub-id pub-id-type="doi">10.1128/JCM.01094-15</pub-id>
<pub-id pub-id-type="pmid">26135861</pub-id>
</element-citation>
</ref>
<ref id="CR144">
<label>144.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Richardson</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bowyer</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Sabino</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>The human lung and <italic>Aspergillus</italic>: You are what you breathe in?</article-title>
<source/>Med Mycol
          <year>2019</year>
<volume>57</volume>
<issue>2</issue>
<fpage>S145</fpage>
<lpage>S154</lpage>
<pub-id pub-id-type="doi">10.1093/mmy/myy149</pub-id>
<pub-id pub-id-type="pmid">30816978</pub-id>
</element-citation>
</ref>
<ref id="CR145">
<label>145.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McTaggart</surname>
<given-names>LR</given-names>
</name>
<name>
<surname>Copeland</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Surendra</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>PW</given-names>
</name>
<name>
<surname>Husain</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Coburn</surname>
<given-names>B</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mycobiome sequencing and analysis applied to fungal community profiling of the lower respiratory tract during fungal pathogenesis</article-title>
<source/>Front Microbiol
          <year>2019</year>
<volume>10</volume>
<fpage>512</fpage>
<pub-id pub-id-type="doi">10.3389/fmicb.2019.00512</pub-id>
<pub-id pub-id-type="pmid">30930884</pub-id>
</element-citation>
</ref>
<ref id="CR146">
<label>146.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoggard</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Vesty</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Montgomery</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Fourie</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Douglas</surname>
<given-names>RG</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Characterizing the human mycobiota: a comparison of small subunit rRNA, ITS1, ITS2, and large subunit rRNA genomic targets</article-title>
<source/>Front Microbiol
          <year>2018</year>
<volume>9</volume>
<fpage>2208</fpage>
<pub-id pub-id-type="doi">10.3389/fmicb.2018.02208</pub-id>
<pub-id pub-id-type="pmid">30283425</pub-id>
</element-citation>
</ref>
<ref id="CR147">
<label>147.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>C</given-names>
</name>
<name>
<surname>He</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Dysbiosis of gut fungal microbiota is associated with mucosal inflammation in Crohn’s disease</article-title>
<source/>J Clin Gastroenterol
          <year>2014</year>
<volume>48</volume>
<issue>6</issue>
<fpage>513</fpage>
<pub-id pub-id-type="doi">10.1097/MCG.0000000000000035</pub-id>
<pub-id pub-id-type="pmid">24275714</pub-id>
</element-citation>
</ref>
<ref id="CR148">
<label>148.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ott</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Kühbacher</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Musfeldt</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rosenstiel</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Hellmig</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Rehman</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Fungi and inflammatory bowel diseases: alterations of composition and diversity</article-title>
<source/>Scand J Gastroenterol
          <year>2008</year>
<volume>43</volume>
<issue>7</issue>
<fpage>831</fpage>
<lpage>841</lpage>
<pub-id pub-id-type="doi">10.1080/00365520801935434</pub-id>
<pub-id pub-id-type="pmid">18584522</pub-id>
</element-citation>
</ref>
<ref id="CR149">
<label>149.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sokol</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Leducq</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Aschard</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Pham</surname>
<given-names>H-P</given-names>
</name>
<name>
<surname>Jegou</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Landman</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Fungal microbiota dysbiosis in IBD</article-title>
<source/>Gut
          <year>2017</year>
<volume>66</volume>
<issue>6</issue>
<fpage>1039</fpage>
<lpage>1048</lpage>
<pub-id pub-id-type="doi">10.1136/gutjnl-2015-310746</pub-id>
<pub-id pub-id-type="pmid">26843508</pub-id>
</element-citation>
</ref>
<ref id="CR150">
<label>150.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoarau</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Mukherjee</surname>
<given-names>PK</given-names>
</name>
<name>
<surname>Gower-Rousseau</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Hager</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Chandra</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Retuerto</surname>
<given-names>MA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Bacteriome and mycobiome interactions underscore microbial dysbiosis in familial Crohn’s disease</article-title>
<source/>MBio
          <year>2016</year>
<volume>7</volume>
<issue>5</issue>
<fpage>e01250-16</fpage>
<pub-id pub-id-type="doi">10.1128/mBio.01250-16</pub-id>
<pub-id pub-id-type="pmid">27651359</pub-id>
</element-citation>
</ref>
<ref id="CR151">
<label>151.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liguori</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Lamas</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Richard</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Brandi</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Da Costa</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Hoffmann</surname>
<given-names>TW</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Fungal dysbiosis in mucosa-associated microbiota of Crohn’s disease patients</article-title>
<source/>J Crohn’s Colitis
          <year>2015</year>
<volume>10</volume>
<issue>3</issue>
<fpage>296</fpage>
<lpage>305</lpage>
<pub-id pub-id-type="doi">10.1093/ecco-jcc/jjv209</pub-id>
<pub-id pub-id-type="pmid">26574491</pub-id>
</element-citation>
</ref>
<ref id="CR152">
<label>152.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Limon</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Wolf</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Michelsen</surname>
<given-names>KS</given-names>
</name>
<name>
<surname>Funari</surname>
<given-names>V</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Malassezia is associated with Crohn’s disease and exacerbates colitis in mouse models</article-title>
<source/>Cell Host Microbe
          <year>2019</year>
<volume>25</volume>
<issue>3</issue>
<fpage>377–88 e6</fpage>
<pub-id pub-id-type="doi">10.1016/j.chom.2019.01.007</pub-id>
<pub-id pub-id-type="pmid">30850233</pub-id>
</element-citation>
</ref>
<ref id="CR153">
<label>153.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wheeler</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Limon</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Bar</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Leal</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Gargus</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Immunological consequences of intestinal fungal dysbiosis</article-title>
<source/>Cell Host Microbe
          <year>2016</year>
<volume>19</volume>
<issue>6</issue>
<fpage>865</fpage>
<lpage>873</lpage>
<pub-id pub-id-type="doi">10.1016/j.chom.2016.05.003</pub-id>
<pub-id pub-id-type="pmid">27237365</pub-id>
</element-citation>
</ref>
<ref id="CR154">
<label>154.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sovran</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Planchais</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Jegou</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Straube</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lamas</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Natividad</surname>
<given-names>JM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Enterobacteriaceae are essential for the modulation of colitis severity by fungi</article-title>
<source/>Microbiome
          <year>2018</year>
<volume>6</volume>
<issue>1</issue>
<fpage>152</fpage>
<pub-id pub-id-type="doi">10.1186/s40168-018-0538-9</pub-id>
<pub-id pub-id-type="pmid">30172257</pub-id>
</element-citation>
</ref>
<ref id="CR155">
<label>155.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mukhopadhya</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Hansen</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Meharg</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Thomson</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Russell</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Berry</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The fungal microbiota of de-novo paediatric inflammatory bowel disease</article-title>
<source/>Microbes Infect
          <year>2015</year>
<volume>17</volume>
<issue>4</issue>
<fpage>304</fpage>
<lpage>310</lpage>
<pub-id pub-id-type="doi">10.1016/j.micinf.2014.12.001</pub-id>
<pub-id pub-id-type="pmid">25522934</pub-id>
</element-citation>
</ref>
<ref id="CR156">
<label>156.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chehoud</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Albenberg</surname>
<given-names>LG</given-names>
</name>
<name>
<surname>Judge</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Hoffmann</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Grunberg</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bittinger</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Fungal signature in the gut microbiota of pediatric patients with inflammatory bowel disease</article-title>
<source/>Inflamm Bowel Dis
          <year>2015</year>
<volume>21</volume>
<issue>8</issue>
<fpage>1948</fpage>
<lpage>1956</lpage>
<pub-id pub-id-type="doi">10.1097/MIB.0000000000000454</pub-id>
<pub-id pub-id-type="pmid">26083617</pub-id>
</element-citation>
</ref>
<ref id="CR157">
<label>157.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Qin</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>The potential role of gut mycobiome in irritable bowel syndrome</article-title>
<source/>Front Microbiol
          <year>2019</year>
<volume>10</volume>
<fpage>1894</fpage>
<pub-id pub-id-type="doi">10.3389/fmicb.2019.01894</pub-id>
<pub-id pub-id-type="pmid">31497000</pub-id>
</element-citation>
</ref>
<ref id="CR158">
<label>158.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Botschuijver</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Roeselers</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Levin</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Jonkers</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Welting</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Heinsbroek</surname>
<given-names>SEM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Intestinal fungal dysbiosis is associated with visceral hypersensitivity in patients with irritable bowel syndrome and rats</article-title>
<source/>Gastroenterology
          <year>2017</year>
<volume>153</volume>
<issue>4</issue>
<fpage>1026</fpage>
<lpage>1039</lpage>
<pub-id pub-id-type="doi">10.1053/j.gastro.2017.06.004</pub-id>
<pub-id pub-id-type="pmid">28624575</pub-id>
</element-citation>
</ref>
<ref id="CR159">
<label>159.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Botschuijver</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Welting</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Levin</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Maria-Ferreira</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Koch</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Montijn</surname>
<given-names>RC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Reversal of visceral hypersensitivity in rat by Menthacarin<sup>®</sup>, a proprietary combination of essential oils from peppermint and caraway, coincides with mycobiome modulation</article-title>
<source/>Neurogastroenterol Motil
          <year>2018</year>
<volume>30</volume>
<issue>6</issue>
<fpage>e13299</fpage>
<pub-id pub-id-type="doi">10.1111/nmo.13299</pub-id>
<pub-id pub-id-type="pmid">29383802</pub-id>
</element-citation>
</ref>
<ref id="CR160">
<label>160.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aykut</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Pushalkar</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Abengozar</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>JI</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The fungal mycobiome promotes pancreatic oncogenesis via activation of MBL</article-title>
<source/>Nature
          <year>2019</year>
<volume>574</volume>
<fpage>264</fpage>
<lpage>267</lpage>
<pub-id pub-id-type="doi">10.1038/s41586-019-1608-2</pub-id>
<pub-id pub-id-type="pmid">31578522</pub-id>
</element-citation>
</ref>
<ref id="CR161">
<label>161.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coker</surname>
<given-names>OO</given-names>
</name>
<name>
<surname>Nakatsu</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Dai</surname>
<given-names>RZ</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>WKK</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Ng</surname>
<given-names>SC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Enteric fungal microbiota dysbiosis and ecological alterations in colorectal cancer</article-title>
<source/>Gut
          <year>2019</year>
<volume>68</volume>
<issue>4</issue>
<fpage>654</fpage>
<lpage>662</lpage>
<pub-id pub-id-type="doi">10.1136/gutjnl-2018-317178</pub-id>
<pub-id pub-id-type="pmid">30472682</pub-id>
</element-citation>
</ref>
<ref id="CR162">
<label>162.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luan</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Miao</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Lv</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Dysbiosis of fungal microbiota in the intestinal mucosa of patients with colorectal adenomas</article-title>
<source/>Sci Rep
          <year>2015</year>
<volume>5</volume>
<fpage>7980</fpage>
<pub-id pub-id-type="doi">10.1038/srep07980</pub-id>
<pub-id pub-id-type="pmid">25613490</pub-id>
</element-citation>
</ref>
<ref id="CR163">
<label>163.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Severance</surname>
<given-names>EG</given-names>
</name>
<name>
<surname>Alaedini</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Halling</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gressitt</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>Stallings</surname>
<given-names>CR</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gastrointestinal inflammation and associated immune activation in schizophrenia</article-title>
<source/>Schizophr Res
          <year>2012</year>
<volume>138</volume>
<issue>1</issue>
<fpage>48</fpage>
<lpage>53</lpage>
<pub-id pub-id-type="doi">10.1016/j.schres.2012.02.025</pub-id>
<pub-id pub-id-type="pmid">22446142</pub-id>
</element-citation>
</ref>
<ref id="CR164">
<label>164.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Severance</surname>
<given-names>EG</given-names>
</name>
<name>
<surname>Gressitt</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>Stallings</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Katsafanas</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Schweinfurth</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Savage</surname>
<given-names>CL</given-names>
</name>
<etal></etal>
</person-group>
<article-title><italic>Candida albicans</italic> exposures, sex specificity and cognitive deficits in schizophrenia and bipolar disorder</article-title>
<source/>NPJ Schizophr
          <year>2016</year>
<volume>2</volume>
<fpage>16018</fpage>
<pub-id pub-id-type="doi">10.1038/npjschz.2016.18</pub-id>
<pub-id pub-id-type="pmid">27336058</pub-id>
</element-citation>
</ref>
<ref id="CR165">
<label>165.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Strati</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Cavalieri</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Albanese</surname>
<given-names>D</given-names>
</name>
<name>
<surname>De Felice</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Donati</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Hayek</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Altered gut microbiota in Rett syndrome</article-title>
<source/>Microbiome
          <year>2016</year>
<volume>4</volume>
<issue>1</issue>
<fpage>41</fpage>
<pub-id pub-id-type="doi">10.1186/s40168-016-0185-y</pub-id>
<pub-id pub-id-type="pmid">27473171</pub-id>
</element-citation>
</ref>
<ref id="CR166">
<label>166.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Strati</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Cavalieri</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Albanese</surname>
<given-names>D</given-names>
</name>
<name>
<surname>De Felice</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Donati</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Hayek</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>New evidences on the altered gut microbiota in autism spectrum disorders</article-title>
<source/>Microbiome
          <year>2017</year>
<volume>5</volume>
<issue>1</issue>
<fpage>24</fpage>
<pub-id pub-id-type="doi">10.1186/s40168-017-0242-1</pub-id>
<pub-id pub-id-type="pmid">28222761</pub-id>
</element-citation>
</ref>
<ref id="CR167">
<label>167.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dinan</surname>
<given-names>TG</given-names>
</name>
<name>
<surname>Cryan</surname>
<given-names>JF</given-names>
</name>
</person-group>
<article-title>The microbiome–gut–brain axis in health and disease</article-title>
<source/>Gastroenterol Clin N Am
          <year>2017</year>
<volume>46</volume>
<issue>1</issue>
<fpage>77</fpage>
<lpage>89</lpage>
<pub-id pub-id-type="doi">10.1016/j.gtc.2016.09.007</pub-id>
</element-citation>
</ref>
<ref id="CR168">
<label>168.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thijssen</surname>
<given-names>AY</given-names>
</name>
<name>
<surname>Jonkers</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Leue</surname>
<given-names>C</given-names>
</name>
<name>
<surname>van der Veek</surname>
<given-names>PP</given-names>
</name>
<name>
<surname>Vidakovic-Vukic</surname>
<given-names>M</given-names>
</name>
<name>
<surname>van Rood</surname>
<given-names>YR</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Dysfunctional cognitions, anxiety and depression in irritable bowel syndrome</article-title>
<source/>J Clin Gastroenterol
          <year>2010</year>
<volume>44</volume>
<issue>10</issue>
<fpage>e236</fpage>
<lpage>e241</lpage>
<pub-id pub-id-type="doi">10.1097/MCG.0b013e3181eed5d8</pub-id>
<pub-id pub-id-type="pmid">20733511</pub-id>
</element-citation>
</ref>
<ref id="CR169">
<label>169.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname>
<given-names>CO</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Teague</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Collins</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Staged development of long-lived T-cell receptor alphabeta TH17 resident memory T-cell population to <italic>Candida albicans</italic> after skin infection</article-title>
<source/>J Allergy Clin Immunol
          <year>2018</year>
<volume>142</volume>
<issue>2</issue>
<fpage>647</fpage>
<lpage>662</lpage>
<pub-id pub-id-type="doi">10.1016/j.jaci.2017.09.042</pub-id>
<pub-id pub-id-type="pmid">29128674</pub-id>
</element-citation>
</ref>
<ref id="CR170">
<label>170.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lagunes</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Rello</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Invasive candidiasis: from mycobiome to infection, therapy, and prevention</article-title>
<source/>Eur J Clin Microbiol Infect Dis
          <year>2016</year>
<volume>35</volume>
<issue>8</issue>
<fpage>1221</fpage>
<lpage>1226</lpage>
<pub-id pub-id-type="doi">10.1007/s10096-016-2658-0</pub-id>
<pub-id pub-id-type="pmid">27146877</pub-id>
</element-citation>
</ref>
<ref id="CR171">
<label>171.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jo</surname>
<given-names>J-H</given-names>
</name>
<name>
<surname>Deming</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Kennedy</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Conlan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Polley</surname>
<given-names>EC</given-names>
</name>
<name>
<surname>Ng</surname>
<given-names>W-I</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Diverse human skin fungal communities in children converge in adulthood</article-title>
<source/>J Invest Dermatol
          <year>2016</year>
<volume>136</volume>
<issue>12</issue>
<fpage>2356</fpage>
<lpage>2363</lpage>
<pub-id pub-id-type="doi">10.1016/j.jid.2016.05.130</pub-id>
<pub-id pub-id-type="pmid">27476723</pub-id>
</element-citation>
</ref>
<ref id="CR172">
<label>172.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kalan</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Loesche</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hodkinson</surname>
<given-names>BP</given-names>
</name>
<name>
<surname>Heilmann</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ruthel</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Gardner</surname>
<given-names>SE</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Redefining the chronic-wound microbiome: fungal communities are prevalent, dynamic, and associated with delayed healing</article-title>
<source/>mBio
          <year>2016</year>
<volume>7</volume>
<issue>5</issue>
<fpage>e01058–16</fpage>
<pub-id pub-id-type="doi">10.1128/mBio.01058-16</pub-id>
<pub-id pub-id-type="pmid">27601572</pub-id>
</element-citation>
</ref>
<ref id="CR173">
<label>173.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wheeler</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Limon</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Underhill</surname>
<given-names>DM</given-names>
</name>
</person-group>
<article-title>Immunity to commensal fungi: detente and disease</article-title>
<source/>Ann Rev Pathol
          <year>2017</year>
<volume>12</volume>
<fpage>359</fpage>
<lpage>385</lpage>
<pub-id pub-id-type="doi">10.1146/annurev-pathol-052016-100342</pub-id>
<pub-id pub-id-type="pmid">28068483</pub-id>
</element-citation>
</ref>
<ref id="CR174">
<label>174.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yan</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Issa</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Afifi</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Jeon</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>HW</given-names>
</name>
<name>
<surname>Liao</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>The role of the skin and gut microbiome in psoriatic disease</article-title>
<source/>Curr Dermatol Rep
          <year>2017</year>
<volume>6</volume>
<issue>2</issue>
<fpage>94</fpage>
<lpage>103</lpage>
<pub-id pub-id-type="doi">10.1007/s13671-017-0178-5</pub-id>
<pub-id pub-id-type="pmid">28804689</pub-id>
</element-citation>
</ref>
<ref id="CR175">
<label>175.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arron</surname>
<given-names>ST</given-names>
</name>
<name>
<surname>Dimon</surname>
<given-names>MT</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Wood</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>Feeney</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>High Rhodotorula sequences in skin transcriptome of patients with diffuse systemic sclerosis</article-title>
<source/>J Invest Dermatol
          <year>2014</year>
<volume>134</volume>
<issue>8</issue>
<fpage>2138</fpage>
<lpage>2145</lpage>
<pub-id pub-id-type="doi">10.1038/jid.2014.127</pub-id>
<pub-id pub-id-type="pmid">24608988</pub-id>
</element-citation>
</ref>
<ref id="CR176">
<label>176.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jo</surname>
<given-names>J-H</given-names>
</name>
<name>
<surname>Kennedy</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Kong</surname>
<given-names>HH</given-names>
</name>
</person-group>
<article-title>Topographical and physiological differences of the skin mycobiome in health and disease</article-title>
<source/>Virulence
          <year>2016</year>
<volume>8</volume>
<issue>3</issue>
<fpage>324</fpage>
<lpage>333</lpage>
<pub-id pub-id-type="doi">10.1080/21505594.2016.1249093</pub-id>
<pub-id pub-id-type="pmid">27754756</pub-id>
</element-citation>
</ref>
<ref id="CR177">
<label>177.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname>
<given-names>HK</given-names>
</name>
<name>
<surname>Ha</surname>
<given-names>M-H</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>S-G</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>MN</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>Characterization of the fungal microbiota (mycobiome) in healthy and dandruff-afflicted human scalps</article-title>
<source/>PLoS ONE
          <year>2012</year>
<volume>7</volume>
<issue>2</issue>
<fpage>e32847-e</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0032847</pub-id>
<pub-id pub-id-type="pmid">22393454</pub-id>
</element-citation>
</ref>
<ref id="CR178">
<label>178.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Johansson</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Vallhov</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Holm</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Gehrmann</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Andersson</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Johansson</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Extracellular nanovesicles released from the commensal yeast <italic>Malassezia sympodialis</italic> are enriched in allergens and interact with cells in human skin</article-title>
<source/>Sci Rep
          <year>2018</year>
<volume>8</volume>
<issue>1</issue>
<fpage>9182</fpage>
<pub-id pub-id-type="doi">10.1038/s41598-018-27451-9</pub-id>
<pub-id pub-id-type="pmid">29907748</pub-id>
</element-citation>
</ref>
<ref id="CR179">
<label>179.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Cheon</surname>
<given-names>HI</given-names>
</name>
<name>
<surname>Hur</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Jung</surname>
<given-names>WH</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>YW</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Analysis of the skin mycobiome in adult patients with atopic dermatitis</article-title>
<source/>Exp Dermatol
          <year>2018</year>
<volume>27</volume>
<issue>4</issue>
<fpage>366</fpage>
<lpage>373</lpage>
<pub-id pub-id-type="doi">10.1111/exd.13500</pub-id>
<pub-id pub-id-type="pmid">29356103</pub-id>
</element-citation>
</ref>
<ref id="CR180">
<label>180.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rayner</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bruhn</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Vallhov</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Andersson</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Billmyre</surname>
<given-names>RB</given-names>
</name>
<name>
<surname>Scheynius</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Identification of small RNAs in extracellular vesicles from the commensal yeast <italic>Malassezia sympodialis</italic></article-title>
<source/>Sci Rep
          <year>2017</year>
<volume>7</volume>
<fpage>39742</fpage>
<pub-id pub-id-type="doi">10.1038/srep39742</pub-id>
<pub-id pub-id-type="pmid">28051166</pub-id>
</element-citation>
</ref>
<ref id="CR181">
<label>181.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sparber</surname>
<given-names>F</given-names>
</name>
<name>
<surname>De Gregorio</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Steckholzer</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ferreira</surname>
<given-names>FM</given-names>
</name>
<name>
<surname>Dolowschiak</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Ruchti</surname>
<given-names>F</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The skin commensal yeast malassezia triggers a type 17 response that coordinates anti-fungal immunity and exacerbates skin inflammation</article-title>
<source/>Cell Host Microbe
          <year>2019</year>
<volume>25</volume>
<issue>3</issue>
<fpage>389</fpage>
<lpage>403</lpage>
<pub-id pub-id-type="doi">10.1016/j.chom.2019.02.002</pub-id>
<pub-id pub-id-type="pmid">30870621</pub-id>
</element-citation>
</ref>
<ref id="CR182">
<label>182.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kraková</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Šoltys</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Puškárová</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bučková</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Jeszeová</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Kucharík</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The microbiomes of a XVIII century mummy from the castle of Krásna Hôrka (Slovakia) and its surrounding environment</article-title>
<source/>Environ Microbiol
          <year>2018</year>
<volume>20</volume>
<issue>9</issue>
<fpage>3294</fpage>
<lpage>3308</lpage>
<pub-id pub-id-type="doi">10.1111/1462-2920.14312</pub-id>
<pub-id pub-id-type="pmid">30051567</pub-id>
</element-citation>
</ref>
<ref id="CR183">
<label>183.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leung</surname>
<given-names>MHY</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>KCK</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>PKH</given-names>
</name>
</person-group>
<article-title>Skin fungal community and its correlation with bacterial community of urban Chinese individuals</article-title>
<source/>Microbiome
          <year>2016</year>
<volume>4</volume>
<issue>1</issue>
<fpage>46</fpage>
<pub-id pub-id-type="doi">10.1186/s40168-016-0192-z</pub-id>
<pub-id pub-id-type="pmid">27558504</pub-id>
</element-citation>
</ref>
<ref id="CR184">
<label>184.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chandra</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Retuerto</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Seite</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Kus</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ghannoum</surname>
<given-names>MA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Effect of an emollient on the mycobiome of atopic dermatitis patients</article-title>
<source/>J Drugs Dermatol JDD
          <year>2018</year>
<volume>17</volume>
<issue>10</issue>
<fpage>1039</fpage>
<lpage>1048</lpage>
<pub-id pub-id-type="pmid">30365583</pub-id>
</element-citation>
</ref>
<ref id="CR185">
<label>185.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Forbes</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Bernstein</surname>
<given-names>CN</given-names>
</name>
<name>
<surname>Tremlett</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Van Domselaar</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Knox</surname>
<given-names>NC</given-names>
</name>
</person-group>
<article-title>A fungal world: could the gut mycobiome be involved in neurological disease?</article-title>
<source/>Front Microbiol.
          <year>2018</year>
<volume>9</volume>
<fpage>3249</fpage>
<pub-id pub-id-type="doi">10.3389/fmicb.2018.03249</pub-id>
<pub-id pub-id-type="pmid">30687254</pub-id>
</element-citation>
</ref>
<ref id="CR186">
<label>186.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tremlett</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Bauer</surname>
<given-names>KC</given-names>
</name>
<name>
<surname>Appel-Cresswell</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Finlay</surname>
<given-names>BB</given-names>
</name>
<name>
<surname>Waubant</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>The gut microbiome in human neurological disease: a review</article-title>
<source/>Ann Neurol
          <year>2017</year>
<volume>81</volume>
<issue>3</issue>
<fpage>369</fpage>
<lpage>382</lpage>
<pub-id pub-id-type="doi">10.1002/ana.24901</pub-id>
<pub-id pub-id-type="pmid">28220542</pub-id>
</element-citation>
</ref>
<ref id="CR187">
<label>187.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alonso</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Fernandez-Fernandez</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Pisa</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Carrasco</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Multiple sclerosis and mixed microbial infections. Direct identification of fungi and bacteria in nervous tissue</article-title>
<source/>Neurobiol Dis
          <year>2018</year>
<volume>117</volume>
<fpage>42</fpage>
<lpage>61</lpage>
<pub-id pub-id-type="doi">10.1016/j.nbd.2018.05.022</pub-id>
<pub-id pub-id-type="pmid">29859870</pub-id>
</element-citation>
</ref>
<ref id="CR188">
<label>188.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jangi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gandhi</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Cox</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>N</given-names>
</name>
<name>
<surname>von Glehn</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Alterations of the human gut microbiome in multiple sclerosis</article-title>
<source/>Nat Commun
          <year>2016</year>
<volume>7</volume>
<fpage>12015</fpage>
<pub-id pub-id-type="doi">10.1038/ncomms12015</pub-id>
<pub-id pub-id-type="pmid">27352007</pub-id>
</element-citation>
</ref>
<ref id="CR189">
<label>189.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tremlett</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Fadrosh</surname>
<given-names>DW</given-names>
</name>
<name>
<surname>Faruqi</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Hart</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Roalstad</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Graves</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gut microbiota composition and relapse risk in pediatric MS: a pilot study</article-title>
<source/>J Neurol Sci
          <year>2016</year>
<volume>363</volume>
<fpage>153</fpage>
<lpage>157</lpage>
<pub-id pub-id-type="doi">10.1016/j.jns.2016.02.042</pub-id>
<pub-id pub-id-type="pmid">27000242</pub-id>
</element-citation>
</ref>
<ref id="CR190">
<label>190.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tremlett</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Fadrosh</surname>
<given-names>DW</given-names>
</name>
<name>
<surname>Faruqi</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Hart</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Roalstad</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gut microbiota in early pediatric multiple sclerosis: a case-control study</article-title>
<source/>Eur J Neurol
          <year>2016</year>
<volume>23</volume>
<issue>8</issue>
<fpage>1308</fpage>
<lpage>1321</lpage>
<pub-id pub-id-type="doi">10.1111/ene.13026</pub-id>
<pub-id pub-id-type="pmid">27176462</pub-id>
</element-citation>
</ref>
<ref id="CR191">
<label>191.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perlejewski</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Bukowska-Osko</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Nakamura</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Motooka</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Stokowy</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Ploski</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Metagenomic analysis of cerebrospinal fluid from patients with multiple sclerosis</article-title>
<source/>Adv Exp Med Biol
          <year>2016</year>
<volume>935</volume>
<fpage>89</fpage>
<lpage>98</lpage>
<pub-id pub-id-type="doi">10.1007/5584_2016_25</pub-id>
<pub-id pub-id-type="pmid">27311319</pub-id>
</element-citation>
</ref>
<ref id="CR192">
<label>192.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jovel</surname>
<given-names>J</given-names>
</name>
<name>
<surname>O’Keefe</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Patterson</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Bording-Jorgensen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Mason</surname>
<given-names>AL</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Cerebrospinal fluid in a small cohort of patients with multiple sclerosis was generally free of microbial DNA</article-title>
<source/>Front Cell Infect Microbiol
          <year>2016</year>
<volume>6</volume>
<fpage>198</fpage>
<pub-id pub-id-type="pmid">28111617</pub-id>
</element-citation>
</ref>
<ref id="CR193">
<label>193.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pisa</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Alonso</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Rabano</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rodal</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Carrasco</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Different brain regions are infected with fungi in Alzheimer’s disease</article-title>
<source/>Sci Rep
          <year>2015</year>
<volume>5</volume>
<fpage>15015</fpage>
<pub-id pub-id-type="doi">10.1038/srep15015</pub-id>
<pub-id pub-id-type="pmid">26468932</pub-id>
</element-citation>
</ref>
<ref id="CR194">
<label>194.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alonso</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Pisa</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Fernandez-Fernandez</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Carrasco</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Infection of fungi and bacteria in brain tissue from elderly persons and patients with Alzheimer’s disease</article-title>
<source/>Front Aging Neurosci
          <year>2018</year>
<volume>10</volume>
<fpage>159</fpage>
<pub-id pub-id-type="doi">10.3389/fnagi.2018.00159</pub-id>
<pub-id pub-id-type="pmid">29881346</pub-id>
</element-citation>
</ref>
<ref id="CR195">
<label>195.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alonso</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Pisa</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Fernandez-Fernandez</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Rabano</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Carrasco</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Fungal infection in neural tissue of patients with amyotrophic lateral sclerosis</article-title>
<source/>Neurobiol Dis
          <year>2017</year>
<volume>108</volume>
<fpage>249</fpage>
<lpage>260</lpage>
<pub-id pub-id-type="doi">10.1016/j.nbd.2017.09.001</pub-id>
<pub-id pub-id-type="pmid">28888971</pub-id>
</element-citation>
</ref>
<ref id="CR196">
<label>196.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Laurence</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Benito-Leon</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Calon</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Malassezia and Parkinson’s disease</article-title>
<source/>Front Neurol
          <year>2019</year>
<volume>10</volume>
<fpage>758</fpage>
<pub-id pub-id-type="doi">10.3389/fneur.2019.00758</pub-id>
<pub-id pub-id-type="pmid">31396143</pub-id>
</element-citation>
</ref>
<ref id="CR197">
<label>197.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baxi</surname>
<given-names>SN</given-names>
</name>
<name>
<surname>Portnoy</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Larenas-Linnemann</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Phipatanakul</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>Exposure and health effects of fungi on humans</article-title>
<source/>J Allergy Clin Immunol Pract
          <year>2016</year>
<volume>4</volume>
<issue>3</issue>
<fpage>396</fpage>
<lpage>404</lpage>
<pub-id pub-id-type="doi">10.1016/j.jaip.2016.01.008</pub-id>
<pub-id pub-id-type="pmid">26947460</pub-id>
</element-citation>
</ref>
<ref id="CR198">
<label>198.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seo</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ji</surname>
<given-names>YG</given-names>
</name>
<name>
<surname>Yoo</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kwon</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Choung</surname>
<given-names>JT</given-names>
</name>
</person-group>
<article-title>Submicron fungal fragments as another indoor biocontaminant in elementary schools</article-title>
<source/>Environ Sci Process Impacts
          <year>2015</year>
<volume>17</volume>
<issue>6</issue>
<fpage>1164</fpage>
<lpage>1172</lpage>
<pub-id pub-id-type="doi">10.1039/C4EM00702F</pub-id>
<pub-id pub-id-type="pmid">25984716</pub-id>
</element-citation>
</ref>
<ref id="CR199">
<label>199.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adams</surname>
<given-names>RI</given-names>
</name>
<name>
<surname>Miletto</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Bruns</surname>
<given-names>TD</given-names>
</name>
</person-group>
<article-title>Dispersal in microbes: fungi in indoor air are dominated by outdoor air and show dispersal limitation at short distances</article-title>
<source/>ISME J
          <year>2013</year>
<volume>7</volume>
<issue>7</issue>
<fpage>1262</fpage>
<lpage>1273</lpage>
<pub-id pub-id-type="doi">10.1038/ismej.2013.28</pub-id>
<pub-id pub-id-type="pmid">23426013</pub-id>
</element-citation>
</ref>
<ref id="CR200">
<label>200.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gusareva</surname>
<given-names>ES</given-names>
</name>
<name>
<surname>Acerbi</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Lau</surname>
<given-names>KJX</given-names>
</name>
<name>
<surname>Luhung</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Premkrishnan</surname>
<given-names>BNV</given-names>
</name>
<name>
<surname>Kolundzija</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Microbial communities in the tropical air ecosystem follow a precise diel cycle</article-title>
<source/>Proc Natl Acad Sci USA
          <year>2019</year>
<volume>116</volume>
<issue>46</issue>
<fpage>23299</fpage>
<lpage>23308</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1908493116</pub-id>
<pub-id pub-id-type="pmid">31659049</pub-id>
</element-citation>
</ref>
<ref id="CR201">
<label>201.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prussin</surname>
<given-names>AJ</given-names>
<suffix>2nd</suffix>
</name>
<name>
<surname>Marr</surname>
<given-names>LC</given-names>
</name>
</person-group>
<article-title>Sources of airborne microorganisms in the built environment</article-title>
<source/>Microbiome
          <year>2015</year>
<volume>3</volume>
<fpage>78</fpage>
<pub-id pub-id-type="doi">10.1186/s40168-015-0144-z</pub-id>
<pub-id pub-id-type="pmid">26694197</pub-id>
</element-citation>
</ref>
<ref id="CR202">
<label>202.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Acerbi</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Chenard</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Gaultier</surname>
<given-names>NE</given-names>
</name>
<name>
<surname>Heinle</surname>
<given-names>CE</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>VW</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Ecological succession of the microbial communities of an air-conditioning cooling coil in the tropics</article-title>
<source/>Indoor Air
          <year>2017</year>
<volume>27</volume>
<issue>2</issue>
<fpage>345</fpage>
<lpage>353</lpage>
<pub-id pub-id-type="doi">10.1111/ina.12306</pub-id>
<pub-id pub-id-type="pmid">27120709</pub-id>
</element-citation>
</ref>
<ref id="CR203">
<label>203.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abarenkov</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Adams</surname>
<given-names>RI</given-names>
</name>
<name>
<surname>Laszlo</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Agan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ambrosio</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Antonelli</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Annotating public fungal ITS sequences from the built environment according to the MIxS-Built Environment standard—a report from a May 23–24, 2016 workshop (Gothenburg, Sweden)</article-title>
<source/>MycoKeys
          <year>2016</year>
<volume>16</volume>
<fpage>1</fpage>
<lpage>15</lpage>
<pub-id pub-id-type="doi">10.3897/mycokeys.16.10000</pub-id>
</element-citation>
</ref>
<ref id="CR204">
<label>204.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Hänninen</surname>
<given-names>OO</given-names>
</name>
</person-group>
<person-group person-group-type="editor">
<name>
<surname>Adan</surname>
<given-names>OCG</given-names>
</name>
<name>
<surname>Samson</surname>
<given-names>RA</given-names>
</name>
</person-group>
<article-title>WHO guidelines for indoor air quality: dampness and mold</article-title>
<source/>Fundamentals of mold growth in indoor environments and strategies for healthy living
          <year>2011</year>
<publisher-loc>Wageningen</publisher-loc>
<publisher-name>Wageningen Academic Publishers</publisher-name>
<fpage>277</fpage>
<lpage>302</lpage>
</element-citation>
</ref>
<ref id="CR205">
<label>205.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nilsson</surname>
<given-names>RH</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>AFS</given-names>
</name>
<name>
<surname>Adams</surname>
<given-names>RI</given-names>
</name>
<name>
<surname>Baschien</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Bengtsson-Palme</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Cangren</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Taxonomic annotation of public fungal ITS sequences from the built environment – a report from an April 10–11, 2017 workshop (Aberdeen, UK)</article-title>
<source/>MycoKeys
          <year>2018</year>
<volume>28</volume>
<fpage>65</fpage>
<lpage>82</lpage>
<pub-id pub-id-type="doi">10.3897/mycokeys.28.20887</pub-id>
</element-citation>
</ref>
<ref id="CR206">
<label>206.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amend</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Seifert</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Samson</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Bruns</surname>
<given-names>TD</given-names>
</name>
</person-group>
<article-title>Indoor fungal composition is geographically patterned and more diverse in temperate zones than in the tropics</article-title>
<source/>Proc Natl Acad Sci
          <year>2010</year>
<volume>107</volume>
<issue>31</issue>
<fpage>13748</fpage>
<lpage>13753</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1000454107</pub-id>
<pub-id pub-id-type="pmid">20616017</pub-id>
</element-citation>
</ref>
<ref id="CR207">
<label>207.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nonnenmann</surname>
<given-names>MW</given-names>
</name>
<name>
<surname>Coronado</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Griffith</surname>
<given-names>WC</given-names>
</name>
<name>
<surname>Hanson</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Vesper</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Utilizing pyrosequencing and quantitative PCR to characterize fungal populations among house dust samples</article-title>
<source/>J Environ Monit JEM
          <year>2012</year>
<volume>14</volume>
<issue>8</issue>
<fpage>2038</fpage>
<lpage>2043</lpage>
<pub-id pub-id-type="doi">10.1039/c2em30229b</pub-id>
<pub-id pub-id-type="pmid">22767010</pub-id>
</element-citation>
</ref>
<ref id="CR208">
<label>208.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Knutsen</surname>
<given-names>AP</given-names>
</name>
<name>
<surname>Bush</surname>
<given-names>RK</given-names>
</name>
<name>
<surname>Demain</surname>
<given-names>JG</given-names>
</name>
<name>
<surname>Denning</surname>
<given-names>DW</given-names>
</name>
<name>
<surname>Dixit</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Fairs</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Fungi and allergic lower respiratory tract diseases</article-title>
<source/>J Allergy Clin Immunol
          <year>2012</year>
<volume>129</volume>
<issue>2</issue>
<fpage>280</fpage>
<lpage>291</lpage>
<pub-id pub-id-type="doi">10.1016/j.jaci.2011.12.970</pub-id>
<pub-id pub-id-type="pmid">22284927</pub-id>
</element-citation>
</ref>
<ref id="CR209">
<label>209.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cooley</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>WC</given-names>
</name>
<name>
<surname>Jumper</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Straus</surname>
<given-names>DC</given-names>
</name>
</person-group>
<article-title>Correlation between the prevalence of certain fungi and sick building syndrome</article-title>
<source/>Occup Environ Med
          <year>1998</year>
<volume>55</volume>
<issue>9</issue>
<fpage>579</fpage>
<lpage>584</lpage>
<pub-id pub-id-type="doi">10.1136/oem.55.9.579</pub-id>
<pub-id pub-id-type="pmid">9861178</pub-id>
</element-citation>
</ref>
<ref id="CR210">
<label>210.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Straus</surname>
<given-names>DC</given-names>
</name>
<name>
<surname>Cooley</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>WC</given-names>
</name>
<name>
<surname>Jumper</surname>
<given-names>CA</given-names>
</name>
</person-group>
<article-title>Studies on the role of fungi in Sick Building Syndrome</article-title>
<source/>Arch Environ Health
          <year>2003</year>
<volume>58</volume>
<issue>8</issue>
<fpage>475</fpage>
<lpage>478</lpage>
<pub-id pub-id-type="doi">10.3200/AEOH.58.8.475-478</pub-id>
<pub-id pub-id-type="pmid">15259426</pub-id>
</element-citation>
</ref>
<ref id="CR211">
<label>211.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bholah</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Subratty</surname>
<given-names>AH</given-names>
</name>
</person-group>
<article-title>Indoor biological contaminants and symptoms of sick building syndrome in office buildings in Mauritius</article-title>
<source/>Int J Environ Health Res
          <year>2002</year>
<volume>12</volume>
<issue>1</issue>
<fpage>93</fpage>
<lpage>98</lpage>
<pub-id pub-id-type="doi">10.1080/09603120120110095</pub-id>
<pub-id pub-id-type="pmid">11970819</pub-id>
</element-citation>
</ref>
<ref id="CR212">
<label>212.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tong</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Leung</surname>
<given-names>MHY</given-names>
</name>
<name>
<surname>Wilkins</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>PKH</given-names>
</name>
</person-group>
<article-title>City-scale distribution and dispersal routes of mycobiome in residences</article-title>
<source/>Microbiome
          <year>2017</year>
<volume>5</volume>
<issue>1</issue>
<fpage>131</fpage>
<pub-id pub-id-type="doi">10.1186/s40168-017-0346-7</pub-id>
<pub-id pub-id-type="pmid">28978345</pub-id>
</element-citation>
</ref>
<ref id="CR213">
<label>213.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adams</surname>
<given-names>RI</given-names>
</name>
<name>
<surname>Miletto</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Bruns</surname>
<given-names>TD</given-names>
</name>
</person-group>
<article-title>The diversity and distribution of fungi on residential surfaces</article-title>
<source/>PLoS ONE
          <year>2013</year>
<volume>8</volume>
<issue>11</issue>
<fpage>e78866</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0078866</pub-id>
<pub-id pub-id-type="pmid">24223861</pub-id>
</element-citation>
</ref>
<ref id="CR214">
<label>214.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Banach</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Szczygłowska</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Pulit</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Bryk</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Building materials with antifungal efficacy enriched with silver nanoparticles</article-title>
<source/>Chem Sci J
          <year>2014</year>
<volume>5</volume>
<fpage>085</fpage>
<pub-id pub-id-type="doi">10.4172/2150-3494.1000085</pub-id>
</element-citation>
</ref>
<ref id="CR215">
<label>215.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vucetic</surname>
<given-names>SB</given-names>
</name>
<name>
<surname>Rudic</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Markov</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Bera</surname>
<given-names>OJ</given-names>
</name>
<name>
<surname>Vidakovic</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Skapin</surname>
<given-names>AS</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Antifungal efficiency assessment of the TiO2 coating on facade paints</article-title>
<source/>Environ Sci Pollut Res Int
          <year>2014</year>
<volume>21</volume>
<issue>19</issue>
<fpage>11228</fpage>
<lpage>11237</lpage>
<pub-id pub-id-type="doi">10.1007/s11356-014-3066-6</pub-id>
<pub-id pub-id-type="pmid">24875311</pub-id>
</element-citation>
</ref>
<ref id="CR216">
<label>216.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adams</surname>
<given-names>RI</given-names>
</name>
<name>
<surname>Bhangar</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Dannemiller</surname>
<given-names>KC</given-names>
</name>
<name>
<surname>Eisen</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Fierer</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Gilbert</surname>
<given-names>JA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Ten questions concerning the microbiomes of buildings</article-title>
<source/>Build Environ
          <year>2016</year>
<volume>109</volume>
<fpage>224</fpage>
<lpage>234</lpage>
<pub-id pub-id-type="doi">10.1016/j.buildenv.2016.09.001</pub-id>
</element-citation>
</ref>
<ref id="CR217">
<label>217.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>van der Velden</surname>
<given-names>WJ</given-names>
</name>
<name>
<surname>Netea</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>de Haan</surname>
<given-names>AF</given-names>
</name>
<name>
<surname>Huls</surname>
<given-names>GA</given-names>
</name>
<name>
<surname>Donnelly</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Blijlevens</surname>
<given-names>NM</given-names>
</name>
</person-group>
<article-title>Role of the mycobiome in human acute graft-versus-host disease</article-title>
<source/>Biol Blood Marrow Transpl
          <year>2013</year>
<volume>19</volume>
<issue>2</issue>
<fpage>329</fpage>
<lpage>332</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbmt.2012.11.008</pub-id>
</element-citation>
</ref>
<ref id="CR218">
<label>218.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iliev</surname>
<given-names>ID</given-names>
</name>
<name>
<surname>Funari</surname>
<given-names>VA</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>KD</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Reyes</surname>
<given-names>CN</given-names>
</name>
<name>
<surname>Strom</surname>
<given-names>SP</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Interactions between commensal fungi and the C-type lectin receptor Dectin-1 influence colitis</article-title>
<source/>Science (New York, NY)
          <year>2012</year>
<volume>336</volume>
<issue>6086</issue>
<fpage>1314</fpage>
<lpage>1317</lpage>
<pub-id pub-id-type="doi">10.1126/science.1221789</pub-id>
</element-citation>
</ref>
<ref id="CR219">
<label>219.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lai</surname>
<given-names>GC</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>TG</given-names>
</name>
<name>
<surname>Pavelka</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>The mammalian mycobiome: a complex system in a dynamic relationship with the host</article-title>
<source/>Wiley Interdiscip Rev Syst Biol Med
          <year>2019</year>
<volume>11</volume>
<issue>1</issue>
<fpage>e1438</fpage>
<pub-id pub-id-type="doi">10.1002/wsbm.1438</pub-id>
<pub-id pub-id-type="pmid">30255552</pub-id>
</element-citation>
</ref>
<ref id="CR220">
<label>220.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>van Nimwegen</surname>
<given-names>FA</given-names>
</name>
<name>
<surname>Penders</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Stobberingh</surname>
<given-names>EE</given-names>
</name>
<name>
<surname>Postma</surname>
<given-names>DS</given-names>
</name>
<name>
<surname>Koppelman</surname>
<given-names>GH</given-names>
</name>
<name>
<surname>Kerkhof</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mode and place of delivery, gastrointestinal microbiota, and their influence on asthma and atopy</article-title>
<source/>J Allergy Clin Immunol.
          <year>2011</year>
<volume>128</volume>
<issue>5</issue>
<fpage>948</fpage>
<lpage>955</lpage>
<pub-id pub-id-type="doi">10.1016/j.jaci.2011.07.027</pub-id>
<pub-id pub-id-type="pmid">21872915</pub-id>
</element-citation>
</ref>
<ref id="CR221">
<label>221.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bjorksten</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Sepp</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Julge</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Voor</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Mikelsaar</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Allergy development and the intestinal microflora during the first year of life</article-title>
<source/>J Allergy Clin Immunol
          <year>2001</year>
<volume>108</volume>
<issue>4</issue>
<fpage>516</fpage>
<lpage>520</lpage>
<pub-id pub-id-type="doi">10.1067/mai.2001.118130</pub-id>
<pub-id pub-id-type="pmid">11590374</pub-id>
</element-citation>
</ref>
<ref id="CR222">
<label>222.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frati</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Salvatori</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Incorvaia</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Bellucci</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Di Cara</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Marcucci</surname>
<given-names>F</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The role of the microbiome in asthma: the gut(–)lung axis</article-title>
<source/>Int J Mol Sci
          <year>2018</year>
<volume>20</volume>
<issue>1</issue>
<fpage>123</fpage>
<pub-id pub-id-type="doi">10.3390/ijms20010123</pub-id>
<pub-id pub-id-type="pmid">6337651</pub-id>
</element-citation>
</ref>
<ref id="CR223">
<label>223.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iovene</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Bombace</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Maresca</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Sapone</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Iardino</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Picardi</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Intestinal dysbiosis and yeast isolation in stool of subjects with autism spectrum disorders</article-title>
<source/>Mycopathologia
          <year>2017</year>
<volume>182</volume>
<issue>3–4</issue>
<fpage>349</fpage>
<lpage>363</lpage>
<pub-id pub-id-type="doi">10.1007/s11046-016-0068-6</pub-id>
<pub-id pub-id-type="pmid">27655151</pub-id>
</element-citation>
</ref>
<ref id="CR224">
<label>224.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sampson</surname>
<given-names>TR</given-names>
</name>
<name>
<surname>Debelius</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Thron</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Janssen</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Shastri</surname>
<given-names>GG</given-names>
</name>
<name>
<surname>Ilhan</surname>
<given-names>ZE</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson’s disease</article-title>
<source/>Cell
          <year>2016</year>
<volume>167</volume>
<issue>6</issue>
<fpage>1469</fpage>
<lpage>1480</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2016.11.018</pub-id>
<pub-id pub-id-type="pmid">27912057</pub-id>
</element-citation>
</ref>
<ref id="CR225">
<label>225.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Queiroz-Telles</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Fahal</surname>
<given-names>AH</given-names>
</name>
<name>
<surname>Falci</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Caceres</surname>
<given-names>DH</given-names>
</name>
<name>
<surname>Chiller</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Pasqualotto</surname>
<given-names>AC</given-names>
</name>
</person-group>
<article-title>Neglected endemic mycoses</article-title>
<source/>Lancet Infect Dis
          <year>2017</year>
<volume>17</volume>
<issue>11</issue>
<fpage>e367</fpage>
<lpage>e377</lpage>
<pub-id pub-id-type="doi">10.1016/S1473-3099(17)30306-7</pub-id>
<pub-id pub-id-type="pmid">28774696</pub-id>
</element-citation>
</ref>
<ref id="CR226">
<label>226.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cornely</surname>
<given-names>OA</given-names>
</name>
<name>
<surname>Arikan-Akdagli</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Dannaoui</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Groll</surname>
<given-names>AH</given-names>
</name>
<name>
<surname>Lagrou</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Chakrabarti</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013</article-title>
<source/>Clin Microbiol Infect
          <year>2014</year>
<volume>20</volume>
<issue>Suppl 3</issue>
<fpage>5</fpage>
<lpage>26</lpage>
<pub-id pub-id-type="doi">10.1111/1469-0691.12371</pub-id>
<pub-id pub-id-type="pmid">24479848</pub-id>
</element-citation>
</ref>
<ref id="CR227">
<label>227.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shikanai-Yasuda</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Mendes</surname>
<given-names>RP</given-names>
</name>
<name>
<surname>Colombo</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Queiroz-Telles</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Kono</surname>
<given-names>ASG</given-names>
</name>
<name>
<surname>Paniago</surname>
<given-names>AMM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Brazilian guidelines for the clinical management of paracoccidioidomycosis</article-title>
<source/>Rev Soc Bras Med Trop
          <year>2017</year>
<volume>50</volume>
<issue>5</issue>
<fpage>715</fpage>
<lpage>740</lpage>
<pub-id pub-id-type="doi">10.1590/0037-8682-0230-2017</pub-id>
<pub-id pub-id-type="pmid">28746570</pub-id>
</element-citation>
</ref>
<ref id="CR228">
<label>228.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brown</surname>
<given-names>GD</given-names>
</name>
<name>
<surname>Denning</surname>
<given-names>DW</given-names>
</name>
<name>
<surname>Gow</surname>
<given-names>NA</given-names>
</name>
<name>
<surname>Levitz</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Netea</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>White</surname>
<given-names>TC</given-names>
</name>
</person-group>
<article-title>Hidden killers: human fungal infections</article-title>
<source/>Sci Transl Med
          <year>2012</year>
<volume>4</volume>
<issue>165</issue>
<fpage>165rv13</fpage>
<pub-id pub-id-type="doi">10.1126/scitranslmed.3004404</pub-id>
<pub-id pub-id-type="pmid">23253612</pub-id>
</element-citation>
</ref>
<ref id="CR229">
<label>229.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kousha</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tadi</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Soubani</surname>
<given-names>AO</given-names>
</name>
</person-group>
<article-title>Pulmonary aspergillosis: a clinical review</article-title>
<source/>Eur Respir Rev
          <year>2011</year>
<volume>20</volume>
<issue>121</issue>
<fpage>156</fpage>
<lpage>174</lpage>
<pub-id pub-id-type="doi">10.1183/09059180.00001011</pub-id>
<pub-id pub-id-type="pmid">21881144</pub-id>
</element-citation>
</ref>
<ref id="CR230">
<label>230.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Patterson</surname>
<given-names>TF</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>GR</given-names>
<suffix>3rd</suffix>
</name>
<name>
<surname>Denning</surname>
<given-names>DW</given-names>
</name>
<name>
<surname>Fishman</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Hadley</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Herbrecht</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America</article-title>
<source/>Clin Infect Dis
          <year>2016</year>
<volume>63</volume>
<issue>4</issue>
<fpage>e1</fpage>
<lpage>e60</lpage>
<pub-id pub-id-type="doi">10.1093/cid/ciw326</pub-id>
<pub-id pub-id-type="pmid">27365388</pub-id>
</element-citation>
</ref>
<ref id="CR231">
<label>231.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perfect</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Cornely</surname>
<given-names>OA</given-names>
</name>
<name>
<surname>Heep</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ostrosky-Zeichner</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Mullane</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Maher</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Isavuconazole treatment for rare fungal diseases and for invasive aspergillosis in patients with renal impairment: challenges and lessons of the VITAL trial</article-title>
<source/>Mycoses
          <year>2018</year>
<volume>61</volume>
<issue>7</issue>
<fpage>420</fpage>
<lpage>429</lpage>
<pub-id pub-id-type="doi">10.1111/myc.12769</pub-id>
<pub-id pub-id-type="pmid">29570857</pub-id>
</element-citation>
</ref>
<ref id="CR232">
<label>232.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Panackal</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Williamson</surname>
<given-names>PR</given-names>
</name>
</person-group>
<article-title>Fungal infections of the central nervous system</article-title>
<source/>Continuum (Minneap Minn)
          <year>2015</year>
<volume>21</volume>
<issue>6 Neuroinfectious Disease</issue>
<fpage>1662</fpage>
<lpage>1678</lpage>
<pub-id pub-id-type="pmid">26633781</pub-id>
</element-citation>
</ref>
<ref id="CR233">
<label>233.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kazan</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Maertens</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Herbrecht</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Weisser</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gachot</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Vekhoff</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A retrospective series of gut aspergillosis in haematology patients</article-title>
<source/>Clin Microbiol Infect
          <year>2011</year>
<volume>17</volume>
<issue>4</issue>
<fpage>588</fpage>
<lpage>594</lpage>
<pub-id pub-id-type="doi">10.1111/j.1469-0691.2010.03310.x</pub-id>
<pub-id pub-id-type="pmid">20636423</pub-id>
</element-citation>
</ref>
<ref id="CR234">
<label>234.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>van Burik</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Colven</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Spach</surname>
<given-names>DH</given-names>
</name>
</person-group>
<article-title>Cutaneous aspergillosis</article-title>
<source/>J Clin Microbiol
          <year>1998</year>
<volume>36</volume>
<issue>11</issue>
<fpage>3115</fpage>
<lpage>3121</lpage>
<pub-id pub-id-type="doi">10.1128/JCM.36.11.3115-3121.1998</pub-id>
<pub-id pub-id-type="pmid">9774549</pub-id>
</element-citation>
</ref>
<ref id="CR235">
<label>235.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cleveland</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Farley</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Harrison</surname>
<given-names>LH</given-names>
</name>
<name>
<surname>Stein</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Hollick</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Lockhart</surname>
<given-names>SR</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Changes in incidence and antifungal drug resistance in candidemia: results from population-based laboratory surveillance in Atlanta and Baltimore, 2008–2011</article-title>
<source/>Clin Infect Dis
          <year>2012</year>
<volume>55</volume>
<issue>10</issue>
<fpage>1352</fpage>
<lpage>1361</lpage>
<pub-id pub-id-type="doi">10.1093/cid/cis697</pub-id>
<pub-id pub-id-type="pmid">22893576</pub-id>
</element-citation>
</ref>
<ref id="CR236">
<label>236.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morgan</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Meltzer</surname>
<given-names>MI</given-names>
</name>
<name>
<surname>Plikaytis</surname>
<given-names>BD</given-names>
</name>
<name>
<surname>Sofair</surname>
<given-names>AN</given-names>
</name>
<name>
<surname>Huie-White</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Wilcox</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Excess mortality, hospital stay, and cost due to candidemia: a case-control study using data from population-based candidemia surveillance</article-title>
<source/>Infect Control Hosp Epidemiol
          <year>2005</year>
<volume>26</volume>
<issue>6</issue>
<fpage>540</fpage>
<lpage>547</lpage>
<pub-id pub-id-type="doi">10.1086/502581</pub-id>
<pub-id pub-id-type="pmid">16018429</pub-id>
</element-citation>
</ref>
<ref id="CR237">
<label>237.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Colombo</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>de Almeida Junior</surname>
<given-names>JN</given-names>
</name>
<name>
<surname>Slavin</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Sorrell</surname>
<given-names>TC</given-names>
</name>
</person-group>
<article-title>Candida and invasive mould diseases in non-neutropenic critically ill patients and patients with haematological cancer</article-title>
<source/>Lancet Infect Dis
          <year>2017</year>
<volume>17</volume>
<issue>11</issue>
<fpage>e344</fpage>
<lpage>e356</lpage>
<pub-id pub-id-type="doi">10.1016/S1473-3099(17)30304-3</pub-id>
<pub-id pub-id-type="pmid">28774702</pub-id>
</element-citation>
</ref>
<ref id="CR238">
<label>238.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oude Lashof</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Rothova</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sobel</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Ruhnke</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Pappas</surname>
<given-names>PG</given-names>
</name>
<name>
<surname>Viscoli</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Ocular manifestations of candidemia</article-title>
<source/>Clin Infect Dis
          <year>2011</year>
<volume>53</volume>
<issue>3</issue>
<fpage>262</fpage>
<lpage>268</lpage>
<pub-id pub-id-type="doi">10.1093/cid/cir355</pub-id>
<pub-id pub-id-type="pmid">21765074</pub-id>
</element-citation>
</ref>
<ref id="CR239">
<label>239.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Mody</surname>
<given-names>CH</given-names>
</name>
</person-group>
<article-title>Cryptococcus</article-title>
<source/>Proc Am Thorac Soc
          <year>2010</year>
<volume>7</volume>
<issue>3</issue>
<fpage>186</fpage>
<lpage>196</lpage>
<pub-id pub-id-type="doi">10.1513/pats.200907-063AL</pub-id>
<pub-id pub-id-type="pmid">20463247</pub-id>
</element-citation>
</ref>
<ref id="CR240">
<label>240.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perfect</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Dismukes</surname>
<given-names>WE</given-names>
</name>
<name>
<surname>Dromer</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Goldman</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Graybill</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Hamill</surname>
<given-names>RJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america</article-title>
<source/>Clin Infect Dis
          <year>2010</year>
<volume>50</volume>
<issue>3</issue>
<fpage>291</fpage>
<lpage>322</lpage>
<pub-id pub-id-type="doi">10.1086/649858</pub-id>
<pub-id pub-id-type="pmid">20047480</pub-id>
</element-citation>
</ref>
<ref id="CR241">
<label>241.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roden</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Zaoutis</surname>
<given-names>TE</given-names>
</name>
<name>
<surname>Buchanan</surname>
<given-names>WL</given-names>
</name>
<name>
<surname>Knudsen</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>Sarkisova</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>Schaufele</surname>
<given-names>RL</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Epidemiology and outcome of zygomycosis: a review of 929 reported cases</article-title>
<source/>Clin Infect Dis
          <year>2005</year>
<volume>41</volume>
<issue>5</issue>
<fpage>634</fpage>
<lpage>653</lpage>
<pub-id pub-id-type="doi">10.1086/432579</pub-id>
<pub-id pub-id-type="pmid">16080086</pub-id>
</element-citation>
</ref>
<ref id="CR242">
<label>242.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pak</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Tucci</surname>
<given-names>VT</given-names>
</name>
<name>
<surname>Vincent</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Sandin</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Greene</surname>
<given-names>JN</given-names>
</name>
</person-group>
<article-title>Mucormycosis in immunochallenged patients</article-title>
<source/>J Emerg Trauma Shock
          <year>2008</year>
<volume>1</volume>
<issue>2</issue>
<fpage>106</fpage>
<lpage>113</lpage>
<pub-id pub-id-type="doi">10.4103/0974-2700.42203</pub-id>
<pub-id pub-id-type="pmid">19561989</pub-id>
</element-citation>
</ref>
<ref id="CR243">
<label>243.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>XM</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>LC</given-names>
</name>
<name>
<surname>Xue</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>YB</given-names>
</name>
</person-group>
<article-title>Pulmonary mucormycosis: a case report and review of the literature</article-title>
<source/>Oncol Lett
          <year>2016</year>
<volume>11</volume>
<issue>5</issue>
<fpage>3049</fpage>
<lpage>3053</lpage>
<pub-id pub-id-type="doi">10.3892/ol.2016.4370</pub-id>
<pub-id pub-id-type="pmid">27123061</pub-id>
</element-citation>
</ref>
<ref id="CR244">
<label>244.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Castrejon-Perez</surname>
<given-names>AD</given-names>
</name>
<name>
<surname>Welsh</surname>
<given-names>EC</given-names>
</name>
<name>
<surname>Miranda</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Ocampo-Candiani</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Welsh</surname>
<given-names>O</given-names>
</name>
</person-group>
<article-title>Cutaneous mucormycosis</article-title>
<source/>An Bras Dermatol
          <year>2017</year>
<volume>92</volume>
<issue>3</issue>
<fpage>304</fpage>
<lpage>311</lpage>
<pub-id pub-id-type="doi">10.1590/abd1806-4841.20176614</pub-id>
<pub-id pub-id-type="pmid">29186239</pub-id>
</element-citation>
</ref>
<ref id="CR245">
<label>245.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dioverti</surname>
<given-names>MV</given-names>
</name>
<name>
<surname>Cawcutt</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Abidi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sohail</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Osmon</surname>
<given-names>DR</given-names>
</name>
</person-group>
<article-title>Gastrointestinal mucormycosis in immunocompromised hosts</article-title>
<source/>Mycoses
          <year>2015</year>
<volume>58</volume>
<issue>12</issue>
<fpage>714</fpage>
<lpage>718</lpage>
<pub-id pub-id-type="doi">10.1111/myc.12419</pub-id>
<pub-id pub-id-type="pmid">26456920</pub-id>
</element-citation>
</ref>
<ref id="CR246">
<label>246.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maschmeyer</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Helweg-Larsen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Pagano</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Robin</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Cordonnier</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Schellongowski</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>ECIL guidelines for treatment of <italic>Pneumocystis jirovecii</italic> pneumonia in non-HIV-infected haematology patients</article-title>
<source/>J Antimicrob Chemother
          <year>2016</year>
<volume>71</volume>
<issue>9</issue>
<fpage>2405</fpage>
<lpage>2413</lpage>
<pub-id pub-id-type="doi">10.1093/jac/dkw158</pub-id>
<pub-id pub-id-type="pmid">27550993</pub-id>
</element-citation>
</ref>
<ref id="CR247">
<label>247.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ng</surname>
<given-names>VL</given-names>
</name>
<name>
<surname>Yajko</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Hadley</surname>
<given-names>WK</given-names>
</name>
</person-group>
<article-title>Extrapulmonary pneumocystosis</article-title>
<source/>Clin Microbiol Rev
          <year>1997</year>
<volume>10</volume>
<issue>3</issue>
<fpage>401</fpage>
<lpage>418</lpage>
<pub-id pub-id-type="doi">10.1128/CMR.10.3.401</pub-id>
<pub-id pub-id-type="pmid">9227859</pub-id>
</element-citation>
</ref>
<ref id="CR248">
<label>248.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kinchen</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kinchen</surname>
<given-names>TH</given-names>
</name>
<name>
<surname>Inglesby</surname>
<given-names>T</given-names>
<suffix>Jr</suffix>
</name>
</person-group>
<article-title>Pneumocystis carinii infection of the small intestine</article-title>
<source/>J Natl Med Assoc
          <year>1998</year>
<volume>90</volume>
<issue>10</issue>
<fpage>625</fpage>
<lpage>627</lpage>
<pub-id pub-id-type="pmid">9803728</pub-id>
</element-citation>
</ref>
<ref id="CR249">
<label>249.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khuu</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Shafir</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bristow</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Sorvillo</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Blastomycosis mortality rates, United States, 1990–2010</article-title>
<source/>Emerg Infect Dis
          <year>2014</year>
<volume>20</volume>
<issue>11</issue>
<fpage>1789</fpage>
<lpage>1794</lpage>
<pub-id pub-id-type="doi">10.3201/eid2011.131175</pub-id>
<pub-id pub-id-type="pmid">25339251</pub-id>
</element-citation>
</ref>
<ref id="CR250">
<label>250.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McBride</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Gauthier</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Klein</surname>
<given-names>BS</given-names>
</name>
</person-group>
<article-title>Clinical manifestations and treatment of blastomycosis</article-title>
<source/>Clin Chest Med
          <year>2017</year>
<volume>38</volume>
<issue>3</issue>
<fpage>435</fpage>
<lpage>449</lpage>
<pub-id pub-id-type="doi">10.1016/j.ccm.2017.04.006</pub-id>
<pub-id pub-id-type="pmid">28797487</pub-id>
</element-citation>
</ref>
<ref id="CR251">
<label>251.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chapman</surname>
<given-names>SW</given-names>
</name>
<name>
<surname>Dismukes</surname>
<given-names>WE</given-names>
</name>
<name>
<surname>Proia</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Bradsher</surname>
<given-names>RW</given-names>
</name>
<name>
<surname>Pappas</surname>
<given-names>PG</given-names>
</name>
<name>
<surname>Threlkeld</surname>
<given-names>MG</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Clinical practice guidelines for the management of blastomycosis: 2008 update by the Infectious Diseases Society of America</article-title>
<source/>Clin Infect Dis
          <year>2008</year>
<volume>46</volume>
<issue>12</issue>
<fpage>1801</fpage>
<lpage>1812</lpage>
<pub-id pub-id-type="doi">10.1086/588300</pub-id>
<pub-id pub-id-type="pmid">18462107</pub-id>
</element-citation>
</ref>
<ref id="CR252">
<label>252.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chu</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Feudtner</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Heydon</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Walsh</surname>
<given-names>TJ</given-names>
</name>
<name>
<surname>Zaoutis</surname>
<given-names>TE</given-names>
</name>
</person-group>
<article-title>Hospitalizations for endemic mycoses: a population-based national study</article-title>
<source/>Clin Infect Dis
          <year>2006</year>
<volume>42</volume>
<issue>6</issue>
<fpage>822</fpage>
<lpage>825</lpage>
<pub-id pub-id-type="doi">10.1086/500405</pub-id>
<pub-id pub-id-type="pmid">16477560</pub-id>
</element-citation>
</ref>
<ref id="CR253">
<label>253.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Azar</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Hage</surname>
<given-names>CA</given-names>
</name>
</person-group>
<article-title>Clinical perspectives in the diagnosis and management of histoplasmosis</article-title>
<source/>Clin Chest Med
          <year>2017</year>
<volume>38</volume>
<issue>3</issue>
<fpage>403</fpage>
<lpage>415</lpage>
<pub-id pub-id-type="doi">10.1016/j.ccm.2017.04.004</pub-id>
<pub-id pub-id-type="pmid">28797485</pub-id>
</element-citation>
</ref>
<ref id="CR254">
<label>254.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wheat</surname>
<given-names>LJ</given-names>
</name>
<name>
<surname>Azar</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Bahr</surname>
<given-names>NC</given-names>
</name>
<name>
<surname>Spec</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Relich</surname>
<given-names>RF</given-names>
</name>
<name>
<surname>Hage</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Histoplasmosis</article-title>
<source/>Infect Dis Clin North Am
          <year>2016</year>
<volume>30</volume>
<issue>1</issue>
<fpage>207</fpage>
<lpage>227</lpage>
<pub-id pub-id-type="doi">10.1016/j.idc.2015.10.009</pub-id>
<pub-id pub-id-type="pmid">26897068</pub-id>
</element-citation>
</ref>
<ref id="CR255">
<label>255.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wheat</surname>
<given-names>LJ</given-names>
</name>
<name>
<surname>Freifeld</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>Kleiman</surname>
<given-names>MB</given-names>
</name>
<name>
<surname>Baddley</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>McKinsey</surname>
<given-names>DS</given-names>
</name>
<name>
<surname>Loyd</surname>
<given-names>JE</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America</article-title>
<source/>Clin Infect Dis
          <year>2007</year>
<volume>45</volume>
<issue>7</issue>
<fpage>807</fpage>
<lpage>825</lpage>
<pub-id pub-id-type="doi">10.1086/521259</pub-id>
<pub-id pub-id-type="pmid">17806045</pub-id>
</element-citation>
</ref>
<ref id="CR256">
<label>256.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Parish</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Blair</surname>
<given-names>JE</given-names>
</name>
</person-group>
<article-title>Coccidioidomycosis</article-title>
<source/>Mayo Clin Proc.
          <year>2008</year>
<volume>83</volume>
<issue>3</issue>
<fpage>343</fpage>
<lpage>348</lpage>
<pub-id pub-id-type="doi">10.4065/83.3.343</pub-id>
<pub-id pub-id-type="pmid">18316002</pub-id>
</element-citation>
</ref>
<ref id="CR257">
<label>257.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Galgiani</surname>
<given-names>JN</given-names>
</name>
<name>
<surname>Ampel</surname>
<given-names>NM</given-names>
</name>
<name>
<surname>Blair</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Catanzaro</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Geertsma</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Hoover</surname>
<given-names>SE</given-names>
</name>
<etal></etal>
</person-group>
<article-title>2016 Infectious Diseases Society of America (IDSA) clinical practice guideline for the treatment of coccidioidomycosis</article-title>
<source/>Clin Infect Dis
          <year>2016</year>
<volume>63</volume>
<issue>6</issue>
<fpage>e112</fpage>
<lpage>e146</lpage>
<pub-id pub-id-type="doi">10.1093/cid/ciw360</pub-id>
<pub-id pub-id-type="pmid">27470238</pub-id>
</element-citation>
</ref>
<ref id="CR258">
<label>258.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garcia Garcia</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Salas Alanis</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Flores</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Gonzalez Gonzalez</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Vera Cabrera</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Ocampo</surname>
<given-names>Candiani J</given-names>
</name>
</person-group>
<article-title>Coccidioidomycosis and the skin: a comprehensive review</article-title>
<source/>An Bras Dermatol
          <year>2015</year>
<volume>90</volume>
<issue>5</issue>
<fpage>610</fpage>
<lpage>619</lpage>
<pub-id pub-id-type="doi">10.1590/abd1806-4841.20153805</pub-id>
<pub-id pub-id-type="pmid">26560205</pub-id>
</element-citation>
</ref>
<ref id="CR259">
<label>259.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bisla</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Taber</surname>
<given-names>TH</given-names>
<suffix>Jr</suffix>
</name>
</person-group>
<article-title>Coccidioidomycosis of bone and joints</article-title>
<source/>Clin Orthop Relat Res
          <year>1976</year>
<volume>121</volume>
<fpage>196</fpage>
<lpage>204</lpage>
</element-citation>
</ref>
<ref id="CR260">
<label>260.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McConnell</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lasco</surname>
<given-names>TM</given-names>
</name>
<name>
<surname>Yoon</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Disseminated coccidioidomycosis with multifocal musculoskeletal disease involvement</article-title>
<source/>Radiol Case Rep.
          <year>2017</year>
<volume>12</volume>
<issue>1</issue>
<fpage>141</fpage>
<lpage>145</lpage>
<pub-id pub-id-type="doi">10.1016/j.radcr.2016.11.017</pub-id>
<pub-id pub-id-type="pmid">28228898</pub-id>
</element-citation>
</ref>
<ref id="CR261">
<label>261.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martinez</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>New trends in paracoccidioidomycosis epidemiology</article-title>
<source/>J Fungi (Basel).
          <year>2017</year>
<volume>3</volume>
<issue>1</issue>
<fpage>1</fpage>
<pub-id pub-id-type="doi">10.3390/jof3010001</pub-id>
</element-citation>
</ref>
<ref id="CR262">
<label>262.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Queiroz-Telles</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Escuissato</surname>
<given-names>DL</given-names>
</name>
</person-group>
<article-title>Pulmonary paracoccidioidomycosis</article-title>
<source/>Semin Respir Crit Care Med
          <year>2011</year>
<volume>32</volume>
<issue>6</issue>
<fpage>764</fpage>
<lpage>774</lpage>
<pub-id pub-id-type="doi">10.1055/s-0031-1295724</pub-id>
<pub-id pub-id-type="pmid">22167404</pub-id>
</element-citation>
</ref>
<ref id="CR263">
<label>263.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Denning</surname>
<given-names>DW</given-names>
</name>
<name>
<surname>Chakrabarti</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Pulmonary and sinus fungal diseases in non-immunocompromised patients</article-title>
<source/>Lancet Infect Dis
          <year>2017</year>
<volume>17</volume>
<issue>11</issue>
<fpage>e357</fpage>
<lpage>e366</lpage>
<pub-id pub-id-type="doi">10.1016/S1473-3099(17)30309-2</pub-id>
<pub-id pub-id-type="pmid">28774699</pub-id>
</element-citation>
</ref>
<ref id="CR264">
<label>264.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wong</surname>
<given-names>SY</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>KF</given-names>
</name>
</person-group>
<article-title><italic>Penicillium marneffei</italic> infection in AIDS</article-title>
<source/>Patholog Res Int
          <year>2011</year>
<volume>2011</volume>
<fpage>764293</fpage>
<pub-id pub-id-type="pmid">21331327</pub-id>
</element-citation>
</ref>
<ref id="CR265">
<label>265.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sirisanthana</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Supparatpinyo</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Perriens</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Nelson</surname>
<given-names>KE</given-names>
</name>
</person-group>
<article-title>Amphotericin B and itraconazole for treatment of disseminated <italic>Penicillium marneffei</italic> infection in human immunodeficiency virus-infected patients</article-title>
<source/>Clin Infect Dis
          <year>1998</year>
<volume>26</volume>
<issue>5</issue>
<fpage>1107</fpage>
<lpage>1110</lpage>
<pub-id pub-id-type="doi">10.1086/520280</pub-id>
<pub-id pub-id-type="pmid">9597237</pub-id>
</element-citation>
</ref>
<ref id="CR266">
<label>266.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Supparatpinyo</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Schlamm</surname>
<given-names>HT</given-names>
</name>
</person-group>
<article-title>Voriconazole as therapy for systemic <italic>Penicillium marneffei</italic> infections in AIDS patients</article-title>
<source/>Am J Trop Med Hyg
          <year>2007</year>
<volume>77</volume>
<issue>2</issue>
<fpage>350</fpage>
<lpage>353</lpage>
<pub-id pub-id-type="doi">10.4269/ajtmh.2007.77.350</pub-id>
<pub-id pub-id-type="pmid">17690411</pub-id>
</element-citation>
</ref>
<ref id="CR267">
<label>267.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hung</surname>
<given-names>HG</given-names>
</name>
<name>
<surname>Lok</surname>
<given-names>KH</given-names>
</name>
</person-group>
<article-title>Intestinal <italic>Penicillium marneffei</italic>: an unusual cause of chronic diarrhea in an AIDS patient</article-title>
<source/>J Digest Dis
          <year>2010</year>
<volume>11</volume>
<issue>3</issue>
<fpage>189</fpage>
<lpage>191</lpage>
<pub-id pub-id-type="doi">10.1111/j.1751-2980.2010.00435.x</pub-id>
</element-citation>
</ref>
<ref id="CR268">
<label>268.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ko</surname>
<given-names>CI</given-names>
</name>
<name>
<surname>Hung</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>MY</given-names>
</name>
<name>
<surname>Hsueh</surname>
<given-names>PR</given-names>
</name>
<name>
<surname>Hsiao</surname>
<given-names>CH</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>JM</given-names>
</name>
</person-group>
<article-title>Endoscopic diagnosis of intestinal <italic>Penicilliosis Marneffei</italic>: report of three cases and review of the literature</article-title>
<source/>Gastrointest Endosc
          <year>1999</year>
<volume>50</volume>
<issue>1</issue>
<fpage>111</fpage>
<lpage>114</lpage>
<pub-id pub-id-type="doi">10.1016/S0016-5107(99)70359-7</pub-id>
<pub-id pub-id-type="pmid">10385737</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>